PARADIGM pathway analysis of mRNASeq expression and copy number data
Lung Squamous Cell Carcinoma (Primary solid tumor)
28 January 2016  |  analyses__2016_01_28
Maintainer Information
Citation Information
Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)
Cite as Broad Institute TCGA Genome Data Analysis Center (2016): PARADIGM pathway analysis of mRNASeq expression and copy number data. Broad Institute of MIT and Harvard. doi:10.7908/C1RB7413
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 28 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
Angiopoietin receptor Tie2-mediated signaling 159
Signaling events mediated by the Hedgehog family 137
Endothelins 96
Fc-epsilon receptor I signaling in mast cells 66
Thromboxane A2 receptor signaling 61
amb2 Integrin signaling 57
IL4-mediated signaling events 56
Signaling mediated by p38-alpha and p38-beta 56
TCGA08_retinoblastoma 56
Aurora B signaling 55
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 501 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 501 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
Angiopoietin receptor Tie2-mediated signaling 0.3174 159 14075 88 -0.68 0.075 1000 -1000 -0.062 -1000
Signaling events mediated by the Hedgehog family 0.2735 137 7159 52 -0.41 0.21 1000 -1000 -0.036 -1000
Endothelins 0.1916 96 9262 96 -0.37 0.1 1000 -1000 -0.054 -1000
Fc-epsilon receptor I signaling in mast cells 0.1317 66 6427 97 -0.14 0.023 1000 -1000 -0.064 -1000
Thromboxane A2 receptor signaling 0.1218 61 6490 105 -0.21 0.057 1000 -1000 -0.051 -1000
amb2 Integrin signaling 0.1138 57 4708 82 -0.48 0.035 1000 -1000 -0.039 -1000
IL4-mediated signaling events 0.1118 56 5122 91 -0.81 0.5 1000 -1000 -0.16 -1000
Signaling mediated by p38-alpha and p38-beta 0.1118 56 2502 44 -0.1 0.022 1000 -1000 -0.034 -1000
TCGA08_retinoblastoma 0.1118 56 454 8 -0.009 0.092 1000 -1000 -0.002 -1000
Aurora B signaling 0.1098 55 3689 67 -0.3 0.28 1000 -1000 -0.05 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.1038 52 2754 52 -0.25 0.048 1000 -1000 -0.048 -1000
Aurora C signaling 0.1018 51 361 7 -0.004 0.15 1000 -1000 -0.013 -1000
Signaling events regulated by Ret tyrosine kinase 0.0878 44 3683 82 -0.11 0.054 1000 -1000 -0.059 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.0778 39 3064 78 -0.16 0.051 1000 -1000 -0.053 -1000
Nongenotropic Androgen signaling 0.0758 38 1978 52 -0.12 0.076 1000 -1000 -0.038 -1000
BMP receptor signaling 0.0739 37 3070 81 -0.26 0.15 1000 -1000 -0.049 -1000
Integrins in angiogenesis 0.0719 36 3090 84 -0.31 0.12 1000 -1000 -0.043 -1000
Calcium signaling in the CD4+ TCR pathway 0.0719 36 1121 31 -0.16 0.024 1000 -1000 -0.04 -1000
Arf6 signaling events 0.0679 34 2115 62 -0.13 0.043 1000 -1000 -0.035 -1000
PLK1 signaling events 0.0659 33 2811 85 -0.026 0.16 1000 -1000 -0.031 -1000
Canonical Wnt signaling pathway 0.0619 31 1615 51 -0.32 0.15 1000 -1000 -0.051 -1000
IL6-mediated signaling events 0.0599 30 2295 75 -0.46 0.048 1000 -1000 -0.058 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.0579 29 2023 68 -0.17 0.039 1000 -1000 -0.079 -1000
Coregulation of Androgen receptor activity 0.0559 28 2178 76 -0.32 0.091 1000 -1000 -0.029 -1000
Reelin signaling pathway 0.0559 28 1592 56 -0.065 0.059 1000 -1000 -0.047 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0539 27 3401 125 -0.12 0.05 1000 -1000 -0.058 -1000
Presenilin action in Notch and Wnt signaling 0.0519 26 1646 61 -0.32 0.15 1000 -1000 -0.057 -1000
Glypican 2 network 0.0519 26 106 4 0.027 0.056 1000 -1000 0.012 -1000
Visual signal transduction: Cones 0.0499 25 987 38 -0.036 0.12 1000 -1000 -0.028 -1000
LPA4-mediated signaling events 0.0479 24 292 12 -0.093 0 1000 -1000 -0.026 -1000
HIF-1-alpha transcription factor network 0.0479 24 1860 76 -0.12 0.12 1000 -1000 -0.11 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0479 24 2076 85 -0.11 0.031 1000 -1000 -0.049 -1000
IL12-mediated signaling events 0.0459 23 2031 87 -0.16 0.044 1000 -1000 -0.084 -1000
TCR signaling in naïve CD8+ T cells 0.0459 23 2211 93 -0.061 0.032 1000 -1000 -0.047 -1000
IL23-mediated signaling events 0.0459 23 1393 60 -0.2 0.025 1000 -1000 -0.13 -1000
Plasma membrane estrogen receptor signaling 0.0459 23 2021 86 -0.11 0.037 1000 -1000 -0.053 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0459 23 779 33 -0.16 0.091 1000 -1000 -0.034 -1000
Regulation of Androgen receptor activity 0.0459 23 1628 70 -0.35 0.14 1000 -1000 -0.042 -1000
Glucocorticoid receptor regulatory network 0.0439 22 2583 114 -0.33 0.063 1000 -1000 -0.053 -1000
Syndecan-1-mediated signaling events 0.0419 21 743 34 -0.09 0.15 1000 -1000 -0.051 -1000
Nectin adhesion pathway 0.0419 21 1351 63 -0.031 0.12 1000 -1000 -0.046 -1000
Wnt signaling 0.0419 21 151 7 0.007 0.054 1000 -1000 -0.011 -1000
FOXM1 transcription factor network 0.0419 21 1076 51 0.022 0.31 1000 -1000 -0.13 -1000
ErbB4 signaling events 0.0399 20 1397 69 -0.13 0.16 1000 -1000 -0.054 -1000
Glypican 1 network 0.0399 20 976 48 -0.14 0.082 1000 -1000 -0.036 -1000
TCGA08_p53 0.0399 20 141 7 -0.032 0.022 1000 -1000 -0.015 -1000
Caspase cascade in apoptosis 0.0359 18 1336 74 -0.063 0.082 1000 -1000 -0.037 -1000
S1P1 pathway 0.0359 18 662 36 -0.1 0.022 1000 -1000 -0.042 -1000
FAS signaling pathway (CD95) 0.0359 18 847 47 -0.19 0.059 1000 -1000 -0.041 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0359 18 2180 120 -0.14 0.06 1000 -1000 -0.045 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.0339 17 941 54 -0.065 0.071 1000 -1000 -0.05 -1000
JNK signaling in the CD4+ TCR pathway 0.0339 17 301 17 -0.037 0.032 1000 -1000 -0.031 -1000
Visual signal transduction: Rods 0.0319 16 860 52 -0.036 0.092 1000 -1000 -0.036 -1000
Noncanonical Wnt signaling pathway 0.0299 15 408 26 -0.051 0.054 1000 -1000 -0.043 -1000
PDGFR-alpha signaling pathway 0.0299 15 666 44 -0.12 0.044 1000 -1000 -0.042 -1000
Syndecan-3-mediated signaling events 0.0299 15 535 35 -0.24 0.055 1000 -1000 -0.034 -1000
p75(NTR)-mediated signaling 0.0279 14 1867 125 -0.046 0.14 1000 -1000 -0.078 -1000
Ephrin B reverse signaling 0.0279 14 681 48 -0.057 0.062 1000 -1000 -0.03 -1000
BCR signaling pathway 0.0279 14 1386 99 -0.093 0.052 1000 -1000 -0.045 -1000
Osteopontin-mediated events 0.0259 13 506 38 -0.048 0.12 1000 -1000 -0.051 -1000
Signaling events mediated by PTP1B 0.0259 13 1032 76 -0.044 0.058 1000 -1000 -0.035 -1000
Effects of Botulinum toxin 0.0259 13 346 26 -0.031 0.029 1000 -1000 -0.014 -1000
EGFR-dependent Endothelin signaling events 0.0259 13 276 21 -0.025 0.049 1000 -1000 -0.04 -1000
S1P4 pathway 0.0259 13 333 25 -0.026 0.032 1000 -1000 -0.028 -1000
Aurora A signaling 0.0240 12 760 60 -0.037 0.2 1000 -1000 -0.028 -1000
HIF-2-alpha transcription factor network 0.0240 12 523 43 -0.07 0.064 1000 -1000 -0.065 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0240 12 900 74 -0.14 0.048 1000 -1000 -0.07 -1000
IGF1 pathway 0.0240 12 728 57 -0.053 0.056 1000 -1000 -0.048 -1000
Ras signaling in the CD4+ TCR pathway 0.0240 12 219 17 -0.02 0.03 1000 -1000 -0.031 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0220 11 330 28 -0.11 0.043 1000 -1000 -0.03 -1000
Hedgehog signaling events mediated by Gli proteins 0.0220 11 725 65 -0.51 0.055 1000 -1000 -0.056 -1000
Syndecan-2-mediated signaling events 0.0200 10 731 69 -0.028 0.082 1000 -1000 -0.04 -1000
Syndecan-4-mediated signaling events 0.0200 10 713 67 -0.032 0.082 1000 -1000 -0.046 -1000
Regulation of nuclear SMAD2/3 signaling 0.0180 9 1322 136 -0.22 0.14 1000 -1000 -0.045 -1000
LPA receptor mediated events 0.0180 9 945 102 -0.06 0.041 1000 -1000 -0.068 -1000
ErbB2/ErbB3 signaling events 0.0160 8 581 65 -0.036 0.033 1000 -1000 -0.053 -1000
Cellular roles of Anthrax toxin 0.0160 8 348 39 -0.06 0.023 1000 -1000 -0.027 -1000
mTOR signaling pathway 0.0160 8 456 53 -0.017 0.092 1000 -1000 -0.036 -1000
Retinoic acid receptors-mediated signaling 0.0160 8 505 58 -0.15 0.045 1000 -1000 -0.055 -1000
IL2 signaling events mediated by PI3K 0.0160 8 482 58 -0.019 0.12 1000 -1000 -0.043 -1000
EPHB forward signaling 0.0160 8 741 85 -0.043 0.07 1000 -1000 -0.066 -1000
IL27-mediated signaling events 0.0160 8 421 51 -0.062 0.029 1000 -1000 -0.057 -1000
IL2 signaling events mediated by STAT5 0.0160 8 184 22 0.003 0.074 1000 -1000 -0.047 -1000
PDGFR-beta signaling pathway 0.0160 8 808 97 -0.045 0.064 1000 -1000 -0.059 -1000
FOXA2 and FOXA3 transcription factor networks 0.0140 7 356 46 -0.23 0.045 1000 -1000 -0.11 -1000
Regulation of p38-alpha and p38-beta 0.0140 7 422 54 -0.035 0.052 1000 -1000 -0.047 -1000
TCGA08_rtk_signaling 0.0140 7 193 26 -0.063 0.081 1000 -1000 -0.01 -1000
Insulin Pathway 0.0140 7 518 74 -0.082 0.059 1000 -1000 -0.065 -1000
Ephrin A reverse signaling 0.0120 6 43 7 -0.011 0.029 1000 -1000 -0.016 -1000
IFN-gamma pathway 0.0120 6 444 68 -0.03 0.064 1000 -1000 -0.068 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0120 6 578 83 -0.063 0.041 1000 -1000 -0.042 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0120 6 302 45 -0.018 0.051 1000 -1000 -0.055 -1000
Class I PI3K signaling events 0.0120 6 484 73 -0.029 0.042 1000 -1000 -0.042 -1000
S1P3 pathway 0.0120 6 293 42 -0.11 0.042 1000 -1000 -0.041 -1000
Signaling events mediated by PRL 0.0120 6 234 34 -0.034 0.064 1000 -1000 -0.044 -1000
E-cadherin signaling in keratinocytes 0.0120 6 296 43 -0.049 0.063 1000 -1000 -0.037 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0100 5 194 34 -0.031 0.05 1000 -1000 -0.031 -1000
EPO signaling pathway 0.0100 5 296 55 -0.01 0.06 1000 -1000 -0.046 -1000
Ceramide signaling pathway 0.0100 5 448 76 -0.011 0.059 1000 -1000 -0.036 -1000
Signaling events mediated by HDAC Class III 0.0100 5 207 40 -0.076 0.041 1000 -1000 -0.028 -1000
ceramide signaling pathway 0.0100 5 260 49 0 0.033 1000 -1000 -0.039 -1000
Signaling events mediated by HDAC Class II 0.0080 4 326 75 -0.034 0.054 1000 -1000 -0.03 -1000
BARD1 signaling events 0.0080 4 257 57 -0.041 0.089 1000 -1000 -0.046 -1000
a4b1 and a4b7 Integrin signaling 0.0080 4 20 5 0.016 0.027 1000 -1000 0.006 -1000
TRAIL signaling pathway 0.0080 4 206 48 -0.034 0.06 1000 -1000 -0.036 -1000
IL1-mediated signaling events 0.0080 4 302 62 -0.019 0.04 1000 -1000 -0.039 -1000
Signaling events mediated by HDAC Class I 0.0080 4 498 104 -0.042 0.055 1000 -1000 -0.038 -1000
FoxO family signaling 0.0080 4 265 64 -0.021 0.07 1000 -1000 -0.062 -1000
VEGFR1 specific signals 0.0080 4 250 56 -0.12 0.054 1000 -1000 -0.057 -1000
Arf6 downstream pathway 0.0060 3 136 43 -0.044 0.045 1000 -1000 -0.022 -1000
Insulin-mediated glucose transport 0.0060 3 96 32 -0.009 0.042 1000 -1000 -0.034 -1000
Class I PI3K signaling events mediated by Akt 0.0060 3 263 68 -0.033 0.047 1000 -1000 -0.036 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0060 3 127 37 -0.013 0.05 1000 -1000 -0.037 -1000
Paxillin-dependent events mediated by a4b1 0.0060 3 113 36 -0.04 0.041 1000 -1000 -0.035 -1000
E-cadherin signaling in the nascent adherens junction 0.0060 3 263 76 -0.012 0.059 1000 -1000 -0.061 -1000
Regulation of Telomerase 0.0060 3 403 102 -0.042 0.065 1000 -1000 -0.045 -1000
p38 MAPK signaling pathway 0.0060 3 143 44 -0.002 0.054 1000 -1000 -0.035 -1000
Canonical NF-kappaB pathway 0.0040 2 84 39 -0.006 0.046 1000 -1000 -0.038 -1000
Signaling mediated by p38-gamma and p38-delta 0.0040 2 30 15 -0.011 0.022 1000 -1000 -0.033 -1000
Arf6 trafficking events 0.0040 2 203 71 -0.05 0.04 1000 -1000 -0.03 -1000
Class IB PI3K non-lipid kinase events 0.0040 2 6 3 -0.019 0.019 1000 -1000 -0.009 -1000
Circadian rhythm pathway 0.0020 1 31 22 -0.006 0.047 1000 -1000 -0.043 -1000
S1P5 pathway 0.0020 1 32 17 -0.015 0.03 1000 -1000 -0.014 -1000
Rapid glucocorticoid signaling 0.0020 1 27 20 -0.01 0.024 1000 -1000 -0.017 -1000
Arf1 pathway 0.0020 1 68 54 -0.005 0.03 1000 -1000 -0.017 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0000 0 16 23 0.003 0.042 1000 -1000 -0.031 -1000
PLK2 and PLK4 events 0.0000 0 1 3 -0.01 0.022 1000 -1000 -0.027 -1000
Atypical NF-kappaB pathway 0.0000 0 11 31 -0.008 0.023 1000 -1000 -0.031 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0000 0 10 27 -0.01 0.053 1000 -1000 -0.038 -1000
E-cadherin signaling events 0.0000 0 0 5 0.021 0.041 1000 -1000 0.005 -1000
Alternative NF-kappaB pathway 0.0000 0 4 13 0 0.06 1000 -1000 0 -1000
Total NA 2460 159831 7203 -14 9.2 131000 -131000 -5.7 -131000
Angiopoietin receptor Tie2-mediated signaling

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.51 0.5 -10000 0 -0.97 263 263
NCK1/PAK1/Dok-R -0.24 0.22 -10000 0 -0.44 263 263
NCK1/Dok-R -0.59 0.63 -10000 0 -1.1 261 261
PIK3CA 0.013 0.012 -10000 0 -10000 0 0
mol:beta2-estradiol 0.063 0.098 0.24 118 -10000 0 118
RELA 0.023 0.002 -10000 0 -10000 0 0
SHC1 0.02 0.005 -10000 0 -10000 0 0
Rac/GDP 0.016 0.003 -10000 0 -10000 0 0
F2 0.075 0.12 0.27 122 -10000 0 122
TNIP2 0.021 0.006 -10000 0 -10000 0 0
NF kappa B/RelA -0.53 0.58 -10000 0 -1.1 261 261
FN1 0.009 0.085 -10000 0 -0.53 12 12
PLD2 -0.62 0.65 -10000 0 -1.2 259 259
PTPN11 0.023 0.002 -10000 0 -10000 0 0
GRB14 -0.01 0.13 0.23 1 -0.53 29 30
ELK1 -0.55 0.56 -10000 0 -1.1 261 261
GRB7 0.025 0.032 0.38 4 -10000 0 4
PAK1 0.023 0.016 0.38 1 -10000 0 1
Tie2/Ang1/alpha5/beta1 Integrin -0.57 0.62 -10000 0 -1.1 261 261
CDKN1A -0.35 0.33 -10000 0 -0.66 259 259
ITGA5 0.023 0.002 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R -0.6 0.64 -10000 0 -1.2 261 261
CRK 0.021 0.005 -10000 0 -10000 0 0
mol:NO -0.36 0.35 -10000 0 -0.69 263 263
PLG -0.62 0.65 -10000 0 -1.2 260 260
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis -0.48 0.47 -10000 0 -0.91 263 263
GRB2 0.022 0.004 -10000 0 -10000 0 0
PIK3R1 0.019 0.006 -10000 0 -10000 0 0
ANGPT2 -0.3 0.32 -10000 0 -0.71 151 151
BMX -0.67 0.67 -10000 0 -1.3 261 261
ANGPT1 -0.35 0.56 -10000 0 -1.3 120 120
tube development -0.4 0.37 -10000 0 -0.75 262 262
ANGPT4 -0.23 0.26 -10000 0 -0.53 211 211
response to hypoxia -0.035 0.033 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 -0.65 0.68 -10000 0 -1.2 261 261
alpha5/beta1 Integrin 0.033 0.007 -10000 0 -10000 0 0
FGF2 0.009 0.085 -10000 0 -0.53 12 12
STAT5A (dimer) -0.46 0.44 -10000 0 -0.87 261 261
mol:L-citrulline -0.36 0.35 -10000 0 -0.69 263 263
AGTR1 -0.13 0.24 -10000 0 -0.53 132 132
MAPK14 -0.67 0.67 -10000 0 -1.3 263 263
Tie2/SHP2 -0.55 0.6 -10000 0 -1.2 234 234
TEK -0.61 0.66 -10000 0 -1.3 234 234
RPS6KB1 -0.49 0.48 -10000 0 -0.93 263 263
Angiotensin II/AT1 -0.094 0.18 -10000 0 -0.39 132 132
Tie2/Ang1/GRB2 -0.64 0.68 -10000 0 -1.2 261 261
MAPK3 -0.56 0.58 -10000 0 -1.1 258 258
MAPK1 -0.55 0.57 -10000 0 -1.1 260 260
Tie2/Ang1/GRB7 -0.64 0.68 -10000 0 -1.2 261 261
NFKB1 0.022 0.005 -10000 0 -10000 0 0
MAPK8 -0.62 0.65 -10000 0 -1.2 261 261
PI3K -0.61 0.59 -10000 0 -1.2 263 263
FES -0.66 0.67 -10000 0 -1.3 263 263
Crk/Dok-R -0.6 0.64 -10000 0 -1.2 261 261
Tie2/Ang1/ABIN2 -0.64 0.69 -10000 0 -1.2 261 261
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity -0.45 0.43 -10000 0 -0.85 263 263
STAT5A 0.022 0.003 -10000 0 -10000 0 0
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 -0.48 0.47 -10000 0 -0.92 263 263
Tie2/Ang2 -0.58 0.56 -10000 0 -1.1 261 261
Tie2/Ang1 -0.68 0.74 -10000 0 -1.3 261 261
FOXO1 -0.45 0.44 -10000 0 -0.86 263 263
ELF1 -0.034 0.067 -10000 0 -10000 0 0
ELF2 -0.62 0.66 -10000 0 -1.2 261 261
mol:Choline -0.58 0.6 -10000 0 -1.1 259 259
cell migration -0.13 0.12 -10000 0 -0.24 263 263
FYN -0.47 0.44 -10000 0 -0.87 261 261
DOK2 -0.021 0.14 -10000 0 -0.53 37 37
negative regulation of cell cycle -0.32 0.3 -10000 0 -0.6 261 261
ETS1 -0.065 0.13 -10000 0 -0.28 119 119
PXN -0.39 0.38 -10000 0 -0.75 262 262
ITGB1 0.022 0.004 -10000 0 -10000 0 0
NOS3 -0.42 0.41 -10000 0 -0.8 263 263
RAC1 0.022 0.004 -10000 0 -10000 0 0
TNF -0.066 0.14 0.24 1 -0.28 120 121
MAPKKK cascade -0.58 0.6 -10000 0 -1.1 259 259
RASA1 0.021 0.006 -10000 0 -10000 0 0
Tie2/Ang1/Shc -0.64 0.68 -10000 0 -1.2 260 260
NCK1 0.019 0.008 -10000 0 -10000 0 0
vasculogenesis -0.32 0.31 -10000 0 -0.61 263 263
mol:Phosphatidic acid -0.58 0.6 -10000 0 -1.1 259 259
mol:Angiotensin II 0 0.001 -10000 0 -10000 0 0
mol:NADP -0.36 0.35 -10000 0 -0.69 263 263
Rac1/GTP -0.45 0.44 -10000 0 -0.86 263 263
MMP2 -0.62 0.65 -10000 0 -1.2 259 259
Signaling events mediated by the Hedgehog family

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 -0.16 0.22 -10000 0 -0.71 30 30
IHH -0.29 0.3 -10000 0 -0.57 267 267
SHH Np/Cholesterol/GAS1 -0.027 0.11 0.19 1 -0.31 68 69
LRPAP1 0.021 0.006 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.027 0.11 0.31 68 -0.19 1 69
SMO/beta Arrestin2 -0.2 0.22 -10000 0 -0.39 252 252
SMO -0.21 0.22 -10000 0 -0.4 265 265
AKT1 -0.11 0.15 -10000 0 -0.56 32 32
ARRB2 0.022 0.005 -10000 0 -10000 0 0
BOC 0.02 0.029 0.23 2 -0.53 1 3
ADRBK1 0.022 0.004 -10000 0 -10000 0 0
heart looping -0.21 0.22 -10000 0 -0.4 265 265
STIL -0.17 0.18 0.24 1 -0.46 68 69
DHH N/PTCH2 0.001 0.11 -10000 0 -0.39 38 38
DHH N/PTCH1 -0.17 0.2 -10000 0 -0.32 294 294
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
DHH -0.022 0.14 -10000 0 -0.53 36 36
PTHLH -0.2 0.26 -10000 0 -0.72 29 29
determination of left/right symmetry -0.21 0.22 -10000 0 -0.4 265 265
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
skeletal system development -0.19 0.25 -10000 0 -0.71 29 29
IHH N/Hhip -0.41 0.27 -10000 0 -0.54 383 383
DHH N/Hhip -0.26 0.22 -10000 0 -0.42 312 312
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.21 0.22 -10000 0 -0.4 265 265
pancreas development -0.32 0.27 -10000 0 -0.53 302 302
HHAT 0.022 0.004 -10000 0 -10000 0 0
PI3K 0.017 0.017 -10000 0 -10000 0 0
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 0.013 0.07 -10000 0 -0.53 8 8
somite specification -0.21 0.22 -10000 0 -0.4 265 265
SHH Np/Cholesterol/PTCH1 -0.17 0.19 -10000 0 -0.41 99 99
SHH Np/Cholesterol/PTCH2 -0.024 0.11 0.19 1 -0.31 63 64
SHH Np/Cholesterol/Megalin -0.17 0.19 -10000 0 -0.34 263 263
SHH -0.056 0.12 0.29 1 -0.39 60 61
catabolic process -0.18 0.2 -10000 0 -0.34 281 281
SMO/Vitamin D3 -0.2 0.21 -10000 0 -0.43 131 131
SHH Np/Cholesterol/Hhip -0.22 0.18 -10000 0 -0.34 310 310
LRP2 -0.25 0.28 -10000 0 -0.53 243 243
receptor-mediated endocytosis -0.3 0.25 -10000 0 -0.56 202 202
SHH Np/Cholesterol/BOC -0.02 0.1 -10000 0 -0.31 52 52
SHH Np/Cholesterol/CDO -0.025 0.11 0.19 1 -0.3 65 66
mesenchymal cell differentiation 0.21 0.18 0.34 310 -10000 0 310
mol:Vitamin D3 -0.17 0.19 0.24 1 -0.44 86 87
IHH N/PTCH2 -0.18 0.2 -10000 0 -0.35 268 268
CDON 0.017 0.055 -10000 0 -0.53 5 5
IHH N/PTCH1 -0.17 0.21 -10000 0 -0.34 281 281
Megalin/LRPAP1 -0.17 0.21 -10000 0 -0.39 241 241
PTCH2 0.02 0.045 0.23 2 -0.53 3 5
SHH Np/Cholesterol -0.03 0.1 -10000 0 -0.3 60 60
PTCH1 -0.18 0.2 -10000 0 -0.34 281 281
HHIP -0.32 0.27 -10000 0 -0.53 302 302
Endothelins

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.1 0.16 -10000 0 -0.41 80 80
PTK2B 0.02 0.007 -10000 0 -10000 0 0
mol:Ca2+ -0.16 0.29 -10000 0 -0.73 74 74
EDN1 -0.093 0.17 -10000 0 -0.45 71 71
EDN3 -0.044 0.16 0.23 15 -0.53 47 62
EDN2 0.041 0.1 0.24 66 -0.53 8 74
HRAS/GDP -0.21 0.26 -10000 0 -0.55 148 148
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.1 0.19 -10000 0 -0.43 92 92
ADCY4 -0.097 0.16 -10000 0 -0.38 93 93
ADCY5 -0.099 0.17 -10000 0 -0.4 93 93
ADCY6 -0.084 0.14 -10000 0 -0.36 75 75
ADCY7 -0.081 0.14 -10000 0 -0.36 73 73
ADCY1 -0.081 0.14 -10000 0 -0.36 72 72
ADCY2 -0.07 0.15 0.26 9 -0.38 67 76
ADCY3 -0.082 0.14 -10000 0 -0.36 75 75
ADCY8 -0.15 0.18 -10000 0 -0.35 188 188
ADCY9 -0.084 0.14 -10000 0 -0.36 75 75
arachidonic acid secretion -0.2 0.24 -10000 0 -0.5 168 168
ETB receptor/Endothelin-1/Gq/GTP -0.26 0.27 -10000 0 -0.43 302 302
GNAO1 0.021 0.029 0.23 2 -0.53 1 3
HRAS 0.022 0.004 -10000 0 -10000 0 0
ETA receptor/Endothelin-1/G12/GTP -0.077 0.16 -10000 0 -0.38 76 76
ETA receptor/Endothelin-1/Gs/GTP -0.075 0.15 -10000 0 -0.37 80 80
mol:GTP -0.001 0.003 -10000 0 -10000 0 0
COL3A1 -0.1 0.15 -10000 0 -0.42 74 74
EDNRB -0.28 0.28 -10000 0 -0.53 272 272
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.11 0.19 -10000 0 -0.48 74 74
CYSLTR1 -0.14 0.24 -10000 0 -0.58 99 99
SLC9A1 -0.054 0.095 -10000 0 -0.29 45 45
mol:GDP -0.23 0.28 -10000 0 -0.59 151 151
SLC9A3 -0.37 0.38 -10000 0 -0.74 199 199
RAF1 -0.23 0.27 -10000 0 -0.56 166 166
JUN -0.14 0.24 -10000 0 -0.68 55 55
JAK2 -0.099 0.16 -10000 0 -0.41 80 80
mol:IP3 -0.2 0.25 -10000 0 -0.54 151 151
ETA receptor/Endothelin-1 -0.11 0.19 -10000 0 -0.45 96 96
PLCB1 0.019 0.026 -10000 0 -0.53 1 1
PLCB2 0.01 0.07 -10000 0 -0.54 8 8
ETA receptor/Endothelin-3 -0.064 0.14 -10000 0 -0.39 59 59
FOS -0.24 0.32 -10000 0 -0.76 110 110
Gai/GDP -0.086 0.28 -10000 0 -0.86 53 53
CRK 0.021 0.005 -10000 0 -10000 0 0
mol:Ca ++ -0.26 0.28 -10000 0 -0.61 157 157
BCAR1 0.022 0.005 -10000 0 -10000 0 0
PRKCB1 -0.2 0.24 -10000 0 -0.51 152 152
GNAQ 0.017 0.028 -10000 0 -0.54 1 1
GNAZ 0.016 0.056 -10000 0 -0.53 5 5
GNAL 0.02 0.035 -10000 0 -0.53 2 2
Gs family/GDP -0.2 0.24 -10000 0 -0.53 148 148
ETA receptor/Endothelin-1/Gq/GTP -0.12 0.2 -10000 0 -0.42 125 125
MAPK14 -0.22 0.23 -10000 0 -0.49 165 165
TRPC6 -0.17 0.31 -10000 0 -0.81 70 70
GNAI2 0.021 0.007 -10000 0 -10000 0 0
GNAI3 0.022 0.005 -10000 0 -10000 0 0
GNAI1 0.021 0.025 -10000 0 -0.53 1 1
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.23 0.24 -10000 0 -0.5 175 175
ETB receptor/Endothelin-2 -0.21 0.22 0.27 1 -0.4 277 278
ETB receptor/Endothelin-3 -0.24 0.23 -10000 0 -0.42 296 296
ETB receptor/Endothelin-1 -0.27 0.23 -10000 0 -0.44 294 294
MAPK3 -0.25 0.32 -10000 0 -0.68 150 150
MAPK1 -0.25 0.33 -10000 0 -0.67 156 156
Rac1/GDP -0.21 0.25 -10000 0 -0.55 147 147
cAMP biosynthetic process -0.091 0.16 0.25 6 -0.43 58 64
MAPK8 -0.17 0.31 -10000 0 -0.72 87 87
SRC 0.022 0.004 -10000 0 -10000 0 0
ETB receptor/Endothelin-1/Gi/GTP -0.16 0.16 -10000 0 -0.3 232 232
p130Cas/CRK/Src/PYK2 -0.22 0.28 -10000 0 -0.6 147 147
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.21 0.25 -10000 0 -0.55 144 144
COL1A2 -0.25 0.23 -10000 0 -0.58 102 102
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.014 0.11 0.27 3 -0.33 26 29
mol:DAG -0.2 0.25 -10000 0 -0.54 151 151
MAP2K2 -0.24 0.28 -10000 0 -0.6 161 161
MAP2K1 -0.24 0.28 -10000 0 -0.6 161 161
EDNRA -0.05 0.095 -10000 0 -0.31 35 35
positive regulation of muscle contraction -0.085 0.14 -10000 0 -0.37 71 71
Gq family/GDP -0.19 0.27 -10000 0 -0.56 144 144
HRAS/GTP -0.23 0.27 -10000 0 -0.56 164 164
PRKCH -0.2 0.24 -10000 0 -0.52 146 146
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCA -0.2 0.24 -10000 0 -0.53 142 142
PRKCB -0.21 0.26 -10000 0 -0.56 147 147
PRKCE -0.19 0.23 -10000 0 -0.52 140 140
PRKCD -0.19 0.24 -10000 0 -0.53 138 138
PRKCG -0.2 0.24 -10000 0 -0.53 149 149
regulation of vascular smooth muscle contraction -0.28 0.38 -10000 0 -0.92 107 107
PRKCQ -0.22 0.26 -10000 0 -0.56 156 156
PLA2G4A -0.21 0.27 -10000 0 -0.54 168 168
GNA14 -0.11 0.24 -10000 0 -0.54 117 117
GNA15 0.02 0.01 -10000 0 -10000 0 0
GNA12 0.022 0.004 -10000 0 -10000 0 0
GNA11 0.02 0.01 -10000 0 -10000 0 0
Rac1/GTP -0.077 0.16 -10000 0 -0.38 77 77
MMP1 0.1 0.1 0.41 18 -10000 0 18
Fc-epsilon receptor I signaling in mast cells

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.021 0.006 -10000 0 -10000 0 0
LAT2 -0.11 0.2 -10000 0 -0.43 105 105
AP1 -0.11 0.26 -10000 0 -0.55 101 101
mol:PIP3 -0.13 0.23 0.3 11 -0.5 102 113
IKBKB -0.06 0.14 0.22 14 -0.29 81 95
AKT1 -0.053 0.2 0.41 19 -0.42 54 73
IKBKG -0.069 0.13 0.23 9 -0.29 82 91
MS4A2 -0.11 0.23 -10000 0 -0.53 115 115
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
MAP3K1 -0.031 0.22 0.31 32 -0.46 60 92
mol:Ca2+ -0.095 0.18 0.27 12 -0.36 102 114
LYN 0.012 0.041 -10000 0 -0.55 2 2
CBLB -0.1 0.19 -10000 0 -0.42 99 99
SHC1 0.022 0.005 -10000 0 -10000 0 0
RasGAP/p62DOK 0.004 0.1 -10000 0 -0.31 47 47
positive regulation of cell migration 0 0 -10000 0 -10000 0 0
INPP5D 0.021 0.025 -10000 0 -0.53 1 1
PLD2 -0.13 0.2 0.32 13 -0.36 184 197
PTPN13 -0.099 0.21 0.41 1 -0.53 62 63
PTPN11 0.008 0.028 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.039 0.17 0.35 19 -0.34 58 77
SYK 0.015 0.018 -10000 0 -10000 0 0
GRB2 0.022 0.004 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.14 0.23 -10000 0 -0.5 111 111
LAT -0.11 0.19 -10000 0 -0.42 106 106
PAK2 -0.038 0.24 0.25 94 -0.51 63 157
NFATC2 -0.13 0.25 -10000 0 -0.7 70 70
HRAS -0.11 0.24 0.23 9 -0.55 86 95
GAB2 0.006 0.092 -10000 0 -0.53 14 14
PLA2G1B -0.079 0.25 -10000 0 -0.92 38 38
Fc epsilon R1 -0.14 0.25 -10000 0 -0.44 187 187
Antigen/IgE/Fc epsilon R1 -0.12 0.23 -10000 0 -0.4 187 187
mol:GDP -0.12 0.26 0.27 1 -0.59 89 90
JUN 0.022 0.004 -10000 0 -10000 0 0
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.021 0.007 -10000 0 -10000 0 0
FOS -0.043 0.18 -10000 0 -0.53 58 58
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.11 0.2 -10000 0 -0.44 106 106
CHUK -0.071 0.13 0.23 9 -0.29 81 90
KLRG1 -0.1 0.18 -10000 0 -0.46 73 73
VAV1 -0.11 0.2 -10000 0 -0.43 104 104
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.11 0.19 -10000 0 -0.42 105 105
negative regulation of mast cell degranulation -0.087 0.18 -10000 0 -0.46 67 67
BTK -0.14 0.28 -10000 0 -0.66 90 90
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.14 0.24 -10000 0 -0.45 137 137
GAB2/PI3K/SHP2 -0.11 0.16 -10000 0 -0.38 97 97
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.11 0.19 -10000 0 -0.36 140 140
RAF1 -0.043 0.27 -10000 0 -0.96 38 38
Fc epsilon R1/FcgammaRIIB/SHIP -0.11 0.24 -10000 0 -0.38 187 187
FCER1G 0.002 0.092 -10000 0 -0.55 13 13
FCER1A -0.14 0.25 -10000 0 -0.55 138 138
Antigen/IgE/Fc epsilon R1/Fyn -0.11 0.22 -10000 0 -0.38 187 187
MAPK3 -0.042 0.25 -10000 0 -0.9 38 38
MAPK1 -0.043 0.25 -10000 0 -0.9 38 38
NFKB1 0.022 0.005 -10000 0 -10000 0 0
MAPK8 -0.05 0.24 0.38 1 -0.84 35 36
DUSP1 -0.035 0.17 -10000 0 -0.53 50 50
NF-kappa-B/RelA -0.039 0.082 -10000 0 -0.19 60 60
actin cytoskeleton reorganization -0.099 0.21 0.43 1 -0.54 64 65
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.091 0.19 -10000 0 -0.51 61 61
FER -0.11 0.19 -10000 0 -0.42 105 105
RELA 0.023 0.002 -10000 0 -10000 0 0
ITK -0.064 0.15 -10000 0 -0.43 59 59
SOS1 0.022 0.004 -10000 0 -10000 0 0
PLCG1 -0.12 0.26 0.4 3 -0.57 91 94
cytokine secretion -0.03 0.057 -10000 0 -0.16 8 8
SPHK1 -0.1 0.19 -10000 0 -0.42 105 105
PTK2 -0.1 0.22 0.43 1 -0.57 63 64
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.14 0.24 -10000 0 -0.51 112 112
EDG1 0 0 -10000 0 -10000 0 0
mol:DAG -0.13 0.23 0.3 11 -0.48 104 115
MAP2K2 -0.045 0.25 -10000 0 -0.9 38 38
MAP2K1 -0.046 0.25 -10000 0 -0.9 38 38
MAP2K7 0.022 0.004 -10000 0 -10000 0 0
KLRG1/SHP2 -0.084 0.18 0.22 2 -0.44 67 69
MAP2K4 -0.036 0.26 -10000 0 -0.97 34 34
Fc epsilon R1/FcgammaRIIB -0.12 0.24 -10000 0 -0.4 188 188
mol:Choline -0.13 0.2 0.32 13 -0.35 184 197
SHC/Grb2/SOS1 -0.078 0.2 -10000 0 -0.48 67 67
FYN 0.021 0.025 -10000 0 -0.53 1 1
DOK1 0.022 0.004 -10000 0 -10000 0 0
PXN -0.098 0.21 0.59 1 -0.53 62 63
HCLS1 -0.1 0.19 -10000 0 -0.42 100 100
PRKCB -0.1 0.18 0.27 8 -0.41 88 96
FCGR2B 0.015 0.061 -10000 0 -0.53 6 6
IGHE -0.003 0.009 -10000 0 -10000 0 0
KLRG1/SHIP -0.089 0.19 -10000 0 -0.47 67 67
LCP2 0.015 0.056 -10000 0 -0.54 5 5
PLA2G4A -0.11 0.2 -10000 0 -0.43 106 106
RASA1 0.021 0.006 -10000 0 -10000 0 0
mol:Phosphatidic acid -0.13 0.2 0.32 13 -0.35 184 197
IKK complex -0.043 0.11 0.2 13 -0.23 62 75
WIPF1 0.022 0.004 -10000 0 -10000 0 0
Thromboxane A2 receptor signaling

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 -0.025 0.15 -10000 0 -0.54 41 41
GNB1/GNG2 -0.069 0.093 -10000 0 -0.19 170 170
AKT1 -0.063 0.12 -10000 0 -0.25 42 42
EGF 0.015 0.068 0.23 3 -0.53 7 10
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR -0.026 0.099 0.22 1 -0.35 30 31
mol:Ca2+ -0.1 0.16 -10000 0 -0.31 172 172
LYN -0.013 0.069 0.26 2 -0.36 8 10
RhoA/GTP -0.039 0.07 -10000 0 -0.14 37 37
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.11 0.18 -10000 0 -0.35 170 170
GNG2 0.016 0.056 -10000 0 -0.53 5 5
ARRB2 0.022 0.005 -10000 0 -10000 0 0
TP alpha/Gq family/GDP/G beta5/gamma2 -0.042 0.14 -10000 0 -0.58 21 21
G beta5/gamma2 -0.088 0.13 -10000 0 -0.26 166 166
PRKCH -0.12 0.19 -10000 0 -0.37 170 170
DNM1 0.023 0.014 0.23 2 -10000 0 2
TXA2/TP beta/beta Arrestin3 0.012 0.064 -10000 0 -0.58 5 5
mol:GTP -0.001 0.001 -10000 0 -10000 0 0
PTGDR 0.008 0.085 -10000 0 -0.53 12 12
G12 family/GTP -0.099 0.16 -10000 0 -0.31 161 161
ADRBK1 0.022 0.004 -10000 0 -10000 0 0
ADRBK2 0.022 0.004 -10000 0 -10000 0 0
RhoA/GTP/ROCK1 0.027 0.01 -10000 0 -10000 0 0
mol:GDP 0.057 0.12 0.4 24 -10000 0 24
mol:NADP 0.017 0.05 -10000 0 -0.53 4 4
RAB11A 0.023 0.002 -10000 0 -10000 0 0
PRKG1 -0.029 0.16 -10000 0 -0.53 45 45
mol:IP3 -0.13 0.2 -10000 0 -0.39 172 172
cell morphogenesis 0.027 0.01 -10000 0 -10000 0 0
PLCB2 -0.18 0.28 -10000 0 -0.54 172 172
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK -0.014 0.082 0.26 2 -0.33 17 19
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.013 0.07 0.26 2 -0.39 8 10
RHOA 0.021 0.007 -10000 0 -10000 0 0
PTGIR 0.011 0.078 -10000 0 -0.53 10 10
PRKCB1 -0.13 0.2 -10000 0 -0.39 175 175
GNAQ 0.021 0.025 -10000 0 -0.53 1 1
mol:L-citrulline 0.017 0.05 -10000 0 -0.53 4 4
TXA2/TXA2-R family -0.18 0.28 -10000 0 -0.55 173 173
LCK -0.013 0.07 0.26 2 -0.38 8 10
TXA2/TP beta/beta Arrestin3/RAB11/GDP 0.009 0.073 -10000 0 -0.32 18 18
TXA2-R family/G12 family/GDP/G beta/gamma -0.002 0.1 -10000 0 -0.44 23 23
TXA2/TP beta/beta Arrestin2/RAB11/GDP 0.012 0.072 -10000 0 -0.32 18 18
MAPK14 -0.075 0.12 -10000 0 -0.24 159 159
TGM2/GTP -0.15 0.24 -10000 0 -0.45 170 170
MAPK11 -0.075 0.12 -10000 0 -0.24 158 158
ARHGEF1 -0.056 0.096 -10000 0 -0.19 148 148
GNAI2 0.021 0.007 -10000 0 -10000 0 0
JNK cascade -0.13 0.2 -10000 0 -0.4 173 173
RAB11/GDP 0.023 0.003 -10000 0 -10000 0 0
ICAM1 -0.099 0.16 -10000 0 -0.31 172 172
cAMP biosynthetic process -0.12 0.19 -10000 0 -0.36 174 174
Gq family/GTP/EBP50 -0.036 0.096 0.24 3 -0.2 112 115
actin cytoskeleton reorganization 0.027 0.01 -10000 0 -10000 0 0
SRC -0.012 0.065 0.26 2 -0.37 6 8
GNB5 0.022 0.003 -10000 0 -10000 0 0
GNB1 0.021 0.025 -10000 0 -0.53 1 1
EGF/EGFR -0.007 0.092 0.2 11 -0.3 21 32
VCAM1 -0.094 0.15 -10000 0 -0.3 173 173
TP beta/Gq family/GDP/G beta5/gamma2 -0.042 0.14 -10000 0 -0.58 21 21
platelet activation -0.1 0.16 -10000 0 -0.31 162 162
PGI2/IP 0.008 0.057 -10000 0 -0.39 10 10
PRKACA -0.001 0.074 -10000 0 -0.35 18 18
Gq family/GDP/G beta5/gamma2 -0.041 0.14 -10000 0 -0.51 24 24
TXA2/TP beta/beta Arrestin2 0.009 0.044 -10000 0 -0.37 3 3
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R -0.011 0.072 -10000 0 -0.34 19 19
mol:DAG -0.14 0.23 -10000 0 -0.44 172 172
EGFR 0.023 0.081 0.36 12 -0.53 6 18
TXA2/TP alpha -0.17 0.26 -10000 0 -0.5 174 174
Gq family/GTP -0.057 0.12 -10000 0 -0.24 129 129
YES1 -0.013 0.065 0.22 1 -0.35 8 9
GNAI2/GTP -0.006 0.067 -10000 0 -0.32 15 15
PGD2/DP 0.005 0.063 -10000 0 -0.35 14 14
SLC9A3R1 0.024 0.023 0.27 4 -10000 0 4
FYN -0.013 0.07 0.26 2 -0.42 6 8
mol:NO 0.017 0.05 -10000 0 -0.53 4 4
GNA15 0.022 0.004 -10000 0 -10000 0 0
PGK/cGMP -0.007 0.11 -10000 0 -0.35 46 46
RhoA/GDP 0.021 0.007 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma -0.001 0.12 -10000 0 -0.47 18 18
NOS3 0.018 0.05 -10000 0 -0.53 4 4
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCA -0.12 0.19 -10000 0 -0.36 171 171
PRKCB -0.12 0.2 -10000 0 -0.38 171 171
PRKCE -0.11 0.19 -10000 0 -0.37 159 159
PRKCD -0.13 0.2 -10000 0 -0.39 172 172
PRKCG -0.13 0.21 -10000 0 -0.4 171 171
muscle contraction -0.17 0.26 -10000 0 -0.5 174 174
PRKCZ -0.11 0.18 -10000 0 -0.35 172 172
ARR3 -0.01 0.016 -10000 0 -10000 0 0
TXA2/TP beta 0.01 0.077 -10000 0 -0.33 18 18
PRKCQ -0.13 0.2 -10000 0 -0.39 177 177
MAPKKK cascade -0.16 0.25 -10000 0 -0.48 173 173
SELE -0.13 0.2 -10000 0 -0.4 172 172
TP beta/GNAI2/GDP/G beta/gamma 0.021 0.083 -10000 0 -0.38 13 13
ROCK1 0.022 0.004 -10000 0 -10000 0 0
GNA14 -0.11 0.24 -10000 0 -0.53 117 117
chemotaxis -0.21 0.31 -10000 0 -0.62 172 172
GNA12 0.022 0.004 -10000 0 -10000 0 0
GNA13 0.022 0.003 -10000 0 -10000 0 0
GNA11 0.022 0.004 -10000 0 -10000 0 0
Rac1/GTP 0.016 0.003 -10000 0 -10000 0 0
amb2 Integrin signaling

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.011 0.16 -10000 0 -0.49 41 41
alphaM/beta2 Integrin/GPIbA -0.012 0.16 -10000 0 -0.48 43 43
alphaM/beta2 Integrin/proMMP-9 -0.002 0.15 0.23 1 -0.47 40 41
PLAUR 0.022 0.004 -10000 0 -10000 0 0
HMGB1 0.014 0.021 -10000 0 -10000 0 0
alphaM/beta2 Integrin/Talin -0.01 0.15 -10000 0 -0.46 41 41
AGER -0.48 0.18 -10000 0 -0.54 443 443
RAP1A 0.022 0.005 -10000 0 -10000 0 0
SELPLG -0.014 0.14 -10000 0 -0.53 33 33
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.33 0.2 -10000 0 -0.37 440 440
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 0.034 0.049 0.24 27 -10000 0 27
CYR61 -0.003 0.12 -10000 0 -0.53 23 23
TLN1 0.021 0.007 -10000 0 -10000 0 0
Rap1/GTP -0.14 0.26 -10000 0 -0.5 119 119
RHOA 0.021 0.007 -10000 0 -10000 0 0
P-selectin oligomer -0.11 0.23 -10000 0 -0.53 115 115
MYH2 -0.22 0.28 -10000 0 -0.6 147 147
MST1R -0.007 0.12 -10000 0 -0.53 25 25
leukocyte activation during inflammatory response -0.015 0.15 -10000 0 -0.4 59 59
APOB -0.011 0.13 0.23 4 -0.53 27 31
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.017 0.05 -10000 0 -0.53 4 4
JAM3 0.021 0.025 -10000 0 -0.53 1 1
GP1BA 0.016 0.051 0.23 1 -0.53 4 5
alphaM/beta2 Integrin/CTGF -0.021 0.18 -10000 0 -0.52 48 48
alphaM/beta2 Integrin -0.18 0.3 -10000 0 -0.58 123 123
JAM3 homodimer 0.021 0.025 -10000 0 -0.53 1 1
ICAM2 -0.014 0.14 -10000 0 -0.53 33 33
ICAM1 -0.017 0.14 -10000 0 -0.53 35 35
phagocytosis triggered by activation of immune response cell surface activating receptor -0.17 0.3 -10000 0 -0.57 123 123
cell adhesion -0.013 0.15 -10000 0 -0.48 43 43
NFKB1 -0.34 0.23 -10000 0 -0.7 109 109
THY1 0.022 0.004 -10000 0 -10000 0 0
RhoA/GDP 0.015 0.005 -10000 0 -10000 0 0
Lipoprotein(a) 0.013 0.087 0.24 1 -0.34 26 27
alphaM/beta2 Integrin/LRP/tPA 0.002 0.14 0.26 4 -0.44 40 44
IL6 -0.36 0.31 -10000 0 -0.91 105 105
ITGB2 -0.006 0.11 -10000 0 -0.54 18 18
elevation of cytosolic calcium ion concentration 0.008 0.15 0.25 1 -0.45 39 40
alphaM/beta2 Integrin/JAM2/JAM3 -0.047 0.2 -10000 0 -0.44 90 90
JAM2 -0.061 0.2 -10000 0 -0.53 74 74
alphaM/beta2 Integrin/ICAM1 -0.02 0.2 -10000 0 -0.44 78 78
alphaM/beta2 Integrin/uPA/Plg 0.008 0.15 0.26 1 -0.45 40 41
RhoA/GTP -0.21 0.3 -10000 0 -0.63 130 130
positive regulation of phagocytosis -0.12 0.23 -10000 0 -0.5 98 98
Ron/MSP 0.008 0.094 -10000 0 -0.39 25 25
alphaM/beta2 Integrin/uPAR/uPA 0.009 0.15 0.26 1 -0.45 39 40
alphaM/beta2 Integrin/uPAR -0.009 0.15 -10000 0 -0.48 40 40
PLAU 0.035 0.053 0.24 32 -10000 0 32
PLAT 0.024 0.035 0.33 6 -10000 0 6
actin filament polymerization -0.22 0.26 -10000 0 -0.56 149 149
MST1 0.021 0.011 0.23 1 -10000 0 1
alphaM/beta2 Integrin/lipoprotein(a) -0.012 0.16 -10000 0 -0.4 59 59
TNF -0.32 0.22 -10000 0 -0.68 106 106
RAP1B 0.022 0.005 -10000 0 -10000 0 0
alphaM/beta2 Integrin/uPA -0.002 0.16 0.26 1 -0.48 40 41
fibrinolysis 0.007 0.15 0.25 1 -0.44 40 41
HCK 0.018 0.043 -10000 0 -0.53 3 3
dendritic cell antigen processing and presentation -0.17 0.3 -10000 0 -0.57 123 123
VTN -0.18 0.27 0.23 2 -0.53 185 187
alphaM/beta2 Integrin/CYR61 -0.025 0.18 -10000 0 -0.51 52 52
LPA 0.02 0.046 0.24 18 -10000 0 18
LRP1 0.023 0.002 -10000 0 -10000 0 0
cell migration -0.013 0.14 -10000 0 -0.46 40 40
FN1 0.009 0.085 -10000 0 -0.53 12 12
alphaM/beta2 Integrin/Thy1 -0.01 0.15 -10000 0 -0.48 40 40
MPO -0.003 0.11 -10000 0 -0.53 22 22
KNG1 0.007 0.053 0.31 13 -10000 0 13
RAP1/GDP 0.028 0.009 -10000 0 -10000 0 0
ROCK1 -0.19 0.28 -10000 0 -0.6 121 121
ELA2 0 0 -10000 0 -10000 0 0
PLG -0.004 0.03 0.23 5 -10000 0 5
CTGF 0.003 0.1 -10000 0 -0.53 18 18
alphaM/beta2 Integrin/Hck -0.01 0.14 -10000 0 -0.46 40 40
ITGAM -0.03 0.15 -10000 0 -0.54 40 40
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.089 0.25 -10000 0 -0.46 129 129
HP -0.13 0.25 -10000 0 -0.53 137 137
leukocyte adhesion -0.32 0.23 -10000 0 -0.58 155 155
SELP -0.11 0.23 -10000 0 -0.53 115 115
IL4-mediated signaling events

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.44 0.53 -10000 0 -1.3 106 106
STAT6 (cleaved dimer) -0.45 0.54 -10000 0 -1.3 116 116
IGHG1 -0.14 0.18 -10000 0 -0.74 3 3
IGHG3 -0.43 0.51 -10000 0 -1.2 114 114
AKT1 -0.21 0.3 -10000 0 -0.95 36 36
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.15 0.26 -10000 0 -1 22 22
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.22 0.32 -10000 0 -1.1 33 33
THY1 -0.45 0.53 -10000 0 -1.3 107 107
MYB 0.026 0.05 0.23 15 -0.53 2 17
HMGA1 0.024 0.019 0.23 4 -10000 0 4
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.25 0.32 -10000 0 -0.83 51 51
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.22 0.32 -10000 0 -1.1 34 34
SP1 0.026 0.003 -10000 0 -10000 0 0
INPP5D 0.021 0.025 -10000 0 -0.53 1 1
SOCS5 0.02 0.03 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.44 0.54 -10000 0 -1.2 116 116
SOCS1 -0.29 0.34 -10000 0 -0.76 101 101
SOCS3 -0.21 0.27 -10000 0 -0.93 20 20
FCER2 -0.41 0.51 -10000 0 -1.3 87 87
PARP14 0.02 0.009 -10000 0 -10000 0 0
CCL17 -0.51 0.6 -10000 0 -1.4 128 128
GRB2 0.022 0.004 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.18 0.26 -10000 0 -0.86 32 32
T cell proliferation -0.44 0.54 -10000 0 -1.3 113 113
IL4R/JAK1 -0.44 0.54 -10000 0 -1.2 112 112
EGR2 -0.46 0.56 -10000 0 -1.3 118 118
JAK2 -0.019 0.047 -10000 0 -10000 0 0
JAK3 0.026 0.009 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
JAK1 0 0.026 -10000 0 -10000 0 0
COL1A2 -0.11 0.16 -10000 0 -10000 0 0
CCL26 -0.44 0.53 -10000 0 -1.2 111 111
IL4R -0.47 0.57 -10000 0 -1.3 111 111
PTPN6 0.026 0.022 -10000 0 -10000 0 0
IL13RA2 -0.47 0.56 -10000 0 -1.3 117 117
IL13RA1 -0.019 0.05 -10000 0 -10000 0 0
IRF4 -0.2 0.37 -10000 0 -0.89 92 92
ARG1 -0.13 0.22 -10000 0 -0.77 30 30
CBL -0.24 0.3 -10000 0 -0.79 48 48
GTF3A 0.028 0.01 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
IL13RA1/JAK2 -0.019 0.067 -10000 0 -10000 0 0
IRF4/BCL6 -0.16 0.32 -10000 0 -0.77 87 87
CD40LG -0.068 0.21 -10000 0 -0.53 83 83
MAPK14 -0.23 0.31 -10000 0 -0.86 38 38
mitosis -0.2 0.28 -10000 0 -0.87 36 36
STAT6 -0.52 0.67 -10000 0 -1.5 114 114
SPI1 -0.014 0.14 -10000 0 -0.53 35 35
RPS6KB1 -0.2 0.27 -10000 0 -0.85 33 33
STAT6 (dimer) -0.52 0.67 -10000 0 -1.5 114 114
STAT6 (dimer)/PARP14 -0.47 0.59 -10000 0 -1.4 110 110
mast cell activation 0.01 0.013 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.23 0.33 -10000 0 -0.96 47 47
FRAP1 -0.21 0.3 -10000 0 -0.94 36 36
LTA -0.44 0.53 -10000 0 -1.3 110 110
FES 0.021 0.025 -10000 0 -0.53 1 1
T-helper 1 cell differentiation 0.5 0.62 1.4 114 -10000 0 114
CCL11 -0.44 0.52 -10000 0 -1.2 115 115
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.2 0.29 -10000 0 -1 27 27
IL2RG 0.019 0.066 -10000 0 -0.52 7 7
IL10 -0.45 0.53 -10000 0 -1.2 112 112
IRS1 0.022 0.004 -10000 0 -10000 0 0
IRS2 0.018 0.043 -10000 0 -0.53 3 3
IL4 -0.14 0.27 -10000 0 -1.1 29 29
IL5 -0.45 0.53 -10000 0 -1.3 108 108
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.37 0.46 -10000 0 -1 111 111
COL1A1 -0.15 0.25 -10000 0 -1 20 20
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.46 0.56 -10000 0 -1.3 105 105
IL2R gamma/JAK3 0.03 0.051 -10000 0 -0.38 7 7
TFF3 -0.49 0.6 -10000 0 -1.4 112 112
ALOX15 -0.66 0.73 -10000 0 -1.5 192 192
MYBL1 0.022 0.01 0.23 1 -10000 0 1
T-helper 2 cell differentiation -0.49 0.51 -10000 0 -1.1 155 155
SHC1 0.022 0.005 -10000 0 -10000 0 0
CEBPB 0.025 0.006 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.21 0.31 -10000 0 -1.1 28 28
mol:PI-3-4-5-P3 -0.21 0.3 -10000 0 -0.94 36 36
PI3K -0.23 0.32 -10000 0 -1.1 35 35
DOK2 -0.021 0.14 -10000 0 -0.53 37 37
ETS1 0.01 0.078 -10000 0 -0.5 10 10
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.16 0.23 -10000 0 -0.74 29 29
ITGB3 -0.46 0.55 -10000 0 -1.3 114 114
PIGR -0.81 0.78 -10000 0 -1.5 263 263
IGHE 0.046 0.053 0.2 13 -10000 0 13
MAPKKK cascade -0.15 0.22 -10000 0 -0.72 29 29
BCL6 0.014 0.011 -10000 0 -10000 0 0
OPRM1 -0.45 0.53 -10000 0 -1.3 110 110
RETNLB -0.43 0.54 -10000 0 -1.2 110 110
SELP -0.6 0.71 -10000 0 -1.5 158 158
AICDA -0.42 0.51 -10000 0 -1.2 108 108
Signaling mediated by p38-alpha and p38-beta

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.1 0.34 -10000 0 -1.1 51 51
MKNK1 0.022 0.004 -10000 0 -10000 0 0
MAPK14 -0.014 0.12 -10000 0 -0.32 68 68
ATF2/c-Jun -0.021 0.096 -10000 0 -0.4 5 5
MAPK11 -0.016 0.12 -10000 0 -0.32 71 71
MITF -0.04 0.15 -10000 0 -0.37 79 79
MAPKAPK5 -0.031 0.14 -10000 0 -0.37 74 74
KRT8 -0.03 0.14 -10000 0 -0.37 73 73
MAPKAPK3 0.021 0.007 -10000 0 -10000 0 0
MAPKAPK2 0.022 0.004 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.029 0.18 -10000 0 -0.47 68 68
CEBPB -0.03 0.14 -10000 0 -0.36 73 73
SLC9A1 -0.033 0.14 -10000 0 -0.38 73 73
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.027 0.14 -10000 0 -0.36 68 68
p38alpha-beta/MNK1 -0.008 0.16 -10000 0 -0.38 67 67
JUN -0.02 0.096 -10000 0 -0.4 5 5
PPARGC1A -0.1 0.23 -10000 0 -0.43 140 140
USF1 -0.029 0.14 -10000 0 -0.36 71 71
RAB5/GDP/GDI1 -0.017 0.11 -10000 0 -0.28 61 61
NOS2 -0.064 0.27 -10000 0 -1.1 29 29
DDIT3 -0.03 0.14 -10000 0 -0.36 73 73
RAB5A 0.021 0.006 -10000 0 -10000 0 0
HSPB1 -0.028 0.12 0.27 8 -0.31 66 74
p38alpha-beta/HBP1 -0.008 0.16 -10000 0 -0.39 65 65
CREB1 -0.033 0.15 -10000 0 -0.39 71 71
RAB5/GDP 0.016 0.005 -10000 0 -10000 0 0
EIF4E -0.032 0.13 -10000 0 -0.35 62 62
RPS6KA4 -0.031 0.14 -10000 0 -0.37 73 73
PLA2G4A -0.033 0.13 0.26 1 -0.35 63 64
GDI1 -0.028 0.14 -10000 0 -0.37 69 69
TP53 -0.052 0.17 -10000 0 -0.47 72 72
RPS6KA5 -0.031 0.14 -10000 0 -0.37 72 72
ESR1 -0.05 0.18 -10000 0 -0.41 86 86
HBP1 0.022 0.005 -10000 0 -10000 0 0
MEF2C -0.041 0.16 -10000 0 -0.39 78 78
MEF2A -0.03 0.14 -10000 0 -0.37 72 72
EIF4EBP1 -0.03 0.15 -10000 0 -0.39 68 68
KRT19 -0.036 0.16 -10000 0 -0.39 76 76
ELK4 -0.03 0.14 -10000 0 -0.36 73 73
ATF6 -0.029 0.14 -10000 0 -0.36 71 71
ATF1 -0.032 0.15 -10000 0 -0.38 71 71
p38alpha-beta/MAPKAPK2 -0.008 0.16 -10000 0 -0.38 68 68
p38alpha-beta/MAPKAPK3 -0.011 0.16 -10000 0 -0.38 68 68
TCGA08_retinoblastoma

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.016 0.036 -10000 0 -0.5 2 2
CDKN2C 0.024 0.02 -10000 0 -10000 0 0
CDKN2A 0.092 0.14 0.23 207 -0.29 20 227
CCND2 -0.008 0.054 0.23 5 -0.38 7 12
RB1 -0.009 0.083 0.43 6 -0.24 39 45
CDK4 -0.001 0.07 0.25 20 -0.43 6 26
CDK6 -0.002 0.071 0.25 20 -0.44 6 26
G1/S progression 0.036 0.1 0.21 110 -0.42 6 116
Aurora B signaling

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex 0.056 0.088 0.27 18 -0.33 8 26
STMN1 -0.045 0.045 -10000 0 -0.26 1 1
Aurora B/RasGAP/Survivin 0.22 0.14 0.32 297 -0.21 7 304
Chromosomal passenger complex/Cul3 protein complex 0.036 0.079 0.2 8 -0.32 12 20
BIRC5 0.21 0.084 0.24 422 -0.32 1 423
DES -0.3 0.31 -10000 0 -0.66 91 91
Aurora C/Aurora B/INCENP 0.12 0.088 0.29 1 -0.33 1 2
Aurora B/TACC1 0.091 0.091 -10000 0 -0.18 17 17
Aurora B/PP2A 0.12 0.097 -10000 0 -0.2 21 21
mol:GTP 0 0 -10000 0 -10000 0 0
CBX5 0.017 0.03 0.13 4 -0.12 1 5
mitotic metaphase/anaphase transition -0.003 0.005 -10000 0 -10000 0 0
NDC80 -0.049 0.1 0.34 22 -0.24 18 40
Cul3 protein complex 0.039 0.029 0.25 1 -10000 0 1
KIF2C 0.066 0.083 0.16 19 -0.38 11 30
PEBP1 0.021 0.006 -10000 0 -10000 0 0
KIF20A 0.11 0.13 0.23 242 -0.3 15 257
mol:GDP 0 0 -10000 0 -10000 0 0
Aurora B/RasGAP 0.12 0.096 -10000 0 -0.21 6 6
SEPT1 0.023 0.01 0.23 1 -10000 0 1
SMC2 0.022 0.004 -10000 0 -10000 0 0
SMC4 0.016 0.011 -10000 0 -10000 0 0
NSUN2/NPM1/Nucleolin 0.07 0.18 -10000 0 -0.58 30 30
PSMA3 0.022 0.004 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.005 0.003 -10000 0 -10000 0 0
H3F3B 0.042 0.061 0.17 8 -0.22 19 27
AURKB 0.16 0.14 0.24 335 -0.3 21 356
AURKC 0.021 0.027 0.23 1 -0.53 1 2
CDCA8 0.079 0.098 0.24 128 -0.32 1 129
cytokinesis 0.044 0.11 0.26 2 -0.4 22 24
Aurora B/Septin1 0.12 0.14 0.3 15 -0.4 17 32
AURKA 0.029 0.049 0.24 24 -10000 0 24
INCENP 0.024 0.009 -10000 0 -10000 0 0
KLHL13 0.028 0.038 0.27 11 -10000 0 11
BUB1 0.042 0.066 0.24 47 -10000 0 47
hSgo1/Aurora B/Survivin 0.26 0.19 0.38 326 -0.25 30 356
EVI5 0.026 0.006 -10000 0 -10000 0 0
RhoA/GTP 0.096 0.094 0.25 29 -0.29 5 34
SGOL1 0.11 0.13 0.23 238 -0.3 21 259
CENPA 0.075 0.078 0.23 11 -0.24 10 21
NCAPG 0.057 0.091 0.23 92 -0.3 5 97
Aurora B/HC8 Proteasome 0.12 0.097 -10000 0 -0.21 17 17
NCAPD2 0.022 0.017 0.38 1 -10000 0 1
Aurora B/PP1-gamma 0.12 0.097 -10000 0 -0.21 21 21
RHOA 0.021 0.007 -10000 0 -10000 0 0
NCAPH 0.13 0.11 0.24 255 -10000 0 255
NPM1 0.016 0.18 -10000 0 -0.72 24 24
RASA1 0.021 0.006 -10000 0 -10000 0 0
KLHL9 0.019 0.009 -10000 0 -10000 0 0
mitotic prometaphase -0.002 0.002 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.12 0.097 -10000 0 -0.2 17 17
PPP1CC 0.023 0.002 -10000 0 -10000 0 0
Centraspindlin 0.1 0.1 0.26 69 -0.31 8 77
RhoA/GDP 0.015 0.005 -10000 0 -10000 0 0
NSUN2 0.06 0.11 -10000 0 -0.36 24 24
MYLK 0.047 0.07 0.16 40 -0.23 19 59
KIF23 0.066 0.085 0.24 97 -10000 0 97
VIM -0.05 0.075 0.28 3 -0.3 22 25
RACGAP1 0.025 0.008 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
NCL 0.034 0.14 -10000 0 -0.5 22 22
Chromosomal passenger complex 0.06 0.08 0.19 15 -0.28 15 30
Chromosomal passenger complex/EVI5 0.28 0.17 0.38 319 -0.25 6 325
TACC1 0.018 0.026 -10000 0 -0.53 1 1
PPP2R5D 0.022 0.004 -10000 0 -10000 0 0
CUL3 0.022 0.005 -10000 0 -10000 0 0
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
RXR and RAR heterodimerization with other nuclear receptor

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.018 0.063 0.36 7 -10000 0 7
VDR 0.021 0.025 -10000 0 -0.53 1 1
FAM120B 0.022 0.004 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA -0.11 0.14 -10000 0 -0.41 20 20
RXRs/LXRs/DNA/Oxysterols -0.096 0.14 -10000 0 -0.56 11 11
MED1 0.022 0.004 -10000 0 -10000 0 0
mol:9cRA 0.001 0.007 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 -0.001 0.07 -10000 0 -0.26 17 17
RXRs/NUR77 -0.16 0.21 -10000 0 -0.35 265 265
RXRs/PPAR -0.14 0.16 -10000 0 -0.29 259 259
NCOR2 0.021 0.025 -10000 0 -0.53 1 1
VDR/VDR/Vit D3 0.016 0.018 -10000 0 -0.39 1 1
RARs/VDR/DNA/Vit D3 0.046 0.029 -10000 0 -0.28 2 2
RARA 0.022 0.004 -10000 0 -10000 0 0
NCOA1 0.022 0.003 -10000 0 -10000 0 0
VDR/VDR/DNA 0.021 0.025 -10000 0 -0.53 1 1
RARs/RARs/DNA/9cRA 0.036 0.022 -10000 0 -0.27 1 1
RARG 0.023 0.002 -10000 0 -10000 0 0
RPS6KB1 0.037 0.081 0.65 7 -10000 0 7
RARs/THRs/DNA/SMRT 0 0.072 -10000 0 -0.27 20 20
THRA 0.022 0.004 -10000 0 -10000 0 0
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.016 0.018 -10000 0 -0.39 1 1
RXRs/PPAR/9cRA/PGJ2/DNA -0.12 0.17 -10000 0 -0.3 241 241
NR1H4 -0.001 0.029 0.23 4 -10000 0 4
RXRs/LXRs/DNA -0.11 0.18 -10000 0 -0.29 235 235
NR1H2 0.023 0.012 -10000 0 -10000 0 0
NR1H3 0.023 0.011 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.12 0.17 -10000 0 -0.29 238 238
NR4A1 -0.05 0.19 -10000 0 -0.53 65 65
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.1 0.12 -10000 0 -0.22 239 239
RXRG -0.25 0.28 -10000 0 -0.53 244 244
RXR alpha/CCPG 0.033 0.012 -10000 0 -10000 0 0
RXRA 0.023 0.011 -10000 0 -10000 0 0
RXRB 0.023 0.011 -10000 0 -10000 0 0
THRB 0.002 0.1 -10000 0 -0.53 17 17
PPARG -0.036 0.17 -10000 0 -0.53 51 51
PPARD 0.022 0.003 -10000 0 -10000 0 0
TNF -0.1 0.19 -10000 0 -1.1 12 12
mol:Oxysterols 0.002 0.006 -10000 0 -10000 0 0
cholesterol transport -0.095 0.13 -10000 0 -0.55 11 11
PPARA 0.022 0.005 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.019 0.036 -10000 0 -0.53 2 2
RXRs/NUR77/BCL2 -0.15 0.17 -10000 0 -0.3 265 265
SREBF1 -0.087 0.13 -10000 0 -0.55 9 9
RXRs/RXRs/DNA/9cRA -0.12 0.17 -10000 0 -0.3 241 241
ABCA1 -0.088 0.13 -10000 0 -0.57 7 7
RARs/THRs 0.048 0.068 -10000 0 -0.29 17 17
RXRs/FXR -0.12 0.18 -10000 0 -0.31 241 241
BCL2 0.023 0.016 0.38 1 -10000 0 1
Aurora C signaling

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.023 0.002 -10000 0 -10000 0 0
Aurora C/Aurora B/INCENP 0.11 0.085 0.29 1 -0.34 1 2
metaphase 0 0 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
H3F3B -0.004 0.022 -10000 0 -0.42 1 1
AURKB 0.15 0.13 0.23 335 -0.3 21 356
AURKC 0.021 0.027 0.23 1 -0.53 1 2
Signaling events regulated by Ret tyrosine kinase

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.021 0.089 -10000 0 -0.42 16 16
Crk/p130 Cas/Paxillin -0.05 0.11 -10000 0 -0.29 53 53
JUN -0.019 0.11 0.26 7 -0.33 6 13
HRAS 0.022 0.004 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/GRB10 -0.001 0.16 0.28 21 -0.32 77 98
RAP1A 0.022 0.005 -10000 0 -10000 0 0
FRS2 0.022 0.005 -10000 0 -10000 0 0
RAP1A/GDP 0.016 0.003 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 -0.003 0.16 0.35 4 -0.32 82 86
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.023 0.002 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.021 0.005 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma -0.019 0.15 0.24 18 -0.31 89 107
RHOA 0.021 0.007 -10000 0 -10000 0 0
RAP1A/GTP -0.007 0.14 0.32 3 -0.28 83 86
GRB7 0.025 0.032 0.38 4 -10000 0 4
RET51/GFRalpha1/GDNF -0.004 0.16 0.27 20 -0.32 81 101
MAPKKK cascade -0.025 0.13 0.27 2 -0.3 69 71
BCAR1 0.022 0.005 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/IRS1 -0.018 0.15 0.24 19 -0.31 89 108
lamellipodium assembly -0.037 0.11 -10000 0 -0.27 56 56
RET51/GFRalpha1/GDNF/SHC -0.005 0.16 0.27 19 -0.32 80 99
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC -0.019 0.15 0.24 17 -0.31 84 101
RET9/GFRalpha1/GDNF/Shank3 -0.02 0.15 0.24 17 -0.31 88 105
MAPK3 -0.041 0.13 0.27 2 -0.28 79 81
DOK1 0.022 0.004 -10000 0 -10000 0 0
DOK6 -0.024 0.15 -10000 0 -0.53 41 41
PXN 0.023 0.002 -10000 0 -10000 0 0
neurite development -0.046 0.13 0.32 1 -0.36 14 15
DOK5 0.021 0.038 0.23 2 -0.53 2 4
GFRA1 -0.11 0.23 -10000 0 -0.53 115 115
MAPK8 -0.032 0.11 0.28 7 -0.34 7 14
HRAS/GTP -0.016 0.15 0.35 2 -0.32 74 76
tube development -0.018 0.15 0.24 18 -0.3 88 106
MAPK1 -0.04 0.12 0.25 3 -0.28 73 76
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.032 0.11 -10000 0 -0.25 86 86
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
SRC 0.022 0.004 -10000 0 -10000 0 0
PDLIM7 0.021 0.006 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok6 -0.019 0.18 0.35 4 -0.34 104 108
SHC1 0.022 0.005 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 -0.005 0.16 0.27 20 -0.32 83 103
RET51/GFRalpha1/GDNF/Dok5 -0.006 0.16 0.28 19 -0.32 83 102
PRKCA 0.02 0.035 -10000 0 -0.53 2 2
HRAS/GDP 0.016 0.003 -10000 0 -10000 0 0
CREB1 -0.037 0.13 0.27 3 -0.28 80 83
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.034 0.12 0.17 15 -0.26 86 101
RET51/GFRalpha1/GDNF/Grb7 -0.003 0.16 0.28 24 -0.31 83 107
mol:GDP 0 0 -10000 0 -10000 0 0
RET 0.029 0.04 0.24 17 -10000 0 17
DOK4 0.022 0.005 -10000 0 -10000 0 0
JNK cascade -0.018 0.11 0.26 7 -0.33 6 13
RET9/GFRalpha1/GDNF/FRS2 -0.017 0.15 0.24 18 -0.31 85 103
SHANK3 0.021 0.025 -10000 0 -0.53 1 1
RASA1 0.021 0.006 -10000 0 -10000 0 0
NCK1 0.019 0.008 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.033 0.11 -10000 0 -0.26 82 82
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 -0.028 0.12 0.26 2 -0.25 76 78
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK -0.031 0.12 0.28 2 -0.28 29 31
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 -0.026 0.11 0.28 2 -0.25 76 78
PI3K -0.037 0.17 0.28 9 -0.39 59 68
SOS1 0.022 0.004 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 -0.012 0.15 0.24 17 -0.3 88 105
GRB10 0.022 0.005 -10000 0 -10000 0 0
activation of MAPKK activity -0.027 0.11 0.2 18 -0.28 1 19
RET51/GFRalpha1/GDNF/FRS2 -0.004 0.16 0.28 20 -0.32 82 102
GAB1 0.021 0.006 -10000 0 -10000 0 0
IRS1 0.022 0.004 -10000 0 -10000 0 0
IRS2 0.018 0.043 -10000 0 -0.53 3 3
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 -0.03 0.12 -10000 0 -0.26 82 82
RET51/GFRalpha1/GDNF/PKC alpha -0.006 0.16 0.28 21 -0.32 86 107
GRB2 0.022 0.004 -10000 0 -10000 0 0
PRKACA 0.022 0.004 -10000 0 -10000 0 0
GDNF 0.054 0.1 0.28 80 -10000 0 80
RAC1 0.022 0.004 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 -0.005 0.16 0.28 21 -0.32 85 106
Rac1/GTP -0.032 0.14 0.21 6 -0.32 55 61
RET9/GFRalpha1/GDNF -0.031 0.16 0.24 19 -0.34 90 109
GFRalpha1/GDNF -0.039 0.18 0.27 19 -0.38 95 114
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.026 0.14 0.33 3 -0.39 53 56
CRKL -0.038 0.14 -10000 0 -0.41 54 54
HRAS -0.033 0.15 -10000 0 -0.4 51 51
mol:PIP3 -0.006 0.14 0.25 1 -0.35 53 54
SPRED1 0.022 0.003 -10000 0 -10000 0 0
SPRED2 0.021 0.005 -10000 0 -10000 0 0
GAB1 -0.04 0.15 -10000 0 -0.42 63 63
FOXO3 -0.026 0.14 -10000 0 -0.37 58 58
AKT1 -0.027 0.15 -10000 0 -0.39 66 66
BAD -0.026 0.14 0.27 1 -0.37 58 59
megakaryocyte differentiation -0.056 0.17 -10000 0 -0.44 67 67
GSK3B -0.008 0.15 0.29 7 -0.37 54 61
RAF1 -0.024 0.12 -10000 0 -0.33 49 49
SHC1 0.022 0.005 -10000 0 -10000 0 0
STAT3 -0.042 0.15 -10000 0 -0.42 63 63
STAT1 -0.12 0.36 -10000 0 -1 63 63
HRAS/SPRED1 -0.014 0.13 -10000 0 -0.38 26 26
cell proliferation -0.04 0.15 -10000 0 -0.41 64 64
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
TEC 0.019 0.036 -10000 0 -0.53 2 2
RPS6KB1 -0.033 0.15 -10000 0 -0.41 63 63
HRAS/SPRED2 -0.015 0.13 -10000 0 -0.35 37 37
LYN/TEC/p62DOK -0.013 0.15 -10000 0 -0.42 53 53
MAPK3 -0.018 0.098 0.36 2 -0.3 18 20
STAP1 -0.052 0.17 -10000 0 -0.47 63 63
GRAP2 -0.008 0.13 -10000 0 -0.53 27 27
JAK2 -0.095 0.32 -10000 0 -0.9 63 63
STAT1 (dimer) -0.11 0.34 -10000 0 -1 63 63
mol:Gleevec 0.001 0.006 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.014 0.16 -10000 0 -0.41 60 60
actin filament polymerization -0.041 0.14 -10000 0 -0.42 59 59
LYN 0.02 0.035 -10000 0 -0.53 2 2
STAP1/STAT5A (dimer) -0.078 0.24 -10000 0 -0.66 63 63
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
CBL/CRKL/GRB2 -0.014 0.14 -10000 0 -0.38 53 53
PI3K -0.021 0.12 -10000 0 -0.4 32 32
PTEN 0.02 0.007 -10000 0 -10000 0 0
SCF/KIT/EPO/EPOR -0.12 0.42 -10000 0 -1.2 63 63
MAPK8 -0.041 0.15 -10000 0 -0.42 64 64
STAT3 (dimer) -0.041 0.14 -10000 0 -0.41 63 63
positive regulation of transcription -0.013 0.082 0.34 2 -0.24 18 20
mol:GDP -0.032 0.15 -10000 0 -0.41 54 54
PIK3C2B -0.041 0.15 -10000 0 -0.42 61 61
CBL/CRKL -0.024 0.14 -10000 0 -0.39 55 55
FER -0.04 0.15 -10000 0 -0.42 63 63
SH2B3 -0.043 0.15 -10000 0 -0.42 64 64
PDPK1 -0.003 0.13 -10000 0 -0.33 48 48
SNAI2 -0.042 0.15 -10000 0 -0.42 62 62
positive regulation of cell proliferation -0.083 0.27 -10000 0 -0.75 64 64
KITLG 0.017 0.022 -10000 0 -10000 0 0
cell motility -0.083 0.27 -10000 0 -0.75 64 64
PTPN6 0.022 0.011 -10000 0 -10000 0 0
EPOR -0.033 0.19 -10000 0 -0.88 14 14
STAT5A (dimer) -0.066 0.22 -10000 0 -0.62 64 64
SOCS1 0.021 0.025 -10000 0 -0.53 1 1
cell migration 0.051 0.16 0.43 67 -10000 0 67
SOS1 0.022 0.004 -10000 0 -10000 0 0
EPO 0.018 0.029 0.23 6 -10000 0 6
VAV1 0.019 0.043 -10000 0 -0.53 3 3
GRB10 -0.04 0.14 -10000 0 -0.42 59 59
PTPN11 0.023 0.007 -10000 0 -10000 0 0
SCF/KIT -0.041 0.16 -10000 0 -0.44 64 64
GO:0007205 0.002 0.008 -10000 0 -10000 0 0
MAP2K1 -0.019 0.1 0.38 2 -0.32 18 20
CBL 0.022 0.004 -10000 0 -10000 0 0
KIT -0.16 0.46 -10000 0 -1.3 70 70
MAP2K2 -0.019 0.1 0.38 2 -0.31 19 21
SHC/Grb2/SOS1 -0.011 0.15 -10000 0 -0.4 55 55
STAT5A -0.066 0.23 -10000 0 -0.65 63 63
GRB2 0.022 0.004 -10000 0 -10000 0 0
response to radiation -0.041 0.14 -10000 0 -0.41 62 62
SHC/GRAP2 0.008 0.096 -10000 0 -0.39 27 27
PTPRO -0.057 0.17 -10000 0 -0.46 67 67
SH2B2 -0.042 0.15 -10000 0 -0.42 59 59
DOK1 0.022 0.004 -10000 0 -10000 0 0
MATK -0.052 0.16 -10000 0 -0.44 66 66
CREBBP 0.017 0.045 -10000 0 -10000 0 0
BCL2 -0.042 0.22 -10000 0 -0.98 17 17
Nongenotropic Androgen signaling

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.005 0.002 -10000 0 -10000 0 0
GNB1/GNG2 -0.032 0.14 -10000 0 -0.3 101 101
regulation of S phase of mitotic cell cycle -0.032 0.09 -10000 0 -0.26 51 51
GNAO1 0.021 0.029 0.23 2 -0.53 1 3
HRAS 0.022 0.004 -10000 0 -10000 0 0
SHBG/T-DHT 0.014 0.004 -10000 0 -10000 0 0
PELP1 0.021 0.006 -10000 0 -10000 0 0
AKT1 -0.004 0.003 -10000 0 -10000 0 0
MAP2K1 -0.069 0.11 -10000 0 -0.28 85 85
T-DHT/AR -0.068 0.16 -10000 0 -0.38 103 103
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.001 0.002 -10000 0 -0.006 60 60
GNAI2 0.021 0.007 -10000 0 -10000 0 0
GNAI3 0.022 0.005 -10000 0 -10000 0 0
GNAI1 0.021 0.025 -10000 0 -0.53 1 1
mol:GDP -0.078 0.15 -10000 0 -0.37 102 102
cell proliferation -0.097 0.17 -10000 0 -0.44 71 71
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
FOS -0.12 0.27 -10000 0 -0.8 62 62
mol:Ca2+ -0.009 0.022 -10000 0 -0.067 35 35
MAPK3 -0.087 0.14 -10000 0 -0.42 36 36
MAPK1 -0.044 0.11 -10000 0 -0.36 24 24
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:IP3 0 0.001 -10000 0 -0.004 60 60
cAMP biosynthetic process 0.002 0.017 -10000 0 -10000 0 0
GNG2 0.016 0.055 -10000 0 -0.53 5 5
potassium channel inhibitor activity 0 0.001 -10000 0 -0.004 60 60
HRAS/GTP -0.032 0.13 -10000 0 -0.28 97 97
actin cytoskeleton reorganization 0.017 0.018 -10000 0 -10000 0 0
SRC 0.022 0.004 -10000 0 -10000 0 0
voltage-gated calcium channel activity 0 0.001 -10000 0 -0.004 60 60
PI3K 0.016 0.016 -10000 0 -10000 0 0
apoptosis 0.076 0.16 0.44 67 -10000 0 67
T-DHT/AR/PELP1 -0.048 0.14 -10000 0 -0.33 100 100
HRAS/GDP -0.064 0.15 -10000 0 -0.36 101 101
CREB1 -0.082 0.17 -10000 0 -0.47 67 67
RAC1-CDC42/GTP 0.022 0.022 -10000 0 -10000 0 0
AR -0.091 0.22 -10000 0 -0.53 100 100
GNB1 0.021 0.025 -10000 0 -0.53 1 1
RAF1 -0.066 0.11 0.2 1 -0.28 90 91
RAC1-CDC42/GDP -0.024 0.17 -10000 0 -0.34 98 98
T-DHT/AR/PELP1/Src -0.035 0.14 -10000 0 -0.31 97 97
MAP2K2 -0.069 0.11 -10000 0 -0.28 85 85
T-DHT/AR/PELP1/Src/PI3K -0.033 0.09 -10000 0 -0.26 51 51
GNAZ 0.016 0.056 -10000 0 -0.53 5 5
SHBG 0.02 0.01 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.032 0.16 -10000 0 -0.52 35 35
mol:T-DHT 0 0.001 0.001 2 -0.002 39 41
RAC1 0.022 0.004 -10000 0 -10000 0 0
GNRH1 -0.006 0.024 -10000 0 -0.39 2 2
Gi family/GTP -0.03 0.084 -10000 0 -0.31 21 21
CDC42 0.022 0.004 -10000 0 -10000 0 0
BMP receptor signaling

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS 0.07 0.14 0.3 25 -0.31 42 67
SMAD6-7/SMURF1 0.009 0.1 -10000 0 -0.33 40 40
NOG 0.001 0.1 0.23 1 -0.53 18 19
SMAD9 -0.085 0.22 -10000 0 -0.52 92 92
SMAD4 0.022 0.005 -10000 0 -10000 0 0
SMAD5 -0.034 0.14 -10000 0 -0.47 28 28
BMP7/USAG1 -0.012 0.2 0.27 3 -0.41 94 97
SMAD5/SKI -0.036 0.16 0.26 1 -0.47 39 40
SMAD1 0.008 0.059 -10000 0 -0.61 2 2
BMP2 -0.043 0.18 -10000 0 -0.53 58 58
SMAD1/SMAD1/SMAD4 -0.012 0.1 -10000 0 -0.48 5 5
BMPR1A 0.022 0.005 -10000 0 -10000 0 0
BMPR1B -0.02 0.14 -10000 0 -0.53 37 37
BMPR1A-1B/BAMBI 0.012 0.1 0.25 1 -0.34 40 41
AHSG 0.019 0.065 0.35 17 -10000 0 17
CER1 -0.008 0.024 0.23 1 -0.3 1 2
BMP2-4/CER1 -0.014 0.13 -10000 0 -0.35 63 63
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.035 0.15 -10000 0 -0.45 36 36
BMP2-4 (homodimer) -0.027 0.15 -10000 0 -0.4 65 65
RGMB 0.021 0.006 -10000 0 -10000 0 0
BMP6/BMPR2/BMPR1A-1B 0.017 0.11 -10000 0 -0.32 46 46
RGMA 0.046 0.076 0.25 54 -0.53 1 55
SMURF1 0.021 0.006 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.028 0.12 -10000 0 -0.45 23 23
BMP2-4/USAG1 -0.074 0.19 -10000 0 -0.38 133 133
SMAD6/SMURF1/SMAD5 -0.033 0.15 0.31 2 -0.46 40 42
SOSTDC1 -0.08 0.22 0.23 1 -0.53 92 93
BMP7/BMPR2/BMPR1A-1B 0.052 0.13 -10000 0 -0.32 42 42
SKI 0.022 0.005 -10000 0 -10000 0 0
BMP6 (homodimer) 0.01 0.082 -10000 0 -0.53 11 11
HFE2 -0.003 0.024 0.23 2 -10000 0 2
ZFYVE16 0.021 0.006 -10000 0 -10000 0 0
MAP3K7 0.023 0.002 -10000 0 -10000 0 0
BMP2-4/CHRD -0.015 0.11 0.25 1 -0.36 42 43
SMAD5/SMAD5/SMAD4 -0.035 0.16 0.31 2 -0.47 39 41
MAPK1 0.021 0.006 -10000 0 -10000 0 0
TAK1/TAB family -0.015 0.12 -10000 0 -0.39 23 23
BMP7 (homodimer) 0.082 0.12 0.23 161 -0.47 8 169
NUP214 0.022 0.003 -10000 0 -10000 0 0
BMP6/FETUA 0.019 0.067 0.27 12 -0.39 7 19
SMAD1/SKI 0.007 0.086 -10000 0 -0.53 4 4
SMAD6 -0.031 0.16 -10000 0 -0.53 48 48
CTDSP2 0.022 0.003 -10000 0 -10000 0 0
BMP2-4/FETUA -0.007 0.12 0.25 13 -0.35 43 56
MAP3K7IP1 0 0 -10000 0 -10000 0 0
GREM1 0.15 0.11 0.23 298 -0.3 2 300
BMPR2 (homodimer) 0.022 0.004 -10000 0 -10000 0 0
GADD34/PP1CA 0.042 0.014 -10000 0 -10000 0 0
BMPR1A-1B (homodimer) 0 0.11 -10000 0 -0.39 37 37
CHRDL1 -0.26 0.28 -10000 0 -0.53 255 255
ENDOFIN/SMAD1 0.009 0.084 -10000 0 -0.52 4 4
SMAD6-7/SMURF1/SMAD1 -0.002 0.12 -10000 0 -0.53 5 5
SMAD6/SMURF1 0.021 0.006 -10000 0 -10000 0 0
BAMBI 0.02 0.047 0.3 2 -0.53 3 5
SMURF2 0.022 0.003 -10000 0 -10000 0 0
BMP2-4/CHRDL1 -0.19 0.22 -10000 0 -0.38 261 261
BMP2-4/GREM1 0.053 0.18 0.25 1 -0.37 64 65
SMAD7 0.022 0.005 -10000 0 -10000 0 0
SMAD8A/SMAD8A/SMAD4 -0.084 0.22 -10000 0 -0.51 99 99
SMAD1/SMAD6 0.006 0.085 -10000 0 -0.54 4 4
TAK1/SMAD6 0.032 0.009 -10000 0 -10000 0 0
BMP7 0.082 0.12 0.23 161 -0.48 8 169
BMP6 0.01 0.082 -10000 0 -0.53 11 11
MAP3K7IP2 0 0 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.022 0.12 -10000 0 -0.41 25 25
PPM1A 0.022 0.004 -10000 0 -10000 0 0
SMAD1/SMURF2 0.006 0.085 -10000 0 -0.5 4 4
SMAD7/SMURF1 0.03 0.01 -10000 0 -10000 0 0
CTDSPL 0.021 0.007 -10000 0 -10000 0 0
PPP1CA 0.022 0.004 -10000 0 -10000 0 0
XIAP 0.022 0.003 -10000 0 -10000 0 0
CTDSP1 0.022 0.004 -10000 0 -10000 0 0
PPP1R15A 0.022 0.004 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.034 0.15 -10000 0 -0.46 34 34
CHRD 0.011 0.04 0.38 1 -0.53 2 3
BMPR2 0.022 0.004 -10000 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.036 0.12 0.2 1 -0.46 24 25
BMP4 0.01 0.082 0.23 1 -0.53 11 12
FST 0.049 0.091 0.24 77 -0.33 7 84
BMP2-4/NOG -0.02 0.15 -10000 0 -0.36 73 73
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 0.059 0.12 -10000 0 -0.3 36 36
Integrins in angiogenesis

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.01 0.091 -10000 0 -0.39 24 24
alphaV beta3 Integrin 0.026 0.08 -10000 0 -0.35 20 20
PTK2 -0.16 0.19 0.34 2 -0.52 62 64
IGF1R 0.022 0.004 -10000 0 -10000 0 0
PI4KB 0.021 0.006 -10000 0 -10000 0 0
MFGE8 0.022 0.003 -10000 0 -10000 0 0
SRC 0.022 0.004 -10000 0 -10000 0 0
CDKN1B -0.17 0.24 -10000 0 -0.48 183 183
VEGFA 0.022 0.004 -10000 0 -10000 0 0
ILK -0.17 0.24 -10000 0 -0.48 185 185
ROCK1 0.022 0.004 -10000 0 -10000 0 0
AKT1 -0.15 0.22 -10000 0 -0.45 171 171
PTK2B -0.018 0.094 0.35 2 -0.34 26 28
alphaV/beta3 Integrin/JAM-A -0.086 0.17 -10000 0 -0.31 172 172
CBL 0.022 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.035 0.056 -10000 0 -0.34 10 10
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.043 0.067 -10000 0 -0.31 16 16
VEGF/Rho/ROCK/alphaV/beta3 Integrin -0.091 0.16 -10000 0 -0.44 50 50
alphaV/beta3 Integrin/Syndecan-1 0.035 0.057 -10000 0 -0.34 11 11
PI4KA 0.021 0.006 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 0.015 0.11 -10000 0 -0.33 40 40
PI4 Kinase 0.03 0.011 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin 0.093 0.098 0.25 1 -0.35 10 11
RPS6KB1 -0.036 0.098 0.32 2 -0.45 11 13
TLN1 0.021 0.007 -10000 0 -10000 0 0
MAPK3 -0.08 0.16 -10000 0 -0.55 38 38
GPR124 0.018 0.026 -10000 0 -0.53 1 1
MAPK1 -0.078 0.16 -10000 0 -0.56 37 37
PXN 0.023 0.002 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Tumstatin -0.19 0.19 -10000 0 -0.35 292 292
cell adhesion 0.025 0.054 -10000 0 -0.33 9 9
ANGPTL3 0.007 0.028 0.23 4 -10000 0 4
VEGFR2 homodimer/VEGFA homodimer/Src 0.024 0.077 -10000 0 -0.33 20 20
IGF-1R heterotetramer 0.022 0.004 -10000 0 -10000 0 0
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
TGFBR2 -0.007 0.12 -10000 0 -0.53 25 25
ITGB3 0.01 0.082 -10000 0 -0.53 11 11
IGF1 0.003 0.1 0.23 1 -0.53 18 19
RAC1 0.022 0.004 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.029 0.054 -10000 0 -0.34 9 9
apoptosis 0.022 0.003 -10000 0 -10000 0 0
CD47 0.019 0.026 -10000 0 -0.53 1 1
alphaV/beta3 Integrin/CD47 0.031 0.055 -10000 0 -0.34 9 9
VCL 0.022 0.005 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Del1 0.013 0.1 -10000 0 -0.35 34 34
CSF1 0.017 0.05 -10000 0 -0.53 4 4
PIK3C2A -0.17 0.24 -10000 0 -0.48 185 185
PI4 Kinase/Pyk2 -0.086 0.16 -10000 0 -0.31 129 129
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.029 0.097 -10000 0 -0.36 26 26
FAK1/Vinculin -0.13 0.15 0.32 2 -0.42 53 55
alphaV beta3/Integrin/ppsTEM5 0.029 0.055 -10000 0 -0.34 9 9
RHOA 0.021 0.007 -10000 0 -10000 0 0
VTN -0.18 0.27 0.23 2 -0.53 185 187
BCAR1 0.022 0.005 -10000 0 -10000 0 0
FGF2 0.008 0.085 -10000 0 -0.53 12 12
F11R -0.018 0.056 -10000 0 -0.39 11 11
alphaV/beta3 Integrin/Lactadherin 0.036 0.055 -10000 0 -0.34 10 10
alphaV/beta3 Integrin/TGFBR2 0.013 0.11 -10000 0 -0.39 30 30
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.049 0.035 -10000 0 -0.31 3 3
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.032 0.047 -10000 0 -0.31 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.009 0.085 -10000 0 -0.53 12 12
alphaV/beta3 Integrin/Pyk2 0.02 0.094 -10000 0 -0.34 26 26
SDC1 0.021 0.025 -10000 0 -0.53 1 1
VAV3 -0.012 0.04 -10000 0 -0.29 4 4
PTPN11 0.023 0.002 -10000 0 -10000 0 0
IRS1 0.022 0.004 -10000 0 -10000 0 0
FAK1/Paxillin -0.13 0.15 0.34 1 -0.42 56 57
cell migration -0.12 0.14 0.26 3 -0.39 51 54
ITGAV 0.022 0.004 -10000 0 -10000 0 0
PI3K -0.048 0.13 -10000 0 -0.3 80 80
SPP1 0.12 0.11 0.23 246 -0.3 6 252
KDR -0.007 0.12 -10000 0 -0.53 25 25
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.022 0.003 -10000 0 -10000 0 0
COL4A3 -0.31 0.27 -10000 0 -0.53 301 301
angiogenesis -0.11 0.18 0.27 1 -0.56 40 41
Rac1/GTP 0.019 0.036 -10000 0 -0.27 4 4
EDIL3 -0.009 0.13 -10000 0 -0.53 27 27
cell proliferation 0.013 0.11 -10000 0 -0.39 30 30
Calcium signaling in the CD4+ TCR pathway

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.004 0.034 -10000 0 -0.41 1 1
NFATC2 -0.047 0.12 -10000 0 -0.36 63 63
NFATC3 -0.003 0.029 -10000 0 -10000 0 0
CD40LG -0.16 0.28 0.34 2 -0.61 112 114
PTGS2 -0.14 0.25 0.34 2 -0.57 102 104
JUNB 0.021 0.025 -10000 0 -0.53 1 1
CaM/Ca2+/Calcineurin A alpha-beta B1 0.003 0.024 -10000 0 -10000 0 0
CaM/Ca2+ 0.003 0.023 -10000 0 -10000 0 0
CALM1 0.01 0.022 -10000 0 -10000 0 0
JUN 0.011 0.022 -10000 0 -10000 0 0
mol:Ca2+ -0.005 0.009 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.009 0.012 -10000 0 -10000 0 0
FOSL1 0.024 0.021 0.28 3 -10000 0 3
CREM 0.022 0.004 -10000 0 -10000 0 0
Jun/NFAT1-c-4/p21SNFT -0.05 0.16 -10000 0 -0.39 58 58
FOS -0.054 0.18 -10000 0 -0.54 58 58
IFNG -0.12 0.22 0.34 1 -0.51 86 87
AP-1/NFAT1-c-4 -0.13 0.26 -10000 0 -0.59 89 89
FASLG -0.13 0.23 0.34 2 -0.56 82 84
NFAT1-c-4/ICER1 -0.044 0.13 -10000 0 -0.34 58 58
IL2RA -0.12 0.22 0.34 1 -0.51 84 85
FKBP12/FK506 0.016 0.003 -10000 0 -10000 0 0
CSF2 -0.14 0.25 0.34 2 -0.54 110 112
JunB/Fra1/NFAT1-c-4 -0.036 0.13 -10000 0 -0.34 59 59
IL4 -0.12 0.22 0.33 2 -0.51 83 85
IL2 -0.032 0.21 -10000 0 -0.93 25 25
IL3 -0.044 0.19 -10000 0 -0.7 35 35
FKBP1A 0.022 0.005 -10000 0 -10000 0 0
BATF3 0.022 0.004 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
POU2F1 0.021 0.006 -10000 0 -10000 0 0
Arf6 signaling events

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.018 0.056 -10000 0 -0.34 11 11
ARNO/beta Arrestin1-2 -0.099 0.21 -10000 0 -0.58 49 49
EGFR 0.023 0.081 0.36 12 -0.53 6 18
EPHA2 0.018 0.043 -10000 0 -0.53 3 3
USP6 0.021 0.006 -10000 0 -10000 0 0
IQSEC1 0.021 0.006 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF 0.024 0.078 0.27 8 -0.42 12 20
ARRB2 0.007 0.004 -10000 0 -10000 0 0
mol:GTP 0.037 0.061 0.16 26 -0.18 7 33
ARRB1 -0.084 0.22 -10000 0 -0.53 95 95
FBXO8 0.021 0.006 -10000 0 -10000 0 0
TSHR 0.026 0.037 0.23 15 -10000 0 15
EGF 0.015 0.068 0.23 3 -0.53 7 10
somatostatin receptor activity 0 0 0.001 4 -0.001 108 112
ARAP2 0.02 0.026 -10000 0 -0.53 1 1
mol:GDP -0.09 0.16 0.2 1 -0.32 113 114
mol:PI-3-4-5-P3 0 0 0.001 3 -0.001 65 68
ITGA2B 0.006 0.092 -10000 0 -0.53 14 14
ARF6 0.022 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.043 0.037 -10000 0 -0.31 3 3
ADAP1 0.015 0.061 -10000 0 -0.53 6 6
KIF13B 0.015 0.056 -10000 0 -0.53 5 5
HGF/MET -0.054 0.17 0.27 1 -0.39 99 100
PXN 0.023 0.002 -10000 0 -10000 0 0
ARF6/GTP -0.084 0.14 0.22 5 -0.29 109 114
EGFR/EGFR/EGF/EGF/ARFGEP100 0.034 0.071 0.25 8 -0.36 12 20
ADRB2 -0.12 0.24 -10000 0 -0.53 123 123
receptor agonist activity 0 0 0 7 0 98 105
actin filament binding 0 0 0 3 -0.001 109 112
SRC 0.022 0.004 -10000 0 -10000 0 0
ITGB3 0.01 0.082 -10000 0 -0.53 11 11
GNAQ 0.021 0.025 -10000 0 -0.53 1 1
EFA6/PI-4-5-P2 0 0.001 0.001 10 -0.001 78 88
ARF6/GDP -0.018 0.16 0.26 8 -0.52 32 40
ARF6/GDP/GULP/ACAP1 -0.071 0.16 -10000 0 -0.37 66 66
alphaIIb/beta3 Integrin/paxillin/GIT1 0.037 0.081 -10000 0 -0.31 25 25
ACAP1 0.021 0.027 0.23 1 -0.53 1 2
ACAP2 0.014 0.011 -10000 0 -10000 0 0
LHCGR/beta Arrestin2 0.014 0.018 0.19 1 -10000 0 1
EFNA1 0.022 0.005 -10000 0 -10000 0 0
HGF -0.09 0.22 -10000 0 -0.53 100 100
CYTH3 -0.005 0.003 -10000 0 -10000 0 0
CYTH2 -0.01 0.16 -10000 0 -1 12 12
NCK1 0.019 0.008 -10000 0 -10000 0 0
fibronectin binding 0 0 0.001 7 0 91 98
endosomal lumen acidification 0 0 0.001 22 0 71 93
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 0.014 0.065 -10000 0 -0.53 7 7
GNAQ/ARNO 0.003 0.15 -10000 0 -0.96 12 12
mol:Phosphatidic acid 0 0 0 2 -10000 0 2
PIP3-E 0 0 0 5 0 12 17
MET 0.02 0.039 0.38 1 -0.53 2 3
GNA14 -0.11 0.24 -10000 0 -0.53 117 117
GNA15 0.022 0.004 -10000 0 -10000 0 0
GIT1 0.022 0.003 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 0.001 9 -0.001 88 97
GNA11 0.022 0.004 -10000 0 -10000 0 0
LHCGR -0.007 0.021 0.23 1 -10000 0 1
AGTR1 -0.13 0.24 -10000 0 -0.53 132 132
desensitization of G-protein coupled receptor protein signaling pathway 0.014 0.018 0.19 1 -10000 0 1
IPCEF1/ARNO 0.009 0.15 -10000 0 -0.84 13 13
alphaIIb/beta3 Integrin 0.012 0.093 -10000 0 -0.39 25 25
PLK1 signaling events

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.008 0.053 0.16 37 -0.11 1 38
BUB1B 0.021 0.03 0.11 1 -0.24 3 4
PLK1 0.009 0.018 0.082 6 -0.086 1 7
PLK1S1 0.009 0.021 -10000 0 -0.19 4 4
KIF2A 0.007 0.021 0.23 3 -10000 0 3
regulation of mitotic centrosome separation 0.009 0.018 0.084 5 -0.086 1 6
GOLGA2 0.022 0.003 -10000 0 -10000 0 0
Hec1/SPC24 0.12 0.1 0.26 127 -0.29 1 128
WEE1 0.008 0.059 -10000 0 -0.33 12 12
cytokinesis 0.018 0.074 0.2 4 -0.31 14 18
PP2A-alpha B56 0.056 0.049 -10000 0 -0.49 2 2
AURKA 0.012 0.024 0.14 3 -0.19 3 6
PICH/PLK1 0.034 0.052 0.22 10 -0.23 1 11
CENPE 0.001 0.024 0.27 1 -0.2 1 2
RhoA/GTP 0.015 0.005 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.007 0.022 0.23 3 -10000 0 3
PPP2CA 0.021 0.006 -10000 0 -10000 0 0
FZR1 0.022 0.004 -10000 0 -10000 0 0
TPX2 0.054 0.042 0.17 36 -10000 0 36
PAK1 0.023 0.016 0.36 1 -10000 0 1
SPC24 0.081 0.099 0.24 137 -0.3 1 138
FBXW11 0.021 0.006 -10000 0 -10000 0 0
CLSPN 0.012 0.044 -10000 0 -0.22 13 13
GORASP1 0.021 0.006 -10000 0 -10000 0 0
metaphase 0 0.002 0.013 7 -0.012 2 9
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.004 0.01 0.045 6 -10000 0 6
G2 phase of mitotic cell cycle -0.001 0.002 0.012 8 -0.013 1 9
STAG2 0.023 0.003 -10000 0 -10000 0 0
GRASP65/GM130/RAB1/GTP -0.026 0.15 -10000 0 -0.53 41 41
spindle elongation 0.009 0.018 0.084 5 -0.086 1 6
ODF2 0.023 0.004 -10000 0 -10000 0 0
BUB1 0.035 0.054 -10000 0 -0.54 2 2
TPT1 -0.003 0.05 -10000 0 -0.19 33 33
CDC25C 0.042 0.097 0.21 2 -0.29 34 36
CDC25B 0.021 0.011 -10000 0 -10000 0 0
SGOL1 0.008 0.053 0.11 1 -0.16 37 38
RHOA 0.021 0.007 -10000 0 -10000 0 0
CCNB1/CDK1 0.04 0.056 -10000 0 -0.23 2 2
CDC14B -0.005 0.003 -10000 0 -10000 0 0
CDC20 0.16 0.11 0.23 326 -0.3 4 330
PLK1/PBIP1 0.003 0.011 -10000 0 -10000 0 0
mitosis -0.002 0.004 0.024 3 -0.018 18 21
FBXO5 0.006 0.02 0.14 2 -10000 0 2
CDC2 0.001 0.003 -10000 0 -0.011 7 7
NDC80 0.1 0.11 0.25 173 -0.3 1 174
metaphase plate congression 0.003 0.049 -10000 0 -0.23 20 20
ERCC6L 0.031 0.054 0.2 9 -0.27 1 10
NLP/gamma Tubulin 0.006 0.014 0.11 1 -0.1 2 3
microtubule cytoskeleton organization -0.003 0.05 -10000 0 -0.19 33 33
G2/M transition DNA damage checkpoint -0.001 0.002 0.01 5 -10000 0 5
PPP1R12A 0.023 0.003 -10000 0 -10000 0 0
interphase -0.001 0.002 0.01 5 -10000 0 5
PLK1/PRC1-2 0.1 0.097 0.25 70 -0.19 8 78
GRASP65/GM130/RAB1/GTP/PLK1 0.038 0.02 -10000 0 -10000 0 0
RAB1A 0.021 0.006 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.006 0.015 0.076 6 -0.072 1 7
mitotic prometaphase 0 0.004 0.018 20 -10000 0 20
proteasomal ubiquitin-dependent protein catabolic process 0.008 0.1 -10000 0 -0.46 18 18
microtubule-based process 0.086 0.084 0.17 238 -0.18 11 249
Golgi organization 0.009 0.018 0.084 5 -0.086 1 6
Cohesin/SA2 0.022 0.015 -10000 0 -10000 0 0
PPP1CB/MYPT1 0.033 0.006 -10000 0 -10000 0 0
KIF20A 0.11 0.13 0.23 242 -0.3 15 257
APC/C/CDC20 0.11 0.077 0.17 322 -0.16 5 327
PPP2R1A 0.022 0.004 -10000 0 -10000 0 0
chromosome segregation 0.003 0.011 -10000 0 -10000 0 0
PRC1 0.044 0.067 0.24 48 -10000 0 48
ECT2 0.096 0.11 0.22 217 -10000 0 217
C13orf34 0.007 0.015 0.071 6 -10000 0 6
NUDC 0.003 0.049 -10000 0 -0.23 20 20
regulation of attachment of spindle microtubules to kinetochore 0.021 0.03 0.11 1 -0.24 3 4
spindle assembly 0.007 0.017 0.12 2 -10000 0 2
spindle stabilization 0.009 0.021 -10000 0 -0.19 4 4
APC/C/HCDH1 0.019 0.005 -10000 0 -10000 0 0
MKLP2/PLK1 0.086 0.084 0.17 238 -0.18 11 249
CCNB1 0.046 0.073 0.24 60 -0.31 2 62
PPP1CB 0.023 0.004 -10000 0 -10000 0 0
BTRC 0.022 0.005 -10000 0 -10000 0 0
ROCK2 0.006 0.047 -10000 0 -0.25 4 4
TUBG1 0.008 0.024 0.11 1 -0.18 6 7
G2/M transition of mitotic cell cycle 0.004 0.028 -10000 0 -0.22 2 2
MLF1IP -0.006 0.011 -10000 0 -10000 0 0
INCENP 0.022 0.002 -10000 0 -10000 0 0
Canonical Wnt signaling pathway

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.023 0.015 -10000 0 -10000 0 0
AES 0.022 0.013 -10000 0 -10000 0 0
FBXW11 0.021 0.006 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.031 0.011 -10000 0 -10000 0 0
SMAD4 0.022 0.005 -10000 0 -10000 0 0
DKK2 -0.074 0.21 -10000 0 -0.53 86 86
TLE1 0.022 0.012 -10000 0 -10000 0 0
MACF1 0.02 0.035 -10000 0 -0.53 2 2
CTNNB1 0.087 0.12 0.29 32 -0.38 6 38
WIF1 -0.32 0.27 0.23 1 -0.53 307 308
beta catenin/RanBP3 0.009 0.1 0.44 17 -0.44 1 18
KREMEN2 0.15 0.11 0.23 317 -0.3 6 323
DKK1 0.021 0.089 0.24 21 -0.51 10 31
beta catenin/beta TrCP1 0.095 0.12 0.3 24 -0.36 4 28
FZD1 0.022 0.006 -10000 0 -10000 0 0
AXIN2 -0.036 0.27 0.57 7 -1.4 17 24
AXIN1 0.023 0.005 -10000 0 -10000 0 0
RAN 0.023 0.002 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.025 0.11 -10000 0 -0.56 13 13
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 0.051 0.13 -10000 0 -0.54 14 14
Axin1/APC/GSK3 0.057 0.076 0.26 10 -0.34 2 12
Axin1/APC/GSK3/beta catenin/Macf1 0.047 0.099 0.28 10 -0.36 6 16
HNF1A 0.026 0.029 0.23 8 -10000 0 8
CTBP1 0.021 0.014 -10000 0 -10000 0 0
MYC 0.055 0.18 0.58 48 -10000 0 48
RANBP3 0.022 0.004 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.026 0.19 -10000 0 -0.37 80 80
NKD1 -0.022 0.15 0.23 4 -0.53 40 44
TCF4 0.019 0.044 -10000 0 -0.52 3 3
TCF3 0.022 0.013 -10000 0 -10000 0 0
WNT1/LRP6/FZD1/Axin1 0.052 0.024 -10000 0 -10000 0 0
Ran/GTP 0.017 0.002 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES -0.006 0.11 0.4 15 -0.4 13 28
LEF1 0.023 0.017 0.23 1 -10000 0 1
DVL1 0.053 0.078 0.23 1 -0.52 4 5
CSNK2A1 0.022 0.005 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES 0.049 0.15 -10000 0 -0.63 13 13
DKK1/LRP6/Kremen 2 0.11 0.11 0.31 15 -0.36 10 25
LRP6 0.022 0.006 -10000 0 -10000 0 0
CSNK1A1 0.022 0.015 -10000 0 -10000 0 0
NLK 0.021 0.009 -10000 0 -10000 0 0
CCND1 0.062 0.26 0.58 67 -1.4 6 73
WNT1 0.022 0.019 0.23 3 -10000 0 3
GSK3A 0.023 0.005 -10000 0 -10000 0 0
GSK3B 0.02 0.007 -10000 0 -10000 0 0
FRAT1 0.02 0.025 -10000 0 -0.53 1 1
PPP2R5D 0.067 0.085 0.32 39 -0.37 1 40
APC 0.014 0.066 0.2 50 -10000 0 50
WNT1/LRP6/FZD1 0.13 0.11 0.23 280 -10000 0 280
CREBBP 0.022 0.013 -10000 0 -10000 0 0
IL6-mediated signaling events

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.15 0.23 -10000 0 -0.68 16 16
CRP -0.15 0.23 -10000 0 -0.65 21 21
cell cycle arrest -0.18 0.26 -10000 0 -0.63 54 54
TIMP1 -0.12 0.21 -10000 0 -0.62 17 17
IL6ST -0.01 0.098 -10000 0 -0.53 16 16
Rac1/GDP -0.066 0.16 -10000 0 -0.4 57 57
AP1 0.038 0.16 -10000 0 -0.59 9 9
GAB2 0.014 0.093 -10000 0 -0.53 14 14
TNFSF11 -0.15 0.23 -10000 0 -0.69 16 16
HSP90B1 -0.002 0.088 -10000 0 -0.76 5 5
GAB1 0.026 0.01 -10000 0 -10000 0 0
MAPK14 -0.044 0.14 -10000 0 -0.55 19 19
AKT1 0.039 0.073 0.29 6 -0.36 3 9
FOXO1 0.037 0.07 0.28 6 -0.36 1 7
MAP2K6 -0.055 0.14 -10000 0 -0.39 52 52
mol:GTP -0.002 0.003 -10000 0 -10000 0 0
MAP2K4 -0.089 0.17 -10000 0 -0.45 54 54
MITF -0.062 0.15 -10000 0 -0.39 59 59
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.022 0.004 -10000 0 -10000 0 0
A2M -0.44 0.65 -10000 0 -1.4 165 165
CEBPB 0.026 0.005 -10000 0 -10000 0 0
GRB2/SOS1/GAB family/SHP2 0.027 0.13 0.27 2 -0.51 11 13
STAT3 -0.18 0.27 -10000 0 -0.67 53 53
STAT1 -0.006 0.1 -10000 0 -0.85 7 7
CEBPD -0.15 0.24 -10000 0 -0.62 34 34
PIK3CA 0.013 0.012 -10000 0 -10000 0 0
PI3K 0.018 0.017 -10000 0 -10000 0 0
JUN 0.022 0.004 -10000 0 -10000 0 0
PIAS3/MITF -0.056 0.15 -10000 0 -0.38 58 58
MAPK11 -0.044 0.14 -10000 0 -0.54 20 20
STAT3 (dimer)/FOXO1 -0.2 0.3 0.4 1 -0.64 104 105
GRB2/SOS1/GAB family 0.007 0.16 -10000 0 -0.46 22 22
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.046 0.15 -10000 0 -0.36 67 67
GRB2 0.027 0.008 -10000 0 -10000 0 0
JAK2 0.02 0.007 -10000 0 -10000 0 0
LBP -0.093 0.19 -10000 0 -0.62 9 9
PIK3R1 0.021 0.007 -10000 0 -10000 0 0
JAK1 0.014 0.02 -10000 0 -10000 0 0
MYC -0.14 0.24 -10000 0 -0.58 40 40
FGG -0.46 0.53 -10000 0 -1 233 233
macrophage differentiation -0.18 0.26 -10000 0 -0.63 54 54
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.029 0.15 -10000 0 -0.34 77 77
JUNB -0.15 0.23 -10000 0 -0.65 20 20
FOS -0.043 0.18 -10000 0 -0.53 58 58
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.063 0.16 -10000 0 -0.39 65 65
STAT1/PIAS1 -0.067 0.16 -10000 0 -0.4 59 59
GRB2/SOS1/GAB family/SHP2/PI3K 0.038 0.071 -10000 0 -0.37 4 4
STAT3 (dimer) -0.18 0.27 -10000 0 -0.66 53 53
PRKCD -0.11 0.2 0.3 3 -0.5 51 54
IL6R 0.004 0.076 -10000 0 -0.53 9 9
SOCS3 -0.032 0.15 -10000 0 -0.63 15 15
gp130 (dimer)/JAK1/JAK1/LMO4 0.012 0.076 -10000 0 -0.33 16 16
Rac1/GTP -0.076 0.17 -10000 0 -0.43 56 56
HCK 0.02 0.043 -10000 0 -0.53 3 3
MAPKKK cascade 0.046 0.14 -10000 0 -0.58 9 9
bone resorption -0.15 0.22 -10000 0 -0.64 17 17
IRF1 -0.16 0.23 -10000 0 -0.68 17 17
mol:GDP -0.067 0.15 -10000 0 -0.41 55 55
SOS1 0.029 0.012 -10000 0 -10000 0 0
VAV1 -0.068 0.15 -10000 0 -0.42 55 55
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.033 0.16 -10000 0 -0.58 26 26
PTPN11 0.008 0.057 -10000 0 -0.81 2 2
IL6/IL6RA -0.049 0.16 -10000 0 -0.42 74 74
gp130 (dimer)/TYK2/TYK2/LMO4 0.015 0.072 -10000 0 -0.33 16 16
gp130 (dimer)/JAK2/JAK2/LMO4 0.014 0.072 -10000 0 -0.33 16 16
IL6 -0.076 0.2 -10000 0 -0.54 77 77
PIAS3 0.021 0.007 -10000 0 -10000 0 0
PTPRE 0.02 0.04 -10000 0 -0.53 2 2
PIAS1 0.023 0.002 -10000 0 -10000 0 0
RAC1 0.021 0.004 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.055 0.14 -10000 0 -0.34 81 81
LMO4 0.008 0.026 0.21 1 -10000 0 1
STAT3 (dimer)/PIAS3 -0.16 0.26 -10000 0 -0.65 50 50
MCL1 0.048 0.082 0.45 3 -10000 0 3
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.03 0.033 0.24 12 -10000 0 12
NFATC2 -0.04 0.22 -10000 0 -0.56 68 68
NFATC3 0.011 0.064 -10000 0 -0.27 9 9
CD40LG -0.17 0.35 -10000 0 -0.88 70 70
ITCH -0.018 0.095 -10000 0 -10000 0 0
CBLB -0.019 0.093 -10000 0 -10000 0 0
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.1 0.28 -10000 0 -0.81 45 45
JUNB 0.021 0.025 -10000 0 -0.53 1 1
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.023 0.12 -10000 0 -0.29 79 79
T cell anergy -0.05 0.16 0.29 3 -0.41 69 72
TLE4 -0.029 0.16 -10000 0 -0.47 38 38
Jun/NFAT1-c-4/p21SNFT -0.047 0.26 -10000 0 -0.91 26 26
AP-1/NFAT1-c-4 -0.12 0.36 -10000 0 -1 39 39
IKZF1 -0.032 0.19 -10000 0 -0.59 33 33
T-helper 2 cell differentiation -0.074 0.25 -10000 0 -0.79 37 37
AP-1/NFAT1 -0.065 0.2 -10000 0 -0.4 97 97
CALM1 -0.004 0.075 -10000 0 -10000 0 0
EGR2 -0.064 0.29 -10000 0 -1.1 27 27
EGR3 -0.067 0.29 -10000 0 -1.1 25 25
NFAT1/FOXP3 -0.006 0.17 -10000 0 -0.46 37 37
EGR1 0.01 0.074 -10000 0 -0.53 9 9
JUN 0.004 0.034 -10000 0 -10000 0 0
EGR4 0.026 0.035 0.24 11 -10000 0 11
mol:Ca2+ -0.022 0.066 -10000 0 -0.17 78 78
GBP3 -0.042 0.2 -10000 0 -0.61 37 37
FOSL1 0.024 0.021 0.28 3 -10000 0 3
NFAT1-c-4/MAF/IRF4 -0.034 0.25 -10000 0 -0.93 24 24
DGKA -0.029 0.16 -10000 0 -0.51 26 26
CREM 0.022 0.004 -10000 0 -10000 0 0
NFAT1-c-4/PPARG -0.073 0.27 -10000 0 -0.9 29 29
CTLA4 -0.021 0.14 -10000 0 -0.49 20 20
NFAT1-c-4 (dimer)/EGR1 -0.044 0.26 -10000 0 -0.99 23 23
NFAT1-c-4 (dimer)/EGR4 -0.036 0.25 -10000 0 -0.94 23 23
FOS -0.06 0.18 -10000 0 -0.54 58 58
IFNG -0.11 0.31 -10000 0 -0.8 64 64
T cell activation -0.064 0.18 -10000 0 -0.67 19 19
MAF 0.022 0.005 -10000 0 -10000 0 0
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.029 0.16 0.73 17 -10000 0 17
TNF -0.062 0.24 -10000 0 -0.86 30 30
FASLG -0.13 0.42 -10000 0 -1.5 39 39
TBX21 -0.031 0.17 -10000 0 -0.53 49 49
BATF3 0.022 0.004 -10000 0 -10000 0 0
PRKCQ -0.026 0.16 -10000 0 -0.54 42 42
PTPN1 -0.029 0.16 -10000 0 -0.53 24 24
NFAT1-c-4/ICER1 -0.039 0.25 -10000 0 -0.93 23 23
GATA3 0.009 0.09 0.23 3 -0.53 13 16
T-helper 1 cell differentiation -0.11 0.3 -10000 0 -0.78 64 64
IL2RA -0.094 0.28 -10000 0 -0.78 48 48
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.026 0.15 -10000 0 -0.51 26 26
E2F1 0.024 0.006 -10000 0 -10000 0 0
PPARG -0.036 0.17 -10000 0 -0.53 51 51
SLC3A2 -0.029 0.16 -10000 0 -0.53 24 24
IRF4 0.015 0.061 -10000 0 -0.53 6 6
PTGS2 -0.15 0.32 -10000 0 -0.85 61 61
CSF2 -0.16 0.32 -10000 0 -0.86 54 54
JunB/Fra1/NFAT1-c-4 -0.029 0.24 -10000 0 -0.89 23 23
IL4 -0.077 0.26 -10000 0 -0.83 37 37
IL5 -0.13 0.29 -10000 0 -0.9 38 38
IL2 -0.065 0.19 -10000 0 -0.68 19 19
IL3 -0.043 0.16 -10000 0 -0.78 18 18
RNF128 -0.082 0.24 -10000 0 -0.61 81 81
NFATC1 -0.03 0.17 -10000 0 -0.73 17 17
CDK4 0.039 0.15 0.58 14 -10000 0 14
PTPRK -0.029 0.16 -10000 0 -0.53 24 24
IL8 -0.13 0.3 -10000 0 -0.9 39 39
POU2F1 0.021 0.006 -10000 0 -10000 0 0
Coregulation of Androgen receptor activity

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.022 0.005 -10000 0 -10000 0 0
SVIL 0.022 0.004 -10000 0 -10000 0 0
ZNF318 0.022 0.005 -10000 0 -10000 0 0
JMJD2C 0.006 0.011 0.055 1 -10000 0 1
T-DHT/AR/Ubc9 -0.075 0.16 -10000 0 -0.36 100 100
CARM1 0.022 0.004 -10000 0 -10000 0 0
PRDX1 0.022 0.004 -10000 0 -10000 0 0
PELP1 0.021 0.005 -10000 0 -10000 0 0
CTNNB1 0.021 0.006 -10000 0 -10000 0 0
AKT1 0.021 0.005 -10000 0 -10000 0 0
PTK2B 0.021 0.007 -10000 0 -10000 0 0
MED1 0.022 0.004 -10000 0 -10000 0 0
MAK -0.026 0.16 -10000 0 -0.53 43 43
response to oxidative stress 0 0 -10000 0 -10000 0 0
HIP1 0.022 0.004 -10000 0 -10000 0 0
GSN 0.023 0.003 -10000 0 -10000 0 0
NCOA2 0.021 0.025 -10000 0 -0.53 1 1
NCOA6 0.022 0.005 -10000 0 -10000 0 0
DNA-PK 0.042 0.013 -10000 0 -10000 0 0
NCOA4 0.022 0.005 -10000 0 -10000 0 0
PIAS3 0.021 0.007 -10000 0 -10000 0 0
cell proliferation -0.088 0.24 -10000 0 -0.77 51 51
XRCC5 0.022 0.004 -10000 0 -10000 0 0
UBE3A 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR/SNURF -0.085 0.17 -10000 0 -0.38 110 110
FHL2 -0.028 0.07 -10000 0 -0.34 3 3
RANBP9 0.022 0.004 -10000 0 -10000 0 0
JMJD1A -0.039 0.063 -10000 0 -0.13 160 160
CDK6 0.023 0.023 0.38 2 -10000 0 2
TGFB1I1 0.023 0.003 -10000 0 -10000 0 0
T-DHT/AR/CyclinD1 -0.071 0.15 0.26 1 -0.36 95 96
XRCC6 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR -0.094 0.18 -10000 0 -0.38 105 105
CTDSP1 0.022 0.004 -10000 0 -10000 0 0
CTDSP2 0.022 0.004 -10000 0 -10000 0 0
BRCA1 0.022 0.003 -10000 0 -10000 0 0
TCF4 0.018 0.043 -10000 0 -0.53 3 3
CDKN2A 0.091 0.14 0.23 207 -0.31 20 227
SRF 0.026 0.005 -10000 0 -10000 0 0
NKX3-1 -0.096 0.12 -10000 0 -0.23 217 217
KLK3 0.016 0.048 -10000 0 -10000 0 0
TMF1 0.02 0.007 -10000 0 -10000 0 0
HNRNPA1 0.023 0.002 -10000 0 -10000 0 0
AOF2 0 0.001 -10000 0 -10000 0 0
APPL1 -0.009 0.004 -10000 0 -10000 0 0
T-DHT/AR/Caspase 8 -0.074 0.15 -10000 0 -0.36 99 99
AR -0.12 0.22 -10000 0 -0.56 100 100
UBA3 0.02 0.007 -10000 0 -10000 0 0
PATZ1 0.022 0.005 -10000 0 -10000 0 0
PAWR 0.023 0.002 -10000 0 -10000 0 0
PRKDC 0.022 0.005 -10000 0 -10000 0 0
PA2G4 0.022 0.002 -10000 0 -10000 0 0
UBE2I 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 -0.067 0.14 -10000 0 -0.33 100 100
RPS6KA3 0.022 0.005 -10000 0 -10000 0 0
T-DHT/AR/ARA70 -0.075 0.16 -10000 0 -0.36 99 99
LATS2 0.021 0.006 -10000 0 -10000 0 0
T-DHT/AR/PRX1 -0.067 0.14 -10000 0 -0.33 100 100
Cyclin D3/CDK11 p58 0.016 0.003 -10000 0 -10000 0 0
VAV3 0.021 0.025 -10000 0 -0.53 1 1
KLK2 -0.038 0.084 -10000 0 -0.42 7 7
CASP8 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.059 0.15 -10000 0 -0.33 99 99
TMPRSS2 -0.32 0.46 -10000 0 -0.97 161 161
CCND1 0.014 0.063 0.38 1 -0.53 6 7
PIAS1 0.023 0.002 -10000 0 -10000 0 0
mol:T-DHT -0.017 0.029 -10000 0 -0.066 119 119
CDC2L1 0 0 -10000 0 -10000 0 0
PIAS4 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR/CDK6 -0.069 0.15 0.24 2 -0.36 93 95
CMTM2 -0.043 0.18 -10000 0 -0.53 56 56
SNURF 0.004 0.095 -10000 0 -0.53 15 15
ZMIZ1 -0.003 0.042 -10000 0 -10000 0 0
CCND3 0.022 0.004 -10000 0 -10000 0 0
TGIF1 0.021 0.005 -10000 0 -10000 0 0
FKBP4 0.022 0.017 0.38 1 -10000 0 1
Reelin signaling pathway

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.035 0.02 -10000 0 -10000 0 0
VLDLR 0.019 0.026 -10000 0 -0.53 1 1
CRKL 0.021 0.006 -10000 0 -10000 0 0
LRPAP1 0.021 0.006 -10000 0 -10000 0 0
FYN 0.021 0.025 -10000 0 -0.53 1 1
ITGA3 0.018 0.05 -10000 0 -0.53 4 4
RELN/VLDLR/Fyn -0.02 0.14 -10000 0 -0.34 76 76
MAPK8IP1/MKK7/MAP3K11/JNK1 0.059 0.029 -10000 0 -0.29 1 1
AKT1 -0.023 0.076 -10000 0 -0.26 28 28
MAP2K7 0.022 0.004 -10000 0 -10000 0 0
RAPGEF1 0.022 0.003 -10000 0 -10000 0 0
DAB1 0.026 0.056 0.24 29 -10000 0 29
RELN/LRP8/DAB1 -0.009 0.13 0.29 1 -0.31 78 79
LRPAP1/LRP8 0.031 0.013 -10000 0 -10000 0 0
RELN/LRP8/DAB1/Fyn 0 0.13 0.29 1 -0.3 78 79
DAB1/alpha3/beta1 Integrin -0.006 0.12 -10000 0 -0.28 65 65
long-term memory -0.01 0.15 0.3 2 -0.31 86 88
DAB1/LIS1 0.005 0.13 -10000 0 -0.28 71 71
DAB1/CRLK/C3G -0.003 0.11 -10000 0 -0.28 56 56
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
DAB1/NCK2 0.007 0.13 0.27 1 -0.28 71 72
ARHGEF2 0.022 0.005 -10000 0 -10000 0 0
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.006 0.12 0.24 24 -0.53 22 46
CDK5R1 0.027 0.032 0.24 10 -10000 0 10
RELN -0.065 0.2 0.23 3 -0.53 78 81
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
RELN/LRP8/Fyn -0.017 0.14 -10000 0 -0.34 78 78
GRIN2A/RELN/LRP8/DAB1/Fyn 0 0.16 0.3 2 -0.32 91 93
MAPK8 0.022 0.004 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.012 0.13 0.33 2 -0.3 76 78
ITGB1 0.022 0.004 -10000 0 -10000 0 0
MAP1B -0.046 0.11 0.28 2 -0.3 74 76
RELN/LRP8 -0.018 0.14 -10000 0 -0.33 78 78
GRIN2B/RELN/LRP8/DAB1/Fyn 0.01 0.14 0.3 1 -0.3 72 73
PI3K 0.017 0.017 -10000 0 -10000 0 0
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.029 0.035 -10000 0 -0.39 3 3
RAP1A -0.035 0.11 0.34 8 -0.3 2 10
PAFAH1B1 0.022 0.005 -10000 0 -10000 0 0
MAPK8IP1 0.021 0.027 0.23 1 -0.53 1 2
CRLK/C3G 0.031 0.01 -10000 0 -10000 0 0
GRIN2B 0 0.03 0.23 5 -10000 0 5
NCK2 0.023 0.002 -10000 0 -10000 0 0
neuron differentiation -0.012 0.09 0.19 1 -0.34 12 13
neuron adhesion -0.037 0.11 0.33 11 -0.33 1 12
LRP8 0.023 0.016 0.23 3 -10000 0 3
GSK3B -0.022 0.069 -10000 0 -0.26 27 27
RELN/VLDLR/DAB1/Fyn -0.003 0.13 0.32 2 -0.29 76 78
MAP3K11 0.023 0.002 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.021 0.085 -10000 0 -0.27 39 39
CDK5 0.022 0.004 -10000 0 -10000 0 0
MAPT 0.007 0.12 0.76 10 -0.49 6 16
neuron migration -0.014 0.12 0.4 1 -0.33 31 32
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 -0.012 0.091 0.19 1 -0.34 12 13
RELN/VLDLR -0.007 0.13 -10000 0 -0.3 76 76
Signaling events mediated by VEGFR1 and VEGFR2

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.024 0.06 -10000 0 -0.39 10 10
AKT1 -0.006 0.18 0.36 11 -0.54 31 42
PTK2B -0.059 0.18 0.37 6 -0.65 27 33
VEGFR2 homodimer/Frs2 -0.056 0.19 -10000 0 -0.45 80 80
CAV1 -0.12 0.24 -10000 0 -0.53 127 127
CALM1 0.022 0.005 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 -0.04 0.18 -10000 0 -0.42 74 74
endothelial cell proliferation -0.012 0.18 0.37 14 -0.54 29 43
mol:Ca2+ -0.041 0.17 0.36 3 -0.62 24 27
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac -0.028 0.18 -10000 0 -0.65 24 24
RP11-342D11.1 -0.057 0.17 -10000 0 -0.64 24 24
CDH5 -0.085 0.22 -10000 0 -0.53 96 96
VEGFA homodimer 0.05 0.022 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
SHC2 0.019 0.043 -10000 0 -0.53 3 3
HRAS/GDP -0.025 0.15 -10000 0 -0.55 24 24
SH2D2A 0.021 0.025 -10000 0 -0.53 1 1
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS -0.023 0.17 -10000 0 -0.57 28 28
VEGFR2 homodimer/VEGFA homodimer/TsAd -0.039 0.18 -10000 0 -0.42 73 73
VEGFR1 homodimer 0.021 0.006 -10000 0 -10000 0 0
SHC/GRB2/SOS1 -0.013 0.17 -10000 0 -0.6 24 24
GRB10 -0.042 0.17 0.35 2 -0.63 24 26
PTPN11 0.023 0.002 -10000 0 -10000 0 0
GRB2 0.022 0.004 -10000 0 -10000 0 0
PAK1 0.023 0.016 0.38 1 -10000 0 1
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin -0.074 0.24 -10000 0 -0.64 55 55
HRAS 0.022 0.004 -10000 0 -10000 0 0
VEGF/Rho/ROCK1/Integrin Complex -0.037 0.13 -10000 0 -0.44 35 35
HIF1A 0.022 0.004 -10000 0 -10000 0 0
FRS2 0.022 0.005 -10000 0 -10000 0 0
oxygen and reactive oxygen species metabolic process -0.029 0.18 -10000 0 -0.64 24 24
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 -0.006 0.12 -10000 0 -0.53 24 24
Nck/Pak 0.028 0.013 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Fyn -0.041 0.19 -10000 0 -0.41 83 83
mol:GDP -0.02 0.16 -10000 0 -0.58 24 24
mol:NADP -0.016 0.17 0.35 9 -0.5 32 41
eNOS/Hsp90 -0.008 0.16 0.35 8 -0.46 32 40
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:IP3 -0.042 0.17 0.36 3 -0.63 24 27
HIF1A/ARNT 0.031 0.01 -10000 0 -10000 0 0
SHB 0.021 0.007 -10000 0 -10000 0 0
VEGFA 0.023 0.004 -10000 0 -10000 0 0
VEGFC 0.019 0.036 -10000 0 -0.53 2 2
FAK1/Vinculin -0.042 0.21 0.34 4 -0.62 38 42
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.021 0.007 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin -0.034 0.19 -10000 0 -0.67 28 28
PTPN6 0.021 0.006 -10000 0 -10000 0 0
EPAS1 -0.077 0.22 -10000 0 -0.54 91 91
mol:L-citrulline -0.016 0.17 0.35 9 -0.5 32 41
ITGAV 0.022 0.004 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 -0.028 0.18 -10000 0 -0.65 24 24
VEGFR2 homodimer/VEGFA homodimer -0.039 0.18 -10000 0 -0.69 24 24
VEGFR2/3 heterodimer -0.072 0.22 -10000 0 -0.47 94 94
VEGFB 0.023 0.002 -10000 0 -10000 0 0
MAPK11 -0.043 0.18 0.41 5 -0.59 29 34
VEGFR2 homodimer -0.069 0.21 -10000 0 -0.52 76 76
FLT1 0.021 0.006 -10000 0 -10000 0 0
NEDD4 0.023 0.003 -10000 0 -10000 0 0
MAPK3 -0.05 0.17 0.34 9 -0.6 25 34
MAPK1 -0.049 0.17 0.32 11 -0.6 25 36
VEGFA145/NRP2 0.03 0.034 -10000 0 -0.38 3 3
VEGFR1/2 heterodimer -0.058 0.19 -10000 0 -0.44 83 83
KDR -0.069 0.21 -10000 0 -0.52 76 76
VEGFA165/NRP1/VEGFR2 homodimer -0.035 0.18 -10000 0 -0.67 24 24
SRC 0.022 0.004 -10000 0 -10000 0 0
platelet activating factor biosynthetic process -0.046 0.17 0.37 8 -0.61 25 33
PI3K -0.036 0.15 -10000 0 -0.61 23 23
VEGFR2 homodimer/VEGFA homodimer/NCK1 -0.037 0.17 -10000 0 -0.43 64 64
FES -0.045 0.18 0.36 1 -0.67 24 25
GAB1 -0.046 0.18 -10000 0 -0.61 31 31
VEGFR2 homodimer/VEGFA homodimer/Src -0.04 0.18 -10000 0 -0.42 75 75
CTNNB1 0.021 0.006 -10000 0 -10000 0 0
SOS1 0.022 0.004 -10000 0 -10000 0 0
ARNT 0.021 0.006 -10000 0 -10000 0 0
eNOS/Caveolin-1 -0.065 0.19 0.33 4 -0.47 57 61
VEGFR2 homodimer/VEGFA homodimer/Yes -0.04 0.18 -10000 0 -0.41 79 79
PI3K/GAB1 -0.007 0.16 -10000 0 -0.53 27 27
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak -0.018 0.16 -10000 0 -0.62 22 22
PRKACA 0.022 0.004 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer -0.058 0.21 -10000 0 -0.47 78 78
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
CDC42 -0.043 0.18 0.36 3 -0.65 24 27
actin cytoskeleton reorganization -0.039 0.18 -10000 0 -0.42 73 73
PTK2 -0.058 0.21 0.32 4 -0.62 44 48
EDG1 -0.057 0.17 -10000 0 -0.64 24 24
mol:DAG -0.042 0.17 0.36 3 -0.63 24 27
CaM/Ca2+ -0.031 0.16 -10000 0 -0.59 23 23
MAP2K3 -0.045 0.13 -10000 0 -0.56 23 23
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 -0.034 0.18 -10000 0 -0.66 24 24
PLCG1 -0.043 0.18 0.36 3 -0.64 24 27
VEGFR2 homodimer/VEGFA homodimer/Src/Shb -0.029 0.17 -10000 0 -0.64 24 24
IQGAP1 0.022 0.004 -10000 0 -10000 0 0
YES1 0.021 0.006 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP2 -0.041 0.18 -10000 0 -0.42 76 76
VEGFR2 homodimer/VEGFA homodimer/SHP1 -0.039 0.18 -10000 0 -0.41 78 78
cell migration -0.056 0.2 0.41 2 -0.57 44 46
mol:PI-3-4-5-P3 -0.033 0.14 -10000 0 -0.56 23 23
FYN 0.021 0.025 -10000 0 -0.53 1 1
VEGFB/NRP1 -0.037 0.16 -10000 0 -0.6 24 24
mol:NO -0.016 0.17 0.35 9 -0.5 32 41
PXN 0.023 0.002 -10000 0 -10000 0 0
HRAS/GTP -0.036 0.14 -10000 0 -0.55 24 24
VEGFR2 homodimer/VEGFA homodimer/GRB10 -0.043 0.17 -10000 0 -0.66 24 24
VHL 0.021 0.006 -10000 0 -10000 0 0
ITGB3 0.01 0.082 -10000 0 -0.53 11 11
NOS3 -0.022 0.18 0.37 8 -0.57 32 40
VEGFR2 homodimer/VEGFA homodimer/Sck -0.042 0.19 -10000 0 -0.44 72 72
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCA -0.054 0.16 0.35 3 -0.59 25 28
PRKCB -0.066 0.18 0.35 3 -0.64 26 29
VCL 0.022 0.005 -10000 0 -10000 0 0
VEGFA165/NRP1 -0.037 0.17 -10000 0 -0.64 24 24
VEGFR1/2 heterodimer/VEGFA homodimer -0.042 0.18 -10000 0 -0.42 75 75
VEGFA165/NRP2 0.03 0.034 -10000 0 -0.38 3 3
MAPKKK cascade -0.036 0.14 -10000 0 -0.54 24 24
NRP2 0.019 0.043 -10000 0 -0.53 3 3
VEGFC homodimer 0.019 0.035 -10000 0 -0.53 2 2
NCK1 0.019 0.008 -10000 0 -10000 0 0
ROCK1 0.022 0.004 -10000 0 -10000 0 0
FAK1/Paxillin -0.042 0.21 0.38 4 -0.61 40 44
MAP3K13 -0.037 0.14 -10000 0 -0.58 23 23
PDPK1 -0.035 0.13 -10000 0 -0.5 23 23
Presenilin action in Notch and Wnt signaling

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.029 0.068 -10000 0 -10000 0 0
HDAC1 0.021 0.005 -10000 0 -10000 0 0
AES 0.022 0.004 -10000 0 -10000 0 0
FBXW11 0.021 0.006 -10000 0 -10000 0 0
DTX1 0.023 0.013 0.23 2 -10000 0 2
LRP6/FZD1 0.03 0.011 -10000 0 -10000 0 0
TLE1 0.022 0.004 -10000 0 -10000 0 0
AP1 -0.051 0.15 -10000 0 -0.34 87 87
NCSTN 0.022 0.005 -10000 0 -10000 0 0
ADAM10 0.023 0.002 -10000 0 -10000 0 0
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 -0.01 0.17 -10000 0 -0.75 23 23
NICD/RBPSUH 0.025 0.067 -10000 0 -10000 0 0
WIF1 -0.32 0.27 0.23 1 -0.53 307 308
NOTCH1 0.01 0.064 -10000 0 -0.4 7 7
PSENEN 0.021 0.007 -10000 0 -10000 0 0
KREMEN2 0.15 0.11 0.23 317 -0.3 6 323
DKK1 0.021 0.089 0.24 21 -0.51 10 31
beta catenin/beta TrCP1 -0.001 0.1 0.28 2 -0.42 12 14
APH1B 0.023 0.002 -10000 0 -10000 0 0
APH1A 0.021 0.006 -10000 0 -10000 0 0
AXIN1 -0.002 0.081 0.26 1 -0.52 8 9
CtBP/CBP/TCF1/TLE1/AES 0.01 0.033 -10000 0 -10000 0 0
PSEN1 0.022 0.005 -10000 0 -10000 0 0
FOS -0.043 0.18 -10000 0 -0.53 58 58
JUN 0.022 0.004 -10000 0 -10000 0 0
MAP3K7 0.022 0.003 -10000 0 -10000 0 0
CTNNB1 -0.008 0.11 0.26 4 -0.42 15 19
MAPK3 0.022 0.003 -10000 0 -10000 0 0
DKK2/LRP6/Kremen 2 0.026 0.19 -10000 0 -0.37 80 80
HNF1A 0.025 0.026 0.23 8 -10000 0 8
CTBP1 0.02 0.006 -10000 0 -10000 0 0
MYC 0.02 0.018 -10000 0 -10000 0 0
NKD1 -0.022 0.15 0.23 4 -0.53 40 44
FZD1 0.021 0.006 -10000 0 -10000 0 0
NOTCH1 precursor/Deltex homolog 1 0.028 0.069 -10000 0 -0.41 1 1
apoptosis -0.051 0.15 -10000 0 -0.34 87 87
Delta 1/NOTCHprecursor 0.027 0.068 -10000 0 -10000 0 0
DLL1 0.022 0.004 -10000 0 -10000 0 0
PPARD 0.006 0.13 -10000 0 -0.95 9 9
Gamma Secretase 0.055 0.027 -10000 0 -10000 0 0
APC -0.018 0.11 0.26 1 -0.42 26 27
DVL1 -0.042 0.089 -10000 0 -0.37 21 21
CSNK2A1 0.022 0.005 -10000 0 -10000 0 0
MAP3K7IP1 -0.001 0.001 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 0.11 0.11 0.31 15 -0.36 10 25
LRP6 0.021 0.006 -10000 0 -10000 0 0
CSNK1A1 0.021 0.006 -10000 0 -10000 0 0
NLK 0.009 0.004 -10000 0 -10000 0 0
CCND1 0.004 0.15 -10000 0 -1.4 6 6
WNT1 0.018 0.022 0.23 3 -10000 0 3
Axin1/APC/beta catenin -0.014 0.13 0.32 4 -0.46 26 30
DKK2 -0.074 0.21 -10000 0 -0.53 86 86
NOTCH1 precursor/DVL1 -0.027 0.11 -10000 0 -0.54 13 13
GSK3B 0.02 0.007 -10000 0 -10000 0 0
FRAT1 0.02 0.025 -10000 0 -0.53 1 1
NOTCH/Deltex homolog 1 0.03 0.069 -10000 0 -0.41 1 1
PPP2R5D 0.015 0.09 0.27 39 -0.41 5 44
MAPK1 0.021 0.006 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 -0.16 0.17 -10000 0 -0.31 279 279
RBPJ 0.021 0.006 -10000 0 -10000 0 0
CREBBP 0.023 0.006 -10000 0 -10000 0 0
Glypican 2 network

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK 0.027 0.033 0.26 9 -9999 0 9
GPC2 0.056 0.085 0.25 73 -9999 0 73
GPC2/Midkine 0.056 0.06 0.27 12 -9999 0 12
neuron projection morphogenesis 0.055 0.06 0.27 12 -9999 0 12
Visual signal transduction: Cones

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.028 0.058 0.22 1 -0.29 14 15
RGS9BP 0.011 0.074 -10000 0 -0.53 9 9
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 -0.004 0.03 0.38 2 -10000 0 2
mol:Na + 0.09 0.07 0.23 9 -0.17 2 11
mol:ADP -0.003 0.062 0.34 14 -10000 0 14
GNAT2 0.018 0.013 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP -0.003 0.12 -10000 0 -0.34 57 57
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.025 0.008 -10000 0 -10000 0 0
GRK7 0.031 0.066 0.3 26 -10000 0 26
CNGB3 0.12 0.11 0.24 248 -0.3 2 250
Cone Metarhodopsin II/X-Arrestin 0.013 0.002 -10000 0 -10000 0 0
mol:Ca2+ -0.008 0.079 0.21 32 -10000 0 32
Cone PDE6 0.01 0.11 -10000 0 -0.3 53 53
Cone Metarhodopsin II 0.028 0.038 0.22 12 -10000 0 12
Na + (4 Units) 0.11 0.094 0.28 50 -0.2 2 52
GNAT2/GDP 0.007 0.11 -10000 0 -0.3 57 57
GNB5 0.023 0.003 -10000 0 -10000 0 0
mol:GMP (4 units) -0.005 0.045 0.18 29 -10000 0 29
Cone Transducin 0.03 0.062 0.24 1 -0.3 14 15
SLC24A2 0.054 0.096 0.24 91 -0.3 5 96
GNB3/GNGT2 0.021 0.075 0.27 1 -0.39 14 15
GNB3 0.025 0.03 0.25 8 -10000 0 8
GNAT2/GTP 0.016 0.004 -10000 0 -10000 0 0
CNGA3 0.011 0.027 0.3 2 -10000 0 2
ARR3 -0.01 0.016 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.091 0.07 0.24 9 -0.17 2 11
mol:Pi -0.003 0.12 -10000 0 -0.34 57 57
Cone CNG Channel 0.078 0.063 -10000 0 -10000 0 0
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.054 0.096 0.24 91 -0.3 5 96
RGS9 -0.036 0.17 -10000 0 -0.53 52 52
PDE6C -0.008 0.017 -10000 0 -10000 0 0
GNGT2 0.005 0.098 -10000 0 -0.53 16 16
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H -0.011 0.015 -10000 0 -10000 0 0
LPA4-mediated signaling events

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 -0.028 0.082 -10000 0 -0.34 31 31
ADCY5 -0.033 0.091 -10000 0 -0.34 39 39
ADCY6 -0.01 0.025 -10000 0 -0.33 3 3
ADCY7 -0.008 0.015 -10000 0 -0.33 1 1
ADCY1 -0.009 0.021 -10000 0 -0.33 2 2
ADCY2 -0.009 0.079 0.27 16 -0.33 16 32
ADCY3 -0.008 0.015 -10000 0 -0.33 1 1
ADCY8 -0.093 0.14 0.21 1 -0.33 129 130
PRKCE -0.006 0.017 -10000 0 -0.39 1 1
ADCY9 -0.009 0.021 -10000 0 -0.33 2 2
mol:DAG 0 0 -10000 0 -10000 0 0
cAMP biosynthetic process -0.016 0.12 0.25 31 -0.28 19 50
HIF-1-alpha transcription factor network

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.018 0.29 -10000 0 -0.87 32 32
HDAC7 0.023 0.007 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 0.071 0.3 -10000 0 -0.81 18 18
SMAD4 0.021 0.01 -10000 0 -10000 0 0
ID2 -0.008 0.3 0.46 1 -0.88 31 32
AP1 -0.024 0.14 -10000 0 -0.4 58 58
ABCG2 -0.042 0.35 0.46 1 -0.9 47 48
HIF1A 0.013 0.076 -10000 0 -0.38 2 2
TFF3 -0.031 0.33 -10000 0 -0.91 39 39
GATA2 -0.039 0.16 -10000 0 -0.53 49 49
AKT1 0.014 0.069 -10000 0 -0.25 1 1
response to hypoxia -0.003 0.065 -10000 0 -0.26 9 9
MCL1 -0.014 0.29 0.46 1 -0.88 29 30
NDRG1 -0.007 0.29 0.46 1 -0.88 28 29
SERPINE1 -0.008 0.29 0.46 1 -0.88 29 30
FECH -0.008 0.3 0.46 1 -0.88 30 31
FURIN -0.007 0.3 0.46 1 -0.88 30 31
NCOA2 0.022 0.025 -10000 0 -0.53 1 1
EP300 0.015 0.072 -10000 0 -0.28 6 6
HMOX1 -0.007 0.3 0.46 1 -0.88 30 31
BHLHE40 -0.009 0.3 0.46 1 -0.87 31 32
BHLHE41 -0.012 0.3 0.46 1 -0.94 29 30
HIF1A/ARNT/SMAD3/SMAD4/SP1 0.056 0.13 -10000 0 -0.43 9 9
ENG 0.005 0.12 0.35 4 -0.63 9 13
JUN 0.018 0.016 -10000 0 -10000 0 0
RORA -0.007 0.3 0.46 1 -0.88 31 32
ABCB1 -0.1 0.38 -10000 0 -1.1 59 59
TFRC -0.029 0.26 -10000 0 -0.86 25 25
CXCR4 -0.007 0.3 0.46 1 -0.88 31 32
TF -0.012 0.3 0.46 1 -0.87 32 33
CITED2 -0.013 0.31 0.46 1 -0.92 31 32
HIF1A/ARNT 0.12 0.41 0.61 2 -1 29 31
LDHA 0.019 0.13 -10000 0 -0.79 9 9
ETS1 -0.014 0.31 0.46 1 -0.94 31 32
PGK1 -0.009 0.3 0.46 1 -0.88 31 32
NOS2 -0.015 0.33 0.46 1 -0.92 34 35
ITGB2 -0.019 0.32 -10000 0 -0.92 36 36
ALDOA -0.006 0.3 0.46 1 -0.88 31 32
Cbp/p300/CITED2 0.003 0.32 -10000 0 -0.96 27 27
FOS -0.047 0.18 -10000 0 -0.54 58 58
HK2 -0.007 0.3 0.46 1 -0.88 31 32
SP1 0.009 0.048 -10000 0 -0.15 8 8
GCK 0.025 0.11 -10000 0 -10000 0 0
HK1 -0.007 0.3 0.46 1 -0.88 31 32
NPM1 -0.009 0.3 0.46 1 -0.87 31 32
EGLN1 -0.008 0.29 0.46 1 -0.88 30 31
CREB1 0.026 0.004 -10000 0 -10000 0 0
PGM1 -0.008 0.3 0.46 1 -0.88 31 32
SMAD3 0.022 0.009 -10000 0 -10000 0 0
EDN1 -0.12 0.38 -10000 0 -1.1 51 51
IGFBP1 -0.008 0.3 0.46 1 -0.87 31 32
VEGFA 0.004 0.23 -10000 0 -0.71 16 16
HIF1A/JAB1 0.025 0.059 -10000 0 -0.27 2 2
CP -0.026 0.29 0.46 1 -0.93 30 31
CXCL12 -0.029 0.34 0.46 1 -0.99 38 39
COPS5 0.023 0.005 -10000 0 -10000 0 0
SMAD3/SMAD4 0.032 0.015 -10000 0 -10000 0 0
BNIP3 -0.007 0.3 0.46 1 -0.88 31 32
EGLN3 0.001 0.3 0.46 1 -0.88 31 32
CA9 0.054 0.34 0.51 8 -0.92 29 37
TERT 0.031 0.3 0.5 8 -0.87 27 35
ENO1 -0.008 0.3 0.46 1 -0.88 31 32
PFKL -0.009 0.3 -10000 0 -0.88 31 31
NCOA1 0.023 0.003 -10000 0 -10000 0 0
ADM -0.008 0.3 0.46 1 -0.88 31 32
ARNT 0.015 0.069 -10000 0 -0.32 1 1
HNF4A 0.027 0.03 0.25 8 -10000 0 8
ADFP -0.018 0.29 -10000 0 -0.87 32 32
SLC2A1 0.051 0.27 0.4 6 -0.69 26 32
LEP 0.006 0.31 0.46 1 -0.88 30 31
HIF1A/ARNT/Cbp/p300 0.065 0.3 -10000 0 -0.79 24 24
EPO 0.035 0.19 -10000 0 -0.75 4 4
CREBBP 0.013 0.076 -10000 0 -0.29 9 9
HIF1A/ARNT/Cbp/p300/HDAC7 0.099 0.32 -10000 0 -0.81 20 20
PFKFB3 -0.008 0.3 0.46 1 -0.87 31 32
NT5E -0.008 0.3 0.46 1 -0.89 31 32
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 0.031 0.03 0.27 1 -0.39 2 3
CRKL -0.048 0.18 0.31 3 -0.6 31 34
mol:PIP3 0.012 0.019 -10000 0 -10000 0 0
AKT1 0.011 0.042 -10000 0 -10000 0 0
PTK2B 0.021 0.007 -10000 0 -10000 0 0
RAPGEF1 -0.046 0.17 0.42 2 -0.57 31 33
RANBP10 0.022 0.005 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
HGF/MET/SHIP2 -0.033 0.15 0.25 1 -0.34 95 96
MAP3K5 -0.042 0.16 0.34 2 -0.54 34 36
HGF/MET/CIN85/CBL/ENDOPHILINS -0.021 0.15 0.25 1 -0.31 97 98
AP1 -0.026 0.12 -10000 0 -0.34 58 58
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
apoptosis -0.11 0.3 -10000 0 -0.78 80 80
STAT3 (dimer) -0.042 0.12 -10000 0 -0.34 21 21
GAB1/CRKL/SHP2/PI3K -0.02 0.14 -10000 0 -0.53 22 22
INPP5D 0.021 0.025 -10000 0 -0.53 1 1
CBL/CRK -0.045 0.17 -10000 0 -0.58 31 31
PTPN11 0.023 0.002 -10000 0 -10000 0 0
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.022 0.004 -10000 0 -10000 0 0
PTEN 0.02 0.007 -10000 0 -10000 0 0
ELK1 -0.004 0.075 0.3 19 -10000 0 19
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 -0.029 0.087 -10000 0 -0.31 21 21
PAK1 0.012 0.048 0.39 1 -10000 0 1
HGF/MET/RANBP10 -0.033 0.15 0.25 1 -0.33 98 99
HRAS -0.056 0.16 -10000 0 -0.6 14 14
DOCK1 -0.047 0.16 0.4 1 -0.57 31 32
GAB1 -0.057 0.18 -10000 0 -0.65 30 30
CRK -0.056 0.17 -10000 0 -0.62 30 30
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP -0.09 0.21 -10000 0 -0.5 99 99
JUN 0.022 0.004 -10000 0 -10000 0 0
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.035 0.089 0.18 1 -0.21 99 100
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
cell morphogenesis 0.018 0.16 0.33 19 -0.43 15 34
GRB2/SHC -0.009 0.09 -10000 0 -0.28 8 8
FOS -0.043 0.18 -10000 0 -0.53 58 58
GLMN 0.003 0.001 -10000 0 -10000 0 0
cell motility -0.004 0.075 0.3 19 -10000 0 19
HGF/MET/MUC20 -0.044 0.14 0.24 1 -0.33 99 100
cell migration -0.009 0.088 -10000 0 -0.28 8 8
GRB2 0.022 0.004 -10000 0 -10000 0 0
CBL 0.022 0.004 -10000 0 -10000 0 0
MET/RANBP10 0.03 0.03 0.27 1 -0.39 2 3
HGF/MET/Paxillin/FAK1/FAK12/RasGAP -0.036 0.11 -10000 0 -0.27 87 87
MET/MUC20 0.015 0.028 0.25 1 -0.39 2 3
RAP1B -0.039 0.16 0.37 4 -0.53 31 35
RAP1A -0.046 0.16 0.35 3 -0.53 31 34
HGF/MET/RANBP9 -0.033 0.15 0.25 1 -0.34 98 99
RAF1 -0.052 0.15 -10000 0 -0.58 13 13
STAT3 -0.042 0.12 -10000 0 -0.35 21 21
cell proliferation -0.057 0.16 0.25 4 -0.36 82 86
RPS6KB1 -0.007 0.043 -10000 0 -0.3 3 3
MAPK3 -0.005 0.1 0.74 7 -10000 0 7
MAPK1 -0.002 0.11 0.68 9 -10000 0 9
RANBP9 0.022 0.004 -10000 0 -10000 0 0
MAPK8 -0.023 0.15 0.34 3 -0.49 32 35
SRC -0.043 0.1 -10000 0 -0.33 16 16
PI3K -0.001 0.064 -10000 0 -0.26 6 6
MET/Glomulin 0.013 0.033 0.27 1 -0.34 2 3
SOS1 0.022 0.004 -10000 0 -10000 0 0
MAP2K1 -0.051 0.14 -10000 0 -0.53 13 13
MET 0.02 0.039 0.38 1 -0.53 2 3
MAP4K1 -0.044 0.18 0.35 2 -0.58 35 37
PTK2 0.021 0.006 -10000 0 -10000 0 0
MAP2K2 -0.05 0.14 -10000 0 -0.53 13 13
BAD 0.01 0.041 -10000 0 -10000 0 0
MAP2K4 -0.039 0.15 0.32 2 -0.49 32 34
SHP2/GRB2/SOS1/GAB1 -0.032 0.16 -10000 0 -0.54 30 30
INPPL1 0.022 0.005 -10000 0 -10000 0 0
PXN 0.023 0.002 -10000 0 -10000 0 0
SH3KBP1 0.02 0.035 -10000 0 -0.53 2 2
HGS -0.036 0.082 0.16 1 -0.2 93 94
PLCgamma1/PKC 0.016 0.003 -10000 0 -10000 0 0
HGF -0.09 0.22 -10000 0 -0.53 100 100
RASA1 0.021 0.006 -10000 0 -10000 0 0
NCK1 0.019 0.008 -10000 0 -10000 0 0
PTPRJ 0.021 0.025 -10000 0 -0.53 1 1
NCK/PLCgamma1 -0.011 0.091 -10000 0 -0.26 4 4
PDPK1 0.008 0.021 -10000 0 -10000 0 0
HGF/MET/SHIP -0.034 0.15 0.25 1 -0.34 99 100
IL12-mediated signaling events

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 0.009 0.12 -10000 0 -0.4 23 23
TBX21 -0.12 0.46 -10000 0 -1.3 58 58
B2M 0.021 0.011 -10000 0 -10000 0 0
TYK2 0.014 0.031 -10000 0 -10000 0 0
IL12RB1 -0.017 0.14 -10000 0 -0.56 29 29
GADD45B -0.063 0.35 -10000 0 -1.1 40 40
IL12RB2 0.036 0.074 0.24 45 -0.29 1 46
GADD45G -0.048 0.32 -10000 0 -1 33 33
natural killer cell activation 0 0.017 0.042 4 -0.042 33 37
RELB 0.023 0.016 0.38 1 -10000 0 1
RELA 0.023 0.002 -10000 0 -10000 0 0
IL18 0.016 0.047 -10000 0 -0.55 3 3
IL2RA 0.021 0.039 0.23 3 -0.53 2 5
IFNG 0.016 0.052 0.23 2 -0.53 4 6
STAT3 (dimer) -0.047 0.28 -10000 0 -0.76 50 50
HLA-DRB5 -0.002 0.007 -10000 0 -0.023 49 49
FASLG -0.078 0.39 -10000 0 -1.2 43 43
NF kappa B2 p52/RelB -0.057 0.34 -10000 0 -0.93 48 48
CD4 0 0.092 -10000 0 -0.53 14 14
SOCS1 0.021 0.025 -10000 0 -0.53 1 1
EntrezGene:6955 -0.002 0.01 -10000 0 -0.028 59 59
CD3D 0.006 0.076 -10000 0 -0.54 9 9
CD3E 0.007 0.072 -10000 0 -0.54 8 8
CD3G -0.017 0.13 -10000 0 -0.54 30 30
IL12Rbeta2/JAK2 0.034 0.065 -10000 0 -10000 0 0
CCL3 -0.067 0.34 -10000 0 -1 38 38
CCL4 -0.07 0.35 -10000 0 -1.1 39 39
HLA-A 0 0.006 -10000 0 -0.042 8 8
IL18/IL18R 0.031 0.11 -10000 0 -0.41 24 24
NOS2 -0.093 0.41 -10000 0 -1.2 52 52
IL12/IL12R/TYK2/JAK2/SPHK2 0.01 0.12 -10000 0 -0.39 23 23
IL1R1 -0.064 0.33 -10000 0 -1 40 40
IL4 -0.007 0.031 -10000 0 -10000 0 0
JAK2 0.013 0.029 -10000 0 -10000 0 0
EntrezGene:6957 -0.002 0.009 -10000 0 -0.025 56 56
TCR/CD3/MHC I/CD8 -0.047 0.26 -10000 0 -1 26 26
RAB7A -0.019 0.28 0.49 2 -0.8 37 39
lysosomal transport -0.015 0.27 0.49 2 -0.75 37 39
FOS -0.16 0.46 -10000 0 -1.1 84 84
STAT4 (dimer) -0.051 0.33 0.44 2 -0.91 47 49
STAT5A (dimer) -0.061 0.34 -10000 0 -0.93 49 49
GZMA -0.071 0.35 -10000 0 -1.1 38 38
GZMB -0.07 0.36 -10000 0 -1.1 36 36
HLX 0.022 0.004 -10000 0 -10000 0 0
LCK -0.074 0.36 -10000 0 -1 48 48
TCR/CD3/MHC II/CD4 -0.039 0.17 -10000 0 -0.36 70 70
IL2/IL2R 0.044 0.067 -10000 0 -0.42 8 8
MAPK14 -0.054 0.34 -10000 0 -1 42 42
CCR5 -0.071 0.36 -10000 0 -1.2 36 36
IL1B 0.002 0.09 -10000 0 -0.56 11 11
STAT6 0.006 0.091 -10000 0 -10000 0 0
STAT4 0.013 0.07 -10000 0 -0.53 8 8
STAT3 0.022 0.003 -10000 0 -10000 0 0
STAT1 0.022 0.004 -10000 0 -10000 0 0
NFKB1 0.022 0.005 -10000 0 -10000 0 0
NFKB2 0.022 0.005 -10000 0 -10000 0 0
IL12B 0.013 0.03 -10000 0 -10000 0 0
CD8A 0.014 0.067 -10000 0 -0.54 7 7
CD8B 0.009 0.092 0.23 4 -0.54 13 17
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity -0.008 0.12 0.4 23 -10000 0 23
IL2RB 0.019 0.043 -10000 0 -0.53 3 3
proteasomal ubiquitin-dependent protein catabolic process -0.04 0.29 0.44 2 -0.81 47 49
IL2RG 0.015 0.065 -10000 0 -0.53 7 7
IL12 0.013 0.058 -10000 0 -0.4 6 6
STAT5A 0.022 0.003 -10000 0 -10000 0 0
CD247 0.002 0.087 -10000 0 -0.54 12 12
IL2 0.001 0.02 -10000 0 -10000 0 0
SPHK2 0.022 0.004 -10000 0 -10000 0 0
FRAP1 0 0 -10000 0 -10000 0 0
IL12A 0.004 0.066 -10000 0 -0.54 6 6
IL12/IL12R/TYK2/JAK2 -0.091 0.4 -10000 0 -1.1 51 51
MAP2K3 -0.061 0.35 -10000 0 -1 43 43
RIPK2 0.022 0.005 -10000 0 -10000 0 0
MAP2K6 -0.052 0.33 -10000 0 -0.99 41 41
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.002 0.008 -10000 0 -0.026 54 54
IL18RAP -0.004 0.11 -10000 0 -0.54 21 21
IL12Rbeta1/TYK2 -0.002 0.11 -10000 0 -0.43 29 29
EOMES -0.062 0.26 -10000 0 -0.93 30 30
STAT1 (dimer) -0.043 0.28 -10000 0 -0.77 45 45
T cell proliferation -0.026 0.24 0.43 2 -0.65 44 46
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.014 0.059 -10000 0 -0.54 5 5
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.046 0.26 -10000 0 -0.75 40 40
ATF2 -0.045 0.31 0.44 1 -0.92 40 41
TCR signaling in naïve CD8+ T cells

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC 0.012 0.16 0.31 12 -0.53 29 41
FYN -0.015 0.21 0.29 14 -0.68 34 48
LAT/GRAP2/SLP76 -0.01 0.18 0.26 4 -0.56 35 39
IKBKB 0.021 0.017 0.38 1 -10000 0 1
AKT1 -0.008 0.14 0.27 10 -0.42 39 49
B2M 0.021 0.012 -10000 0 -10000 0 0
IKBKG 0.001 0.043 0.1 7 -0.14 16 23
MAP3K8 0.021 0.025 -10000 0 -0.53 1 1
mol:Ca2+ -0.013 0.015 0.087 1 -0.082 7 8
integrin-mediated signaling pathway 0.029 0.007 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.021 0.21 0.32 9 -0.62 40 49
TRPV6 0.007 0.17 1.1 9 -0.55 8 17
CD28 0.018 0.05 -10000 0 -0.54 4 4
SHC1 -0.015 0.2 0.3 16 -0.68 30 46
receptor internalization -0.026 0.21 0.23 4 -0.68 38 42
PRF1 -0.061 0.32 -10000 0 -1 43 43
KRAS 0.021 0.006 -10000 0 -10000 0 0
GRB2 0.022 0.004 -10000 0 -10000 0 0
COT/AKT1 0.006 0.12 0.26 9 -0.34 35 44
LAT -0.018 0.19 0.28 6 -0.69 29 35
EntrezGene:6955 0 0.004 -10000 0 -10000 0 0
CD3D 0.012 0.076 -10000 0 -0.55 9 9
CD3E 0.012 0.072 -10000 0 -0.55 8 8
CD3G -0.012 0.13 -10000 0 -0.54 30 30
RASGRP2 -0.018 0.061 -10000 0 -0.17 66 66
RASGRP1 -0.009 0.14 0.27 10 -0.43 34 44
HLA-A 0 0.005 -10000 0 -10000 0 0
RASSF5 0.022 0.004 -10000 0 -10000 0 0
RAP1A/GTP/RAPL 0.029 0.007 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.011 0.058 0.15 25 -0.13 21 46
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.015 0.06 -10000 0 -0.24 23 23
PRKCA -0.003 0.085 0.16 12 -0.28 27 39
GRAP2 -0.008 0.13 -10000 0 -0.53 27 27
mol:IP3 -0.017 0.12 0.23 4 -0.42 32 36
EntrezGene:6957 0 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.026 0.18 -10000 0 -0.7 27 27
ORAI1 -0.013 0.13 0.62 1 -0.96 8 9
CSK -0.018 0.2 0.28 6 -0.7 29 35
B7 family/CD28 -0.012 0.22 -10000 0 -0.76 32 32
CHUK 0.022 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.037 0.22 0.24 1 -0.67 41 42
PTPN6 -0.025 0.19 0.25 3 -0.7 29 32
VAV1 -0.021 0.2 0.3 5 -0.71 29 34
Monovalent TCR/CD3 -0.021 0.16 -10000 0 -0.48 38 38
CBL 0.022 0.004 -10000 0 -10000 0 0
LCK -0.016 0.21 0.3 12 -0.69 33 45
PAG1 -0.016 0.2 0.27 11 -0.7 29 40
RAP1A 0.022 0.005 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.034 0.22 0.29 4 -0.75 34 38
CD80 0.002 0.099 -10000 0 -0.54 16 16
CD86 0.015 0.056 -10000 0 -0.54 5 5
PDK1/CARD11/BCL10/MALT1 -0.009 0.075 -10000 0 -0.28 24 24
HRAS 0.022 0.004 -10000 0 -10000 0 0
GO:0035030 -0.029 0.17 -10000 0 -0.57 35 35
CD8A 0.014 0.067 -10000 0 -0.54 7 7
CD8B 0.008 0.093 0.23 4 -0.54 13 17
PTPRC -0.012 0.14 -10000 0 -0.54 31 31
PDK1/PKC theta -0.021 0.17 0.28 9 -0.52 38 47
CSK/PAG1 -0.016 0.19 0.27 11 -0.67 28 39
SOS1 0.022 0.004 -10000 0 -10000 0 0
peptide-MHC class I 0.015 0.017 -10000 0 -0.15 3 3
GRAP2/SLP76 -0.012 0.21 0.3 2 -0.66 36 38
STIM1 -0.004 0.078 1.3 1 -0.93 1 2
RAS family/GTP 0.019 0.071 0.19 22 -0.19 18 40
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.03 0.23 0.23 4 -0.74 38 42
mol:DAG -0.027 0.1 -10000 0 -0.37 33 33
RAP1A/GDP 0.008 0.028 0.088 15 -0.066 9 24
PLCG1 0.022 0.004 -10000 0 -10000 0 0
CD247 0.008 0.087 -10000 0 -0.54 12 12
cytotoxic T cell degranulation -0.055 0.3 -10000 0 -0.96 43 43
RAP1A/GTP -0.006 0.023 -10000 0 -0.064 66 66
mol:PI-3-4-5-P3 -0.012 0.17 0.28 12 -0.5 40 52
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.015 0.16 0.25 4 -0.55 32 36
NRAS 0.022 0.005 -10000 0 -10000 0 0
ZAP70 0.013 0.07 -10000 0 -0.53 8 8
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.019 0.16 -10000 0 -0.55 33 33
MALT1 0.022 0.005 -10000 0 -10000 0 0
TRAF6 0.022 0.004 -10000 0 -10000 0 0
CD8 heterodimer 0.017 0.098 -10000 0 -0.51 15 15
CARD11 0.022 0.031 0.3 2 -0.53 1 3
PRKCB -0.01 0.099 0.16 12 -0.31 36 48
PRKCE -0.006 0.081 0.16 7 -0.28 25 32
PRKCQ -0.027 0.2 0.29 9 -0.59 40 49
LCP2 0.015 0.056 -10000 0 -0.53 5 5
BCL10 0.022 0.004 -10000 0 -10000 0 0
regulation of survival gene product expression -0.004 0.12 0.23 15 -0.36 37 52
IKK complex 0.011 0.054 0.14 30 -0.12 17 47
RAS family/GDP -0.002 0.01 -10000 0 -10000 0 0
MAP3K14 0.002 0.091 0.18 14 -0.28 29 43
PDPK1 -0.007 0.14 0.27 10 -0.41 35 45
TCR/CD3/MHC I/CD8/Fyn -0.032 0.22 -10000 0 -0.81 29 29
IL23-mediated signaling events

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.11 0.42 -10000 0 -1.3 34 34
IL23A -0.085 0.39 -10000 0 -1.3 26 26
NF kappa B1 p50/RelA/I kappa B alpha -0.074 0.4 -10000 0 -1.1 37 37
positive regulation of T cell mediated cytotoxicity -0.11 0.45 -10000 0 -1.3 41 41
ITGA3 -0.094 0.39 -10000 0 -1.2 32 32
IL17F -0.006 0.28 -10000 0 -0.73 28 28
IL12B 0.019 0.04 -10000 0 -10000 0 0
STAT1 (dimer) -0.1 0.42 -10000 0 -1.2 39 39
CD4 -0.093 0.42 -10000 0 -1.3 34 34
IL23 -0.076 0.38 -10000 0 -1.2 26 26
IL23R -0.002 0.17 -10000 0 -0.92 12 12
IL1B -0.095 0.41 -10000 0 -1.3 28 28
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.088 0.38 -10000 0 -1.1 31 31
TYK2 0.016 0.033 -10000 0 -10000 0 0
STAT4 0.013 0.07 -10000 0 -0.53 8 8
STAT3 0.022 0.003 -10000 0 -10000 0 0
IL18RAP -0.001 0.11 -10000 0 -0.53 21 21
IL12RB1 -0.016 0.14 -10000 0 -0.56 29 29
PIK3CA 0.013 0.011 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 -0.001 0.11 -10000 0 -0.42 29 29
IL23R/JAK2 0.013 0.16 -10000 0 -0.92 9 9
positive regulation of chronic inflammatory response -0.11 0.45 -10000 0 -1.3 41 41
natural killer cell activation 0 0.006 -10000 0 -10000 0 0
JAK2 0.019 0.039 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
NFKB1 0.02 0.012 -10000 0 -10000 0 0
RELA 0.021 0.011 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.07 0.36 -10000 0 -1.1 26 26
ALOX12B -0.086 0.38 -10000 0 -1.2 27 27
CXCL1 -0.11 0.44 -10000 0 -1.3 42 42
T cell proliferation -0.11 0.45 -10000 0 -1.3 41 41
NFKBIA 0.02 0.012 -10000 0 -10000 0 0
IL17A 0.003 0.23 -10000 0 -0.59 19 19
PI3K -0.1 0.37 -10000 0 -1.2 32 32
IFNG -0.001 0.035 0.1 3 -0.11 25 28
STAT3 (dimer) -0.092 0.36 -10000 0 -1.1 32 32
IL18R1 0.017 0.055 -10000 0 -0.53 5 5
IL23/IL23R/JAK2/TYK2/SOCS3 -0.062 0.31 -10000 0 -0.87 39 39
IL18/IL18R 0.025 0.095 -10000 0 -0.38 24 24
macrophage activation -0.005 0.018 0.029 1 -0.045 21 22
TNF -0.099 0.42 -10000 0 -1.3 32 32
STAT3/STAT4 -0.093 0.41 -10000 0 -1.2 39 39
STAT4 (dimer) -0.1 0.43 -10000 0 -1.2 40 40
IL18 0.019 0.043 -10000 0 -0.53 3 3
IL19 -0.089 0.38 -10000 0 -1.2 26 26
STAT5A (dimer) -0.1 0.43 -10000 0 -1.2 40 40
STAT1 0.022 0.004 -10000 0 -10000 0 0
SOCS3 0.02 0.035 -10000 0 -0.53 2 2
CXCL9 -0.11 0.41 -10000 0 -1.2 39 39
MPO -0.12 0.44 -10000 0 -1.2 45 45
positive regulation of humoral immune response -0.11 0.45 -10000 0 -1.3 41 41
IL23/IL23R/JAK2/TYK2 -0.12 0.5 -10000 0 -1.4 40 40
IL6 -0.2 0.55 -10000 0 -1.3 90 90
STAT5A 0.022 0.003 -10000 0 -10000 0 0
IL2 0.008 0.021 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0 0.006 -10000 0 -10000 0 0
CD3E -0.098 0.4 -10000 0 -1.3 26 26
keratinocyte proliferation -0.11 0.45 -10000 0 -1.3 41 41
NOS2 -0.12 0.45 -10000 0 -1.3 47 47
Plasma membrane estrogen receptor signaling

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.029 0.085 -10000 0 -0.32 25 25
ER alpha/Gai/GDP/Gbeta gamma -0.037 0.18 -10000 0 -0.54 44 44
AKT1 -0.027 0.2 -10000 0 -0.77 30 30
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K -0.023 0.2 -10000 0 -0.78 30 30
mol:Ca2+ -0.097 0.18 -10000 0 -0.41 114 114
IGF1R 0.022 0.004 -10000 0 -10000 0 0
E2/ER alpha (dimer)/Striatin 0.013 0.075 -10000 0 -0.33 22 22
SHC1 0.022 0.005 -10000 0 -10000 0 0
apoptosis 0.025 0.18 0.73 30 -10000 0 30
RhoA/GTP 0.006 0.057 -10000 0 -0.26 20 20
E2/ER alpha (dimer)/PELP1/Src/p130 Cas -0.009 0.15 -10000 0 -0.46 40 40
regulation of stress fiber formation 0.01 0.069 0.43 2 -0.22 3 5
E2/ERA-ERB (dimer) 0.013 0.075 -10000 0 -0.33 22 22
KRAS 0.021 0.006 -10000 0 -10000 0 0
G13/GTP 0.014 0.067 -10000 0 -0.3 21 21
pseudopodium formation -0.01 0.069 0.22 3 -0.43 2 5
E2/ER alpha (dimer)/PELP1 0.012 0.076 -10000 0 -0.33 23 23
GRB2 0.022 0.004 -10000 0 -10000 0 0
GNG2 0.016 0.055 -10000 0 -0.53 5 5
GNAO1 0.021 0.029 0.23 2 -0.53 1 3
HRAS 0.022 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO -0.027 0.17 -10000 0 -0.53 40 40
E2/ER beta (dimer) 0.016 0.003 -10000 0 -10000 0 0
mol:GDP -0.005 0.086 -10000 0 -0.38 23 23
mol:NADP -0.027 0.17 -10000 0 -0.53 40 40
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:IP3 -0.1 0.19 -10000 0 -0.43 114 114
IGF-1R heterotetramer 0.022 0.004 -10000 0 -10000 0 0
PLCB1 -0.095 0.19 -10000 0 -0.44 112 112
PLCB2 -0.1 0.2 -10000 0 -0.44 120 120
IGF1 0.003 0.1 0.23 1 -0.53 18 19
mol:L-citrulline -0.027 0.17 -10000 0 -0.53 40 40
RHOA 0.021 0.007 -10000 0 -10000 0 0
Gai/GDP -0.038 0.2 -10000 0 -0.62 53 53
JNK cascade 0.016 0.003 -10000 0 -10000 0 0
BCAR1 0.022 0.005 -10000 0 -10000 0 0
ESR2 0.022 0.005 -10000 0 -10000 0 0
GNAQ 0.021 0.025 -10000 0 -0.53 1 1
ESR1 -0.003 0.12 -10000 0 -0.53 23 23
Gq family/GDP/Gbeta gamma -0.069 0.2 -10000 0 -0.67 34 34
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 0.014 0.073 -10000 0 -0.47 3 3
E2/ER alpha (dimer)/PELP1/Src/p52 SHC -0.008 0.15 -10000 0 -0.46 39 39
GNAZ 0.016 0.056 -10000 0 -0.53 5 5
E2/ER alpha (dimer) -0.002 0.085 -10000 0 -0.38 24 24
STRN 0.022 0.003 -10000 0 -10000 0 0
GNAL 0.02 0.035 -10000 0 -0.53 2 2
PELP1 0.022 0.005 -10000 0 -10000 0 0
MAPK11 0.01 0.003 -10000 0 -10000 0 0
GNAI2 0.021 0.007 -10000 0 -10000 0 0
GNAI3 0.022 0.005 -10000 0 -10000 0 0
GNAI1 0.021 0.025 -10000 0 -0.53 1 1
HBEGF -0.037 0.18 0.3 7 -0.59 35 42
cAMP biosynthetic process 0.01 0.063 -10000 0 -0.28 20 20
SRC -0.034 0.17 0.26 2 -0.51 43 45
PI3K 0.017 0.017 -10000 0 -10000 0 0
GNB1 0.021 0.025 -10000 0 -0.53 1 1
G13/GDP/Gbeta gamma 0.015 0.095 -10000 0 -0.41 19 19
SOS1 0.022 0.004 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.027 0.12 -10000 0 -0.4 37 37
Gs family/GTP 0.016 0.065 -10000 0 -0.29 20 20
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.037 0.016 -10000 0 -10000 0 0
vasodilation -0.025 0.16 -10000 0 -0.5 40 40
mol:DAG -0.1 0.19 -10000 0 -0.43 114 114
Gs family/GDP/Gbeta gamma 0 0.087 -10000 0 -0.4 18 18
MSN -0.011 0.073 0.23 3 -0.46 2 5
Gq family/GTP -0.095 0.21 -10000 0 -0.45 122 122
mol:PI-3-4-5-P3 -0.021 0.19 -10000 0 -0.75 30 30
NRAS 0.022 0.005 -10000 0 -10000 0 0
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion 0.025 0.16 0.5 40 -10000 0 40
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
RhoA/GDP 0.007 0.087 -10000 0 -0.39 19 19
NOS3 -0.03 0.18 -10000 0 -0.57 40 40
GNA11 0.022 0.004 -10000 0 -10000 0 0
MAPKKK cascade -0.01 0.16 0.32 1 -0.61 28 29
E2/ER alpha (dimer)/PELP1/Src -0.015 0.16 -10000 0 -0.48 42 42
ruffle organization -0.01 0.069 0.22 3 -0.43 2 5
ROCK2 -0.008 0.074 0.24 3 -10000 0 3
GNA14 -0.11 0.24 -10000 0 -0.53 117 117
GNA15 0.022 0.004 -10000 0 -10000 0 0
GNA13 0.022 0.003 -10000 0 -10000 0 0
MMP9 -0.028 0.16 0.32 8 -0.49 40 48
MMP2 -0.029 0.17 0.29 4 -0.57 29 33
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A -0.16 0.26 -10000 0 -0.53 162 162
oxygen homeostasis 0 0 -10000 0 -10000 0 0
TCEB2 0.022 0.004 -10000 0 -10000 0 0
TCEB1 0.022 0.005 -10000 0 -10000 0 0
HIF1A/p53 0.012 0.067 0.25 2 -0.28 17 19
HIF1A -0.004 0.048 -10000 0 -0.27 15 15
COPS5 0.022 0.004 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/RBX1/CUL2 0.058 0.024 -10000 0 -10000 0 0
FIH (dimer) 0.022 0.005 -10000 0 -10000 0 0
CDKN2A 0.091 0.14 0.23 207 -0.31 20 227
ARNT/IPAS -0.1 0.19 -10000 0 -0.39 147 147
HIF1AN 0.022 0.005 -10000 0 -10000 0 0
GNB2L1 0.021 0.006 -10000 0 -10000 0 0
HIF1A/ARNT 0.01 0.063 -10000 0 -0.28 19 19
CUL2 0.022 0.004 -10000 0 -10000 0 0
OS9 0.023 0.002 -10000 0 -10000 0 0
RACK1/Elongin B/Elongin C 0.041 0.015 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF1A/Hsp90 0.012 0.064 0.26 1 -0.28 20 21
PHD1-3/OS9 0.068 0.051 0.25 2 -10000 0 2
HIF1A/RACK1/Elongin B/Elongin C 0.031 0.061 -10000 0 -0.28 5 5
VHL 0.021 0.006 -10000 0 -10000 0 0
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
HIF1A/JAB1 0.013 0.062 0.25 2 -0.28 16 18
EGLN3 0.054 0.077 0.23 76 -10000 0 76
EGLN2 0.021 0.006 -10000 0 -10000 0 0
EGLN1 0.022 0.004 -10000 0 -10000 0 0
TP53 0.02 0.025 -10000 0 -0.53 1 1
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A -0.014 0.17 -10000 0 -0.58 38 38
ARNT 0.021 0.006 -10000 0 -10000 0 0
ARD1A 0 0 -10000 0 -10000 0 0
RBX1 0.022 0.004 -10000 0 -10000 0 0
HIF1A/p19ARF 0.053 0.11 0.28 9 -0.33 20 29
Regulation of Androgen receptor activity

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 -0.01 0.003 -10000 0 -10000 0 0
SMARCC1 0.004 0.022 -10000 0 -10000 0 0
REL 0.021 0.007 -10000 0 -10000 0 0
HDAC7 -0.067 0.11 -10000 0 -0.32 13 13
JUN 0.022 0.004 -10000 0 -10000 0 0
EP300 0.022 0.004 -10000 0 -10000 0 0
KAT2B 0.021 0.006 -10000 0 -10000 0 0
KAT5 0.023 0.002 -10000 0 -10000 0 0
MAPK14 -0.009 0.023 -10000 0 -10000 0 0
FOXO1 0.021 0.006 -10000 0 -10000 0 0
T-DHT/AR -0.054 0.12 -10000 0 -0.31 38 38
MAP2K6 0.007 0.026 0.22 1 -10000 0 1
BRM/BAF57 0.029 0.022 -10000 0 -0.39 1 1
MAP2K4 0.007 0.024 -10000 0 -10000 0 0
SMARCA2 0.019 0.026 -10000 0 -0.53 1 1
PDE9A -0.082 0.22 -10000 0 -0.94 20 20
NCOA2 0.021 0.025 -10000 0 -0.53 1 1
CEBPA 0.02 0.026 -10000 0 -0.53 1 1
EHMT2 0.022 0.004 -10000 0 -10000 0 0
cell proliferation -0.078 0.16 0.33 4 -0.43 46 50
NR0B1 0.07 0.12 0.23 152 -0.3 7 159
EGR1 0.011 0.074 -10000 0 -0.53 9 9
RXRs/9cRA -0.13 0.17 -10000 0 -0.31 241 241
AR/RACK1/Src -0.025 0.077 0.3 3 -0.28 1 4
AR/GR -0.043 0.12 -10000 0 -0.28 91 91
GNB2L1 0.021 0.006 -10000 0 -10000 0 0
PKN1 0.022 0.004 -10000 0 -10000 0 0
RCHY1 0.022 0.005 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
MAPK8 -0.009 0.022 -10000 0 -10000 0 0
T-DHT/AR/TIF2/CARM1 -0.018 0.081 0.27 1 -0.32 2 3
SRC -0.027 0.036 0.2 3 -10000 0 3
NR3C1 0.021 0.006 -10000 0 -10000 0 0
KLK3 -0.04 0.13 -10000 0 -0.52 3 3
APPBP2 0.007 0.024 -10000 0 -10000 0 0
TRIM24 0.022 0.004 -10000 0 -10000 0 0
T-DHT/AR/TIP60 -0.031 0.074 -10000 0 -0.29 1 1
TMPRSS2 -0.35 0.51 -10000 0 -1.1 165 165
RXRG -0.25 0.27 -10000 0 -0.53 244 244
mol:9cRA 0 0 -10000 0 -10000 0 0
RXRA 0.022 0.004 -10000 0 -10000 0 0
RXRB 0.022 0.004 -10000 0 -10000 0 0
CARM1 0.022 0.004 -10000 0 -10000 0 0
NR2C2 0.021 0.006 -10000 0 -10000 0 0
KLK2 -0.013 0.074 0.34 2 -0.35 2 4
AR -0.06 0.12 -10000 0 -0.3 87 87
SENP1 0.023 0.003 -10000 0 -10000 0 0
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
MDM2 0.023 0.016 0.38 1 -10000 0 1
SRY 0 0 -10000 0 -10000 0 0
GATA2 -0.034 0.16 -10000 0 -0.53 49 49
MYST2 0 0 -10000 0 -10000 0 0
HOXB13 0.14 0.11 0.23 293 -10000 0 293
T-DHT/AR/RACK1/Src -0.025 0.077 0.3 3 -0.28 1 4
positive regulation of transcription -0.034 0.16 -10000 0 -0.53 49 49
DNAJA1 0.007 0.023 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.012 0.01 0.22 1 -10000 0 1
NCOA1 0.031 0.02 -10000 0 -10000 0 0
SPDEF -0.044 0.18 0.23 4 -0.53 61 65
T-DHT/AR/TIF2 -0.022 0.081 -10000 0 -0.36 13 13
T-DHT/AR/Hsp90 -0.029 0.073 0.22 1 -0.29 1 2
GSK3B 0.016 0.013 -10000 0 -10000 0 0
NR2C1 0.023 0.002 -10000 0 -10000 0 0
mol:T-DHT -0.029 0.034 -10000 0 -10000 0 0
SIRT1 0.022 0.005 -10000 0 -10000 0 0
ZMIZ2 0.022 0.005 -10000 0 -10000 0 0
POU2F1 -0.011 0.061 -10000 0 -0.18 5 5
T-DHT/AR/DAX-1 -0.018 0.11 0.28 4 -0.3 2 6
CREBBP 0.022 0.005 -10000 0 -10000 0 0
SMARCE1 0.022 0.004 -10000 0 -10000 0 0
Glucocorticoid receptor regulatory network

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 -0.006 0.092 -10000 0 -0.43 4 4
SMARCC2 0.023 0.002 -10000 0 -10000 0 0
SMARCC1 0.021 0.007 -10000 0 -10000 0 0
TBX21 -0.071 0.29 0.45 3 -0.87 50 53
SUMO2 0.021 0.008 -10000 0 -10000 0 0
STAT1 (dimer) 0.026 0.005 -10000 0 -10000 0 0
FKBP4 0.022 0.017 0.38 1 -10000 0 1
FKBP5 0.022 0.003 -10000 0 -10000 0 0
GR alpha/HSP90/FKBP51/HSP90 0.013 0.11 0.29 14 -10000 0 14
PRL 0.011 0.09 0.41 1 -10000 0 1
cortisol/GR alpha (dimer)/TIF2 0.011 0.25 0.51 46 -0.39 38 84
RELA -0.061 0.13 -10000 0 -0.3 51 51
FGG -0.22 0.33 0.47 13 -0.57 206 219
GR beta/TIF2 0.005 0.12 0.3 21 -0.3 1 22
IFNG 0.015 0.19 -10000 0 -0.81 10 10
apoptosis -0.005 0.11 0.5 3 -0.52 5 8
CREB1 0.026 0.01 -10000 0 -10000 0 0
histone acetylation -0.002 0.11 0.32 1 -0.35 14 15
BGLAP 0.016 0.11 -10000 0 -0.48 1 1
GR/PKAc 0.013 0.11 0.31 8 -10000 0 8
NF kappa B1 p50/RelA -0.12 0.24 -10000 0 -0.4 167 167
SMARCD1 0.023 0.002 -10000 0 -10000 0 0
MDM2 0.006 0.079 0.23 22 -10000 0 22
GATA3 0.012 0.091 0.23 3 -0.53 13 16
AKT1 0.019 0.005 -10000 0 -10000 0 0
CSF2 -0.12 0.35 -10000 0 -1.2 49 49
GSK3B 0.019 0.01 -10000 0 -10000 0 0
NR1I3 0.003 0.11 0.56 3 -0.62 1 4
CSN2 -0.04 0.17 0.37 17 -0.35 41 58
BRG1/BAF155/BAF170/BAF60A 0.055 0.02 -10000 0 -10000 0 0
NFATC1 0.021 0.025 -10000 0 -0.53 1 1
POU2F1 0.023 0.007 -10000 0 -10000 0 0
CDKN1A 0.008 0.045 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
response to UV 0 0.004 -10000 0 -10000 0 0
SFN 0.039 0.069 0.23 46 -0.38 3 49
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.029 0.12 0.31 7 -10000 0 7
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.01 0.14 0.5 2 -0.8 11 13
JUN 0.029 0.1 0.36 2 -0.37 6 8
IL4 0.005 0.11 -10000 0 -0.49 1 1
CDK5R1 0.027 0.032 0.24 10 -10000 0 10
PRKACA 0.022 0.004 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.13 0.14 -10000 0 -0.38 91 91
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.019 0.11 0.32 8 -10000 0 8
cortisol/GR alpha (monomer) 0.004 0.29 0.59 47 -0.45 41 88
NCOA2 0.021 0.025 -10000 0 -0.53 1 1
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.007 0.19 -10000 0 -0.53 58 58
AP-1/NFAT1-c-4 0.056 0.19 0.36 2 -0.5 13 15
AFP 0.034 0.092 -10000 0 -10000 0 0
SUV420H1 0.022 0.004 -10000 0 -10000 0 0
IRF1 0.005 0.13 0.4 10 -0.38 1 11
TP53 0.029 0.026 -10000 0 -0.53 1 1
PPP5C 0.022 0.004 -10000 0 -10000 0 0
KRT17 0.049 0.17 -10000 0 -0.56 10 10
KRT14 0.032 0.13 0.44 1 -0.66 4 5
TBP 0.026 0.004 -10000 0 -10000 0 0
CREBBP -0.01 0.044 0.34 1 -10000 0 1
HDAC1 0.021 0.005 -10000 0 -10000 0 0
HDAC2 0.029 0.023 -10000 0 -10000 0 0
AP-1 0.056 0.19 0.36 2 -0.5 13 15
MAPK14 0.021 0.008 -10000 0 -10000 0 0
MAPK10 0.013 0.066 -10000 0 -0.53 7 7
MAPK11 0.021 0.008 -10000 0 -10000 0 0
KRT5 0.049 0.18 -10000 0 -0.79 6 6
interleukin-1 receptor activity 0.007 0.023 -10000 0 -10000 0 0
NCOA1 0.023 0.003 -10000 0 -10000 0 0
STAT1 0.026 0.005 -10000 0 -10000 0 0
CGA 0.01 0.11 -10000 0 -0.49 1 1
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 -0.028 0.18 0.46 38 -0.33 16 54
MAPK3 0.022 0.008 -10000 0 -10000 0 0
MAPK1 0.021 0.008 -10000 0 -10000 0 0
ICAM1 -0.14 0.37 -10000 0 -1.1 53 53
NFKB1 -0.059 0.13 -10000 0 -0.29 57 57
MAPK8 0.022 0.13 0.28 3 -0.36 19 22
MAPK9 0.02 0.009 -10000 0 -10000 0 0
cortisol/GR alpha (dimer) -0.008 0.11 0.5 2 -0.54 5 7
BAX 0.007 0.043 -10000 0 -10000 0 0
POMC -0.034 0.21 0.48 3 -1.1 8 11
EP300 -0.011 0.044 0.34 1 -10000 0 1
cortisol/GR alpha (dimer)/p53 0.009 0.25 0.51 42 -0.39 33 75
proteasomal ubiquitin-dependent protein catabolic process -0.005 0.068 0.23 15 -10000 0 15
SGK1 -0.001 0.073 -10000 0 -10000 0 0
IL13 0.002 0.16 -10000 0 -0.64 10 10
IL6 -0.2 0.46 -10000 0 -1.1 91 91
PRKACG -0.01 0.019 0.23 1 -10000 0 1
IL5 0.001 0.14 -10000 0 -0.68 4 4
IL2 0.012 0.16 -10000 0 -0.57 8 8
CDK5 0.022 0.005 -10000 0 -10000 0 0
PRKACB 0.022 0.004 -10000 0 -10000 0 0
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
IL8 -0.073 0.23 -10000 0 -0.64 39 39
CDK5R1/CDK5 0.034 0.022 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.063 0.19 -10000 0 -0.44 51 51
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.018 0.23 0.5 45 -0.36 31 76
SMARCA4 0.023 0.005 -10000 0 -10000 0 0
chromatin remodeling 0.005 0.13 0.36 17 -0.36 2 19
NF kappa B1 p50/RelA/Cbp -0.084 0.2 0.36 1 -0.48 54 55
JUN (dimer) 0.029 0.1 0.36 2 -0.37 6 8
YWHAH 0.022 0.004 -10000 0 -10000 0 0
VIPR1 -0.27 0.45 -10000 0 -0.89 165 165
NR3C1 -0.004 0.17 0.43 24 -0.26 1 25
NR4A1 -0.049 0.19 -10000 0 -0.53 68 68
TIF2/SUV420H1 0.031 0.021 -10000 0 -0.39 1 1
MAPKKK cascade -0.005 0.11 0.5 3 -0.52 5 8
cortisol/GR alpha (dimer)/Src-1 0.013 0.25 0.51 46 -0.39 38 84
PBX1 0.021 0.036 -10000 0 -0.53 2 2
POU1F1 0.004 0.026 0.23 3 -10000 0 3
SELE -0.33 0.55 -10000 0 -1.1 159 159
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.005 0.14 0.36 17 -0.36 2 19
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.018 0.23 0.5 45 -0.36 31 76
mol:cortisol -0.005 0.16 0.32 49 -0.23 47 96
MMP1 0.063 0.11 -10000 0 -0.6 6 6
Syndecan-1-mediated signaling events

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.022 0.005 -10000 0 -10000 0 0
CCL5 0.012 0.074 -10000 0 -0.53 9 9
SDCBP 0.022 0.005 -10000 0 -10000 0 0
FGFR/FGF2/Syndecan-1 0.021 0.064 0.28 7 -0.38 3 10
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 0.028 0.071 0.26 8 -0.37 3 11
Syndecan-1/Syntenin 0.03 0.068 0.26 8 -0.36 3 11
MAPK3 0.022 0.063 0.24 8 -0.36 2 10
HGF/MET -0.053 0.17 0.27 1 -0.39 99 100
TGFB1/TGF beta receptor Type II 0.022 0.005 -10000 0 -10000 0 0
BSG 0.022 0.004 -10000 0 -10000 0 0
keratinocyte migration 0.028 0.07 0.25 8 -0.36 3 11
Syndecan-1/RANTES 0.024 0.086 0.26 7 -0.43 7 14
Syndecan-1/CD147 0.04 0.07 0.28 3 -0.35 3 6
Syndecan-1/Syntenin/PIP2 0.028 0.065 0.27 3 -0.35 3 6
LAMA5 0.021 0.025 -10000 0 -0.53 1 1
positive regulation of cell-cell adhesion 0.027 0.064 0.26 3 -0.34 3 6
MMP7 0.021 0.087 0.23 22 -0.53 9 31
HGF -0.09 0.22 -10000 0 -0.53 100 100
Syndecan-1/CASK 0.012 0.062 0.22 5 -0.34 4 9
Syndecan-1/HGF/MET -0.019 0.14 0.29 3 -0.41 20 23
regulation of cell adhesion 0.011 0.058 0.31 1 -0.4 1 2
HPSE 0.022 0.005 -10000 0 -10000 0 0
positive regulation of cell migration 0.021 0.064 0.28 7 -0.38 3 10
SDC1 0.022 0.059 0.27 6 -0.4 2 8
Syndecan-1/Collagen 0.021 0.064 0.28 7 -0.38 3 10
PPIB 0.023 0.002 -10000 0 -10000 0 0
MET 0.02 0.039 0.38 1 -0.53 2 3
PRKACA 0.022 0.004 -10000 0 -10000 0 0
MMP9 0.034 0.049 0.24 27 -10000 0 27
MAPK1 0.019 0.06 0.22 5 -0.34 3 8
homophilic cell adhesion 0.021 0.066 0.28 7 -0.38 3 10
MMP1 0.15 0.11 0.23 303 -0.3 4 307
Nectin adhesion pathway

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.02 0.025 -10000 0 -0.53 1 1
alphaV beta3 Integrin 0.024 0.06 -10000 0 -0.39 10 10
PTK2 0.009 0.14 -10000 0 -0.45 31 31
positive regulation of JNK cascade 0 0.1 -10000 0 -0.32 34 34
CDC42/GDP 0.016 0.14 0.36 1 -0.42 38 39
Rac1/GDP 0.015 0.14 -10000 0 -0.42 37 37
RAP1B 0.022 0.005 -10000 0 -10000 0 0
RAP1A 0.022 0.005 -10000 0 -10000 0 0
CTNNB1 0.021 0.006 -10000 0 -10000 0 0
CDC42/GTP 0.008 0.13 -10000 0 -0.4 33 33
nectin-3/I-afadin 0.001 0.1 -10000 0 -0.39 33 33
RAPGEF1 -0.002 0.14 -10000 0 -0.47 33 33
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.007 0.16 -10000 0 -0.53 33 33
PDGFB-D/PDGFRB 0.02 0.025 -10000 0 -0.53 1 1
TLN1 -0.031 0.099 -10000 0 -0.42 23 23
Rap1/GTP -0.003 0.1 -10000 0 -0.34 31 31
IQGAP1 0.022 0.004 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.04 0.013 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin 0.001 0.1 -10000 0 -0.39 33 33
PVR 0.022 0.005 -10000 0 -10000 0 0
Necl-5(dimer) 0.022 0.005 -10000 0 -10000 0 0
mol:GDP 0.001 0.17 0.39 1 -0.52 39 40
MLLT4 0.022 0.004 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
PI3K 0.019 0.068 -10000 0 -0.29 14 14
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.098 0.075 0.27 1 -0.21 1 2
positive regulation of lamellipodium assembly 0.004 0.11 -10000 0 -0.33 35 35
PVRL1 0.12 0.11 0.23 235 -0.3 1 236
PVRL3 -0.017 0.14 -10000 0 -0.53 33 33
PVRL2 0.022 0.004 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
CDH1 0.022 0.005 -10000 0 -10000 0 0
CLDN1 0.063 0.12 0.31 85 -0.53 2 87
JAM-A/CLDN1 0.042 0.099 0.25 30 -0.31 17 47
SRC -0.012 0.17 -10000 0 -0.58 33 33
ITGB3 0.01 0.082 -10000 0 -0.53 11 11
nectin-1(dimer)/I-afadin/I-afadin 0.098 0.075 0.27 1 -0.21 1 2
FARP2 0.001 0.18 -10000 0 -0.54 34 34
RAC1 0.022 0.004 -10000 0 -10000 0 0
CTNNA1 0.021 0.006 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.014 0.095 -10000 0 -0.33 33 33
nectin-1/I-afadin 0.098 0.075 0.27 1 -0.21 1 2
nectin-2/I-afadin 0.032 0.008 -10000 0 -10000 0 0
RAC1/GTP/IQGAP1/filamentous actin 0.029 0.007 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.061 0.13 -10000 0 -0.35 33 33
CDC42/GTP/IQGAP1/filamentous actin 0.029 0.007 -10000 0 -10000 0 0
F11R 0.022 0.005 -10000 0 -10000 0 0
positive regulation of filopodium formation 0 0.1 -10000 0 -0.32 34 34
alphaV/beta3 Integrin/Talin 0.005 0.13 0.27 4 -0.43 25 29
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.032 0.008 -10000 0 -10000 0 0
nectin-2(dimer)/I-afadin/I-afadin 0.032 0.008 -10000 0 -10000 0 0
PIP5K1C -0.029 0.11 -10000 0 -0.33 47 47
VAV2 0.002 0.17 -10000 0 -0.52 39 39
RAP1/GDP 0.015 0.13 0.36 1 -0.39 36 37
ITGAV 0.022 0.004 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.014 0.095 -10000 0 -0.33 33 33
nectin-3(dimer)/I-afadin/I-afadin 0.001 0.1 -10000 0 -0.39 33 33
Rac1/GTP 0.01 0.14 -10000 0 -0.41 34 34
PTPRM -0.028 0.12 -10000 0 -0.34 51 51
E-cadherin/beta catenin/alpha catenin 0.1 0.061 -10000 0 -10000 0 0
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.022 0.004 -10000 0 -10000 0 0
Wnt signaling

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD 0.008 0.077 0.23 2 -0.3 20 22
FZD6 0.022 0.005 -10000 0 -10000 0 0
WNT6 0.054 0.08 0.23 81 -0.3 1 82
WNT4 0.019 0.053 0.23 4 -0.53 4 8
FZD3 0.021 0.007 -10000 0 -10000 0 0
WNT5A 0.023 0.041 0.23 9 -0.42 2 11
WNT11 0.007 0.11 0.24 10 -0.53 18 28
FOXM1 transcription factor network

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 0.24 0.24 0.65 1 -1.1 4 5
PLK1 0.1 0.093 -10000 0 -0.49 3 3
BIRC5 0.13 0.066 -10000 0 -0.52 1 1
HSPA1B 0.24 0.24 0.57 2 -1.1 4 6
MAP2K1 0.061 0.04 -10000 0 -10000 0 0
BRCA2 0.24 0.24 -10000 0 -1.2 3 3
FOXM1 0.25 0.28 0.62 2 -1.5 4 6
XRCC1 0.24 0.24 0.65 7 -1.1 4 11
FOXM1B/p19 0.13 0.27 0.58 6 -1.2 5 11
Cyclin D1/CDK4 0.19 0.24 0.6 6 -1.1 4 10
CDC2 0.24 0.25 0.58 3 -1.2 4 7
TGFA 0.22 0.22 0.55 9 -0.96 4 13
SKP2 0.27 0.26 0.68 31 -1.1 3 34
CCNE1 0.084 0.11 0.28 110 -10000 0 110
CKS1B 0.24 0.24 0.54 8 -1.1 4 12
RB1 0.14 0.2 0.42 39 -0.79 7 46
FOXM1C/SP1 0.24 0.25 -10000 0 -1.3 4 4
AURKB 0.086 0.18 -10000 0 -0.92 7 7
CENPF 0.25 0.24 0.68 6 -1.1 4 10
CDK4 0.038 0.025 0.38 1 -10000 0 1
MYC 0.2 0.22 0.5 7 -0.94 4 11
CHEK2 0.059 0.04 -10000 0 -10000 0 0
ONECUT1 0.24 0.24 0.57 11 -1.1 4 15
CDKN2A 0.074 0.14 0.22 207 -0.32 20 227
LAMA4 0.23 0.27 0.59 1 -1.2 7 8
FOXM1B/HNF6 0.24 0.26 0.62 4 -1.4 4 8
FOS 0.13 0.46 0.71 4 -0.98 63 67
SP1 0.023 0.002 -10000 0 -10000 0 0
CDC25B 0.24 0.24 0.66 9 -1.1 4 13
response to radiation 0.033 0.027 -10000 0 -10000 0 0
CENPB 0.24 0.24 0.67 8 -1.1 4 12
CENPA 0.26 0.24 0.66 6 -1.1 4 10
NEK2 0.26 0.24 0.69 6 -1.2 3 9
HIST1H2BA 0.23 0.24 -10000 0 -1.2 3 3
CCNA2 0.083 0.099 0.25 127 -0.29 2 129
EP300 0.022 0.004 -10000 0 -10000 0 0
CCNB1/CDK1 0.23 0.26 -10000 0 -1.3 4 4
CCNB2 0.25 0.24 0.6 1 -1.1 4 5
CCNB1 0.24 0.25 0.6 1 -1.2 4 5
ETV5 0.31 0.29 0.66 69 -1.1 7 76
ESR1 0.2 0.34 0.65 2 -1.1 22 24
CCND1 0.18 0.24 0.6 3 -1.1 4 7
GSK3A 0.051 0.035 -10000 0 -10000 0 0
Cyclin A-E1/CDK1-2 0.14 0.11 0.31 100 -10000 0 100
CDK2 0.03 0.012 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle 0.041 0.033 -10000 0 -10000 0 0
FOXM1B/Cbp/p300 0.22 0.24 -10000 0 -1.2 4 4
GAS1 0.22 0.28 0.69 1 -1.2 10 11
MMP2 0.23 0.26 0.71 1 -1.2 7 8
RB1/FOXM1C 0.2 0.26 0.58 16 -1.2 4 20
CREBBP 0.022 0.005 -10000 0 -10000 0 0
ErbB4 signaling events

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF -0.046 0.1 -10000 0 -0.38 14 14
epithelial cell differentiation -0.022 0.086 -10000 0 -0.41 4 4
ITCH 0.037 0.021 -10000 0 -10000 0 0
WWP1 -0.037 0.076 -10000 0 -10000 0 0
FYN 0.021 0.025 -10000 0 -0.53 1 1
EGFR 0.023 0.081 0.36 12 -0.53 6 18
PRL 0.001 0.035 0.23 8 -10000 0 8
neuron projection morphogenesis -0.03 0.077 -10000 0 -0.34 5 5
PTPRZ1 0.15 0.13 0.23 320 -0.48 9 329
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC -0.011 0.09 -10000 0 -0.37 5 5
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta -0.036 0.082 -10000 0 -0.34 13 13
ADAM17 0.037 0.022 -10000 0 -10000 0 0
ErbB4/ErbB4 -0.053 0.091 -10000 0 -0.29 5 5
ErbB4/ErbB4/neuregulin 3/neuregulin 3 -0.12 0.17 -10000 0 -0.38 123 123
NCOR1 0.022 0.005 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn -0.031 0.085 -10000 0 -0.38 7 7
GRIN2B -0.034 0.081 -10000 0 -0.37 6 6
ErbB4/ErbB2/betacellulin -0.04 0.11 -10000 0 -0.38 18 18
STAT1 0.022 0.004 -10000 0 -10000 0 0
HBEGF 0.004 0.095 -10000 0 -0.53 15 15
PRLR 0.019 0.098 0.29 21 -0.53 10 31
E4ICDs/ETO2 -0.041 0.097 -10000 0 -0.39 5 5
axon guidance -0.034 0.071 -10000 0 -0.43 2 2
NEDD4 0.037 0.022 -10000 0 -10000 0 0
Prolactin receptor/Prolactin receptor/Prolactin 0.026 0.075 0.28 9 -0.39 10 19
CBFA2T3 0.016 0.056 -10000 0 -0.53 5 5
ErbB4/ErbB2/HBEGF -0.028 0.086 -10000 0 -0.36 8 8
MAPK3 -0.022 0.084 -10000 0 -0.35 5 5
STAT1 (dimer) -0.037 0.09 -10000 0 -10000 0 0
MAPK1 -0.021 0.081 -10000 0 -0.35 5 5
JAK2 0.02 0.007 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 1 beta -0.034 0.082 -10000 0 -0.39 6 6
NRG1 -0.006 0.068 -10000 0 -0.39 14 14
NRG3 -0.13 0.24 -10000 0 -0.53 126 126
NRG2 -0.036 0.16 -10000 0 -0.53 48 48
NRG4 0.046 0.069 0.23 59 -0.3 1 60
heart development -0.034 0.071 -10000 0 -0.43 2 2
neural crest cell migration -0.033 0.081 -10000 0 -0.38 6 6
ERBB2 0.008 0.028 0.31 2 -10000 0 2
WWOX/E4ICDs -0.035 0.088 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 -0.018 0.12 0.29 1 -0.42 3 4
apoptosis 0.16 0.24 0.5 135 -10000 0 135
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta -0.068 0.13 -10000 0 -0.38 45 45
ErbB4/ErbB2/epiregulin -0.068 0.14 -10000 0 -0.38 48 48
ErbB4/ErbB4/betacellulin/betacellulin -0.06 0.13 -10000 0 -0.38 35 35
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 -0.021 0.11 0.37 1 -0.41 9 10
MDM2 -0.042 0.086 0.25 6 -10000 0 6
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta -0.021 0.072 -10000 0 -0.36 6 6
STAT5A -0.034 0.068 -10000 0 -0.41 2 2
ErbB4/EGFR/neuregulin 1 beta -0.027 0.1 0.27 2 -0.43 11 13
DLG4 0.021 0.005 -10000 0 -10000 0 0
GRB2/SHC 0.031 0.009 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 -0.036 0.082 -10000 0 -10000 0 0
STAT5A (dimer) -0.019 0.095 -10000 0 -0.48 3 3
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) -0.024 0.076 -10000 0 -0.41 2 2
LRIG1 0.02 0.026 -10000 0 -0.53 1 1
EREG -0.072 0.22 0.24 14 -0.53 89 103
BTC -0.019 0.14 -10000 0 -0.53 36 36
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.034 0.07 -10000 0 -0.43 2 2
ERBB4 -0.051 0.091 -10000 0 -0.29 5 5
STAT5B 0.022 0.003 -10000 0 -10000 0 0
YAP1 -0.009 0.076 -10000 0 -0.52 9 9
GRB2 0.022 0.004 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 -0.013 0.09 0.31 3 -10000 0 3
glial cell differentiation 0.036 0.082 -10000 0 -10000 0 0
WWOX 0.021 0.006 -10000 0 -10000 0 0
cell proliferation -0.056 0.12 0.32 1 -0.47 13 14
Glypican 1 network

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.031 0.069 -10000 0 -0.33 12 12
fibroblast growth factor receptor signaling pathway 0.03 0.068 -10000 0 -0.33 12 12
LAMA1 0.082 0.1 0.24 142 -0.42 2 144
PRNP 0.022 0.005 -10000 0 -10000 0 0
GPC1/SLIT2 -0.051 0.17 -10000 0 -0.4 96 96
SMAD2 -0.029 0.067 0.18 5 -0.3 24 29
GPC1/PrPc/Cu2+ 0.035 0.03 -10000 0 -10000 0 0
GPC1/Laminin alpha1 0.08 0.084 0.31 23 -0.3 2 25
TDGF1 0.014 0.024 0.23 3 -10000 0 3
CRIPTO/GPC1 0.038 0.035 -10000 0 -10000 0 0
APP/GPC1 0.039 0.034 -10000 0 -10000 0 0
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.014 0.012 -10000 0 -10000 0 0
FLT1 0.021 0.006 -10000 0 -10000 0 0
GPC1/TGFB/TGFBR1/TGFBR2 0.026 0.092 -10000 0 -0.33 25 25
SERPINC1 0.014 0.03 0.23 6 -10000 0 6
FYN -0.015 0.018 -10000 0 -0.3 1 1
FGR -0.035 0.08 -10000 0 -0.34 32 32
positive regulation of MAPKKK cascade -0.018 0.1 0.31 3 -0.36 21 24
SLIT2 -0.087 0.22 -10000 0 -0.53 97 97
GPC1/NRG 0.025 0.079 -10000 0 -0.39 14 14
NRG1 0.004 0.092 -10000 0 -0.53 14 14
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.049 0.033 -10000 0 -10000 0 0
LYN -0.015 0.023 -10000 0 -0.33 2 2
mol:Spermine -0.008 0.013 -10000 0 -10000 0 0
cell growth 0.03 0.068 -10000 0 -0.33 12 12
BMP signaling pathway -0.033 0.047 -10000 0 -0.23 27 27
SRC -0.014 0.012 -10000 0 -10000 0 0
TGFBR1 0.022 0.004 -10000 0 -10000 0 0
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.14 0.25 0.23 2 -0.53 140 142
GPC1 0.033 0.047 0.23 27 -10000 0 27
TGFBR1 (dimer) 0.022 0.004 -10000 0 -10000 0 0
VEGFA 0.022 0.004 -10000 0 -10000 0 0
BLK -0.018 0.053 -10000 0 -0.34 11 11
HCK -0.016 0.028 -10000 0 -0.34 3 3
FGF2 0.008 0.085 -10000 0 -0.53 12 12
FGFR1 0.017 0.026 -10000 0 -0.53 1 1
VEGFR1 homodimer 0.021 0.006 -10000 0 -10000 0 0
TGFBR2 -0.007 0.12 -10000 0 -0.53 25 25
cell death 0.039 0.033 -10000 0 -10000 0 0
ATIII/GPC1 0.039 0.036 -10000 0 -10000 0 0
PLA2G2A/GPC1 -0.086 0.2 -10000 0 -0.39 140 140
LCK -0.015 0.019 -10000 0 -0.34 1 1
neuron differentiation 0.025 0.079 -10000 0 -0.39 14 14
PrPc/Cu2+ 0.016 0.004 -10000 0 -10000 0 0
APP 0.022 0.005 -10000 0 -10000 0 0
TGFBR2 (dimer) -0.007 0.12 -10000 0 -0.53 25 25
TCGA08_p53

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.032 0.06 0.3 6 -0.21 20 26
TP53 -0.003 0.048 -10000 0 -0.19 24 24
Senescence -0.004 0.05 -10000 0 -0.2 25 25
Apoptosis -0.004 0.05 -10000 0 -0.2 25 25
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 -0.001 0.073 0.23 35 -0.21 6 41
MDM4 0.022 0.004 -10000 0 -10000 0 0
Caspase cascade in apoptosis

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.024 0.15 0.28 1 -0.48 38 39
ACTA1 -0.033 0.14 0.27 3 -0.52 30 33
NUMA1 -0.028 0.16 0.28 1 -0.49 41 42
SPTAN1 -0.036 0.14 0.32 3 -0.52 30 33
LIMK1 -0.034 0.14 0.31 2 -0.52 29 31
BIRC3 0.015 0.061 -10000 0 -0.53 6 6
BIRC2 0.022 0.004 -10000 0 -10000 0 0
BAX 0.022 0.004 -10000 0 -10000 0 0
CASP10 -0.03 0.091 -10000 0 -0.43 23 23
CRMA 0 0 -10000 0 -10000 0 0
XIAP 0.022 0.003 -10000 0 -10000 0 0
PTK2 -0.024 0.15 0.26 1 -0.49 36 37
DIABLO 0.023 0.002 -10000 0 -10000 0 0
apoptotic nuclear changes -0.035 0.14 0.32 3 -0.51 30 33
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.023 0.002 -10000 0 -10000 0 0
GSN -0.036 0.14 0.31 2 -0.53 29 31
MADD 0.022 0.004 -10000 0 -10000 0 0
TFAP2A 0.081 0.18 -10000 0 -0.7 21 21
BID -0.007 0.05 -10000 0 -0.25 19 19
MAP3K1 -0.035 0.16 -10000 0 -0.57 34 34
TRADD 0.022 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.032 0.007 -10000 0 -10000 0 0
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.026 0.15 0.32 3 -0.55 26 29
CASP9 0.022 0.005 -10000 0 -10000 0 0
DNA repair 0.002 0.046 0.2 9 -0.16 2 11
neuron apoptosis -0.011 0.15 -10000 0 -0.73 18 18
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.034 0.16 0.29 1 -0.51 39 40
APAF1 0.023 0.002 -10000 0 -10000 0 0
CASP6 -0.032 0.22 -10000 0 -0.98 22 22
TRAF2 0.022 0.004 -10000 0 -10000 0 0
ICAD/CAD -0.035 0.14 0.33 3 -0.52 28 31
CASP7 -0.005 0.066 0.31 5 -0.27 4 9
KRT18 0.009 0.046 -10000 0 -0.62 1 1
apoptosis -0.04 0.16 0.41 1 -0.56 33 34
DFFA -0.035 0.14 0.29 1 -0.52 30 31
DFFB -0.035 0.14 0.29 1 -0.53 29 30
PARP1 -0.002 0.047 0.16 2 -0.2 9 11
actin filament polymerization 0.029 0.14 0.48 28 -0.34 7 35
TNF 0.012 0.079 0.23 1 -0.53 10 11
CYCS -0.002 0.06 0.18 8 -0.23 19 27
SATB1 -0.033 0.2 -10000 0 -0.91 22 22
SLK -0.036 0.14 0.32 1 -0.52 30 31
p15 BID/BAX 0.006 0.063 0.2 3 -0.3 11 14
CASP2 0.007 0.051 0.2 2 -0.37 2 4
JNK cascade 0.035 0.16 0.57 34 -10000 0 34
CASP3 -0.035 0.15 0.32 1 -0.55 30 31
LMNB2 -0.004 0.12 0.28 3 -0.44 24 27
RIPK1 0.022 0.004 -10000 0 -10000 0 0
CASP4 0.021 0.025 -10000 0 -0.53 1 1
Mammalian IAPs/DIABLO 0.051 0.042 -10000 0 -0.31 6 6
negative regulation of DNA binding 0.082 0.18 -10000 0 -0.68 21 21
stress fiber formation -0.035 0.14 0.31 1 -0.5 30 31
GZMB -0.033 0.11 -10000 0 -0.49 24 24
CASP1 0.008 0.039 -10000 0 -0.56 2 2
LMNB1 -0.024 0.19 0.28 3 -0.58 37 40
APP -0.011 0.15 -10000 0 -0.75 18 18
TNFRSF1A 0.021 0.006 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
CASP8 -0.005 0.002 -10000 0 -10000 0 0
VIM -0.038 0.16 0.4 1 -0.55 36 37
LMNA 0.004 0.099 0.28 3 -0.4 19 22
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.01 0.056 -10000 0 -0.35 3 3
LRDD 0 0 -10000 0 -10000 0 0
SREBF1 -0.035 0.14 0.32 2 -0.53 29 31
APAF-1/Caspase 9 -0.007 0.13 -10000 0 -0.64 19 19
nuclear fragmentation during apoptosis -0.027 0.15 0.27 1 -0.48 41 42
CFL2 -0.03 0.14 0.34 7 -0.5 28 35
GAS2 -0.063 0.16 -10000 0 -0.42 66 66
positive regulation of apoptosis -0.008 0.15 0.29 3 -0.5 29 32
PRF1 -0.002 0.11 -10000 0 -0.53 21 21
S1P1 pathway

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.005 0.092 -10000 0 -0.39 24 24
PDGFRB 0.019 0.026 -10000 0 -0.54 1 1
SPHK1 0 0.054 -10000 0 -0.73 2 2
mol:S1P -0.004 0.053 -10000 0 -0.64 2 2
S1P1/S1P/Gi -0.049 0.16 -10000 0 -0.42 64 64
GNAO1 0.017 0.032 0.22 2 -0.53 1 3
PDGFB-D/PDGFRB/PLCgamma1 -0.032 0.15 0.25 3 -0.38 61 64
PLCG1 -0.051 0.15 -10000 0 -0.4 64 64
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.019 0.026 -10000 0 -0.54 1 1
GNAI2 0.016 0.016 -10000 0 -10000 0 0
GNAI3 0.018 0.015 -10000 0 -10000 0 0
GNAI1 0.016 0.029 -10000 0 -0.54 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.024 0.07 -10000 0 -0.33 24 24
S1P1/S1P -0.018 0.078 -10000 0 -0.35 10 10
negative regulation of cAMP metabolic process -0.047 0.16 -10000 0 -0.41 64 64
MAPK3 -0.072 0.21 -10000 0 -0.56 69 69
calcium-dependent phospholipase C activity -0.001 0.003 -10000 0 -10000 0 0
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
RhoA/GDP 0.015 0.005 -10000 0 -10000 0 0
KDR -0.01 0.12 -10000 0 -0.53 25 25
PLCB2 -0.009 0.088 0.25 4 -0.33 8 12
RAC1 0.022 0.004 -10000 0 -10000 0 0
RhoA/GTP -0.012 0.069 -10000 0 -0.32 8 8
receptor internalization -0.018 0.073 -10000 0 -0.33 10 10
PTGS2 -0.1 0.33 0.34 1 -0.95 58 59
Rac1/GTP -0.012 0.069 -10000 0 -0.31 9 9
RHOA 0.021 0.007 -10000 0 -10000 0 0
VEGFA 0.019 0.013 -10000 0 -10000 0 0
negative regulation of T cell proliferation -0.047 0.16 -10000 0 -0.41 64 64
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ 0.012 0.057 -10000 0 -0.54 5 5
MAPK1 -0.064 0.19 -10000 0 -0.54 65 65
S1P1/S1P/PDGFB-D/PDGFRB -0.008 0.092 0.28 1 -0.37 10 11
ABCC1 0.019 0.017 0.24 1 -10000 0 1
FAS signaling pathway (CD95)

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 -0.008 0.023 0.24 1 -0.25 1 2
RFC1 -0.006 0.031 0.22 5 -0.25 1 6
PRKDC -0.003 0.044 0.22 13 -0.25 1 14
RIPK1 0.023 0.005 -10000 0 -10000 0 0
CASP7 -0.016 0.12 -10000 0 -0.6 18 18
FASLG/FAS/FADD/FAF1 -0.006 0.061 0.21 4 -0.28 18 22
MAP2K4 -0.02 0.15 0.33 3 -0.42 23 26
mol:ceramide -0.018 0.095 -10000 0 -0.36 20 20
GSN -0.008 0.023 0.24 1 -0.25 1 2
FASLG/FAS/FADD/FAF1/Caspase 8 -0.007 0.086 -10000 0 -0.34 21 21
FAS 0.013 0.032 -10000 0 -0.55 1 1
BID -0.014 0.055 0.51 4 -10000 0 4
MAP3K1 0.009 0.13 0.35 5 -0.46 20 25
MAP3K7 0.017 0.015 -10000 0 -10000 0 0
RB1 -0.008 0.029 0.23 2 -0.3 2 4
CFLAR 0.023 0.005 -10000 0 -10000 0 0
HGF/MET -0.035 0.15 0.25 1 -0.34 99 100
ARHGDIB 0.001 0.053 0.22 23 -0.25 1 24
FADD 0.013 0.018 -10000 0 -10000 0 0
actin filament polymerization 0.019 0.046 0.25 1 -0.24 1 2
NFKB1 -0.033 0.14 -10000 0 -0.67 16 16
MAPK8 -0.049 0.19 0.45 1 -0.43 84 85
DFFA -0.007 0.027 0.23 2 -0.25 1 3
DNA fragmentation during apoptosis -0.015 0.047 0.22 4 -0.25 1 5
FAS/FADD/MET 0.025 0.043 0.25 1 -0.34 3 4
CFLAR/RIP1 0.034 0.01 -10000 0 -10000 0 0
FAIM3 0.019 0.051 0.23 1 -0.53 4 5
FAF1 0.014 0.022 -10000 0 -10000 0 0
PARP1 -0.006 0.035 0.22 6 -0.2 4 10
DFFB -0.006 0.031 0.22 4 -0.25 1 5
CHUK -0.03 0.13 -10000 0 -0.61 16 16
FASLG -0.007 0.11 -10000 0 -0.54 19 19
FAS/FADD 0.017 0.033 -10000 0 -0.42 1 1
HGF -0.09 0.22 -10000 0 -0.53 100 100
LMNA -0.011 0.043 0.21 1 -10000 0 1
CASP6 -0.006 0.027 0.23 3 -0.25 1 4
CASP10 0.013 0.031 -10000 0 -0.53 1 1
CASP3 -0.003 0.021 0.25 2 -0.28 1 3
PTPN13 0.018 0.043 -10000 0 -0.53 3 3
CASP8 -0.016 0.044 0.44 4 -10000 0 4
IL6 -0.19 0.49 -10000 0 -1.2 89 89
MET 0.02 0.039 0.38 1 -0.53 2 3
ICAD/CAD -0.008 0.03 0.26 3 -0.24 1 4
FASLG/FAS/FADD/FAF1/Caspase 10 -0.018 0.096 -10000 0 -0.37 20 20
activation of caspase activity by cytochrome c -0.014 0.054 0.51 4 -10000 0 4
PAK2 0.059 0.1 0.22 150 -10000 0 150
BCL2 0.023 0.016 0.38 1 -10000 0 1
Neurotrophic factor-mediated Trk receptor signaling

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.021 0.006 -10000 0 -10000 0 0
RAS family/GTP/Tiam1 -0.04 0.091 -10000 0 -0.26 23 23
NT3 (dimer)/TRKC -0.088 0.19 -10000 0 -0.4 134 134
NT3 (dimer)/TRKB 0.04 0.13 0.31 2 -0.36 34 36
SHC/Grb2/SOS1/GAB1/PI3K 0.009 0.022 -10000 0 -10000 0 0
RAPGEF1 0.022 0.003 -10000 0 -10000 0 0
BDNF -0.045 0.18 -10000 0 -0.53 60 60
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
DYNLT1 0.022 0.003 -10000 0 -10000 0 0
NTRK1 0.016 0.056 -10000 0 -0.53 5 5
NTRK2 0.02 0.16 0.23 79 -0.53 32 111
NTRK3 -0.14 0.25 0.23 3 -0.53 140 143
NT-4/5 (dimer)/TRKB 0.043 0.13 0.27 5 -0.36 36 41
neuron apoptosis 0.042 0.17 0.41 48 -10000 0 48
SHC 2-3/Grb2 -0.047 0.18 -10000 0 -0.45 48 48
SHC1 0.022 0.005 -10000 0 -10000 0 0
SHC2 0.004 0.12 -10000 0 -0.43 16 16
SHC3 -0.074 0.22 -10000 0 -0.51 87 87
STAT3 (dimer) 0.022 0.042 -10000 0 -0.35 6 6
NT3 (dimer)/TRKA 0.043 0.068 0.25 1 -0.34 10 11
RIN/GDP -0.026 0.089 0.24 4 -0.28 5 9
GIPC1 0.022 0.004 -10000 0 -10000 0 0
KRAS 0.021 0.006 -10000 0 -10000 0 0
DNAJA3 0.028 0.058 0.23 1 -0.24 5 6
RIN/GTP 0.012 0.003 -10000 0 -10000 0 0
CCND1 0.001 0.089 0.36 1 -0.79 6 7
MAGED1 0.022 0.004 -10000 0 -10000 0 0
PTPN11 0.023 0.002 -10000 0 -10000 0 0
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) 0.013 0.07 -10000 0 -0.53 8 8
SHC/GRB2/SOS1 0.042 0.014 -10000 0 -10000 0 0
GRB2 0.022 0.004 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.018 0.094 0.25 1 -0.33 31 32
TRKA/NEDD4-2 0.027 0.043 -10000 0 -0.39 5 5
ELMO1 0.014 0.065 -10000 0 -0.53 7 7
RhoG/GTP/ELMO1/DOCK1 0.023 0.044 -10000 0 -0.33 7 7
NGF 0.013 0.077 0.28 3 -0.53 9 12
HRAS 0.022 0.004 -10000 0 -10000 0 0
DOCK1 0.022 0.004 -10000 0 -10000 0 0
GAB2 0.006 0.092 -10000 0 -0.53 14 14
RIT2 -0.015 0.011 -10000 0 -10000 0 0
RIT1 0.022 0.005 -10000 0 -10000 0 0
FRS2 0.022 0.005 -10000 0 -10000 0 0
DNM1 0.023 0.014 0.23 2 -10000 0 2
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.021 0.005 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP 0.036 0.062 -10000 0 -0.24 9 9
mol:GDP -0.04 0.12 0.31 5 -0.4 10 15
NGF (dimer) 0.013 0.077 0.28 3 -0.53 9 12
RhoG/GDP 0.01 0.049 -10000 0 -0.39 7 7
RIT1/GDP -0.023 0.087 0.26 3 -0.28 5 8
TIAM1 0.021 0.025 -10000 0 -0.53 1 1
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
BDNF (dimer)/TRKB -0.004 0.18 0.25 1 -0.38 78 79
KIDINS220/CRKL/C3G 0.031 0.01 -10000 0 -10000 0 0
SHC/RasGAP 0.03 0.011 -10000 0 -10000 0 0
FRS2 family/SHP2 0.043 0.013 -10000 0 -10000 0 0
SHC/GRB2/SOS1/GAB1 0.05 0.021 -10000 0 -10000 0 0
RIT1/GTP 0.016 0.004 -10000 0 -10000 0 0
NT3 (dimer) 0.014 0.067 0.23 2 -0.53 7 9
RAP1/GDP -0.024 0.072 -10000 0 -0.24 6 6
KIDINS220/CRKL 0.021 0.006 -10000 0 -10000 0 0
BDNF (dimer) -0.044 0.18 -10000 0 -0.53 60 60
ubiquitin-dependent protein catabolic process 0.03 0.066 0.25 1 -0.34 14 15
Schwann cell development -0.039 0.03 -10000 0 -10000 0 0
EHD4 0.022 0.003 -10000 0 -10000 0 0
FRS2 family/GRB2/SOS1 0.052 0.019 -10000 0 -10000 0 0
FRS2 family/SHP2/CRK family/C3G/GAB2 0.011 0.054 -10000 0 -0.32 4 4
RAP1B 0.022 0.005 -10000 0 -10000 0 0
RAP1A 0.022 0.005 -10000 0 -10000 0 0
CDC42/GTP -0.091 0.2 -10000 0 -0.34 169 169
ABL1 0.022 0.003 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
Rap1/GTP -0.016 0.091 -10000 0 -0.38 8 8
STAT3 0.022 0.042 -10000 0 -0.35 6 6
axon guidance -0.094 0.18 -10000 0 -0.32 169 169
MAPK3 -0.026 0.079 0.18 15 -0.3 30 45
MAPK1 -0.026 0.077 0.18 13 -0.3 29 42
CDC42/GDP -0.022 0.092 0.26 5 -0.28 6 11
NTF3 0.014 0.067 0.23 2 -0.53 7 9
NTF4 0.013 0.07 -10000 0 -0.53 8 8
NGF (dimer)/TRKA/FAIM 0.026 0.065 0.25 1 -0.34 13 14
PI3K 0.017 0.017 -10000 0 -10000 0 0
FRS3 0.022 0.004 -10000 0 -10000 0 0
FAIM 0.019 0.009 -10000 0 -10000 0 0
GAB1 0.021 0.006 -10000 0 -10000 0 0
RASGRF1 -0.12 0.14 -10000 0 -0.28 143 143
SOS1 0.022 0.004 -10000 0 -10000 0 0
MCF2L -0.1 0.15 0.25 1 -0.34 133 134
RGS19 0.022 0.004 -10000 0 -10000 0 0
CDC42 0.022 0.004 -10000 0 -10000 0 0
RAS family/GTP -0.021 0.08 0.37 1 -0.42 4 5
Rac1/GDP -0.023 0.091 0.24 4 -0.28 6 10
NGF (dimer)/TRKA/GRIT 0.018 0.062 0.24 1 -0.33 14 15
neuron projection morphogenesis 0.034 0.12 -10000 0 -0.81 7 7
NGF (dimer)/TRKA/NEDD4-2 0.031 0.066 0.25 1 -0.34 14 15
MAP2K1 0.001 0.057 0.55 1 -10000 0 1
NGFR 0.041 0.062 0.24 43 -10000 0 43
NGF (dimer)/TRKA/GIPC/GAIP 0.012 0.047 -10000 0 -0.26 12 12
RAS family/GTP/PI3K 0.009 0.01 -10000 0 -10000 0 0
FRS2 family/SHP2/GRB2/SOS1 0.06 0.023 -10000 0 -10000 0 0
NRAS 0.022 0.005 -10000 0 -10000 0 0
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
PRKCI 0.013 0.011 -10000 0 -10000 0 0
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCZ 0.022 0.005 -10000 0 -10000 0 0
MAPKKK cascade -0.028 0.14 -10000 0 -0.56 24 24
RASA1 0.021 0.006 -10000 0 -10000 0 0
TRKA/c-Abl 0.028 0.043 -10000 0 -0.39 5 5
SQSTM1 0.021 0.006 -10000 0 -10000 0 0
BDNF (dimer)/TRKB/GIPC 0.008 0.17 0.25 1 -0.35 75 76
NGF (dimer)/TRKA/p62/Atypical PKCs 0.027 0.059 -10000 0 -0.29 10 10
MATK 0.001 0.11 -10000 0 -0.53 19 19
NEDD4L 0.022 0.005 -10000 0 -10000 0 0
RAS family/GDP -0.037 0.056 -10000 0 -0.24 2 2
NGF (dimer)/TRKA 0.005 0.045 0.19 1 -0.25 7 8
Rac1/GTP -0.1 0.098 -10000 0 -0.26 67 67
FRS2 family/SHP2/CRK family 0.056 0.026 -10000 0 -10000 0 0
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.022 0.005 -10000 0 -10000 0 0
VLDLR 0.019 0.026 -10000 0 -0.53 1 1
LRPAP1 0.021 0.006 -10000 0 -10000 0 0
NUDC 0.022 0.004 -10000 0 -10000 0 0
RELN/LRP8 -0.018 0.14 -10000 0 -0.33 78 78
CaM/Ca2+ 0.016 0.004 -10000 0 -10000 0 0
KATNA1 0.022 0.003 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 -0.051 0.12 -10000 0 -0.3 78 78
IQGAP1/CaM 0.032 0.009 -10000 0 -10000 0 0
DAB1 0.026 0.056 0.24 29 -10000 0 29
IQGAP1 0.022 0.004 -10000 0 -10000 0 0
PLA2G7 0.018 0.05 -10000 0 -0.53 4 4
CALM1 0.022 0.005 -10000 0 -10000 0 0
DYNLT1 0.022 0.003 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.031 0.013 -10000 0 -10000 0 0
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.023 0.002 -10000 0 -10000 0 0
CDK5R1 0.027 0.032 0.24 10 -10000 0 10
LIS1/Poliovirus Protein 3A -0.007 0.003 -10000 0 -10000 0 0
CDK5R2 0.071 0.096 0.23 128 -0.3 2 130
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.015 0.14 0.35 2 -0.33 76 78
YWHAE 0.022 0.005 -10000 0 -10000 0 0
NDEL1/14-3-3 E -0.015 0.11 0.31 2 -0.32 5 7
MAP1B 0.005 0.01 0.21 1 -10000 0 1
RAC1 0.009 0.004 -10000 0 -10000 0 0
p35/CDK5 -0.046 0.11 0.28 1 -0.28 73 74
RELN -0.065 0.2 0.23 3 -0.53 78 81
PAFAH/LIS1 0.019 0.028 -10000 0 -0.33 3 3
LIS1/CLIP170 0.021 0.007 -10000 0 -10000 0 0
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain -0.009 0.092 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.035 0.12 -10000 0 -0.33 40 40
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 -0.033 0.11 0.34 1 -0.32 10 11
LIS1/IQGAP1 0.021 0.008 -10000 0 -10000 0 0
RHOA 0.009 0.004 -10000 0 -10000 0 0
PAFAH1B1 -0.009 0.003 -10000 0 -10000 0 0
PAFAH1B3 0.025 0.029 0.34 4 -10000 0 4
PAFAH1B2 0.022 0.004 -10000 0 -10000 0 0
MAP1B/LIS1/Dynein heavy chain 0.015 0.027 -10000 0 -10000 0 0
NDEL1/Katanin 60/Dynein heavy chain -0.007 0.11 0.3 2 -0.34 2 4
LRP8 0.023 0.016 0.23 3 -10000 0 3
NDEL1/Katanin 60 -0.018 0.11 0.31 2 -0.32 6 8
P39/CDK5 -0.017 0.14 0.3 7 -0.29 67 74
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.021 0.008 -10000 0 -10000 0 0
CDK5 -0.051 0.11 -10000 0 -0.29 77 77
PPP2R5D 0.022 0.004 -10000 0 -10000 0 0
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.018 0.006 -10000 0 -10000 0 0
CSNK2A1 0.022 0.005 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 -0.004 0.12 0.29 2 -0.29 68 70
RELN/VLDLR -0.007 0.13 -10000 0 -0.3 76 76
CDC42 0.009 0.004 -10000 0 -10000 0 0
JNK signaling in the CD4+ TCR pathway

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.024 0.093 -10000 0 -0.33 29 29
MAP4K1 0.016 0.05 -10000 0 -0.53 4 4
MAP3K8 0.021 0.025 -10000 0 -0.53 1 1
PRKCB -0.006 0.12 -10000 0 -0.53 25 25
DBNL 0.022 0.005 -10000 0 -10000 0 0
CRKL 0.021 0.006 -10000 0 -10000 0 0
MAP3K1 -0.002 0.079 -10000 0 -0.31 21 21
JUN -0.037 0.2 -10000 0 -0.64 43 43
MAP3K7 -0.009 0.088 -10000 0 -0.3 29 29
GRAP2 -0.008 0.13 -10000 0 -0.53 27 27
CRK 0.021 0.005 -10000 0 -10000 0 0
MAP2K4 0.002 0.096 0.28 5 -0.51 8 13
LAT 0.022 0.003 -10000 0 -10000 0 0
LCP2 0.015 0.056 -10000 0 -0.53 5 5
MAPK8 -0.036 0.21 -10000 0 -0.68 43 43
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family 0 0.092 -10000 0 -0.3 33 33
LAT/GRAP2/SLP76/HPK1/HIP-55 0.032 0.091 -10000 0 -0.31 28 28
Visual signal transduction: Rods

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.023 0.002 -10000 0 -10000 0 0
GNAT1/GTP 0.015 0.02 0.16 7 -0.2 1 8
Metarhodopsin II/Arrestin 0.023 0.012 -10000 0 -10000 0 0
PDE6G/GNAT1/GTP 0.021 0.053 -10000 0 -0.32 10 10
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.008 0.035 0.23 7 -0.3 1 8
GRK1 -0.004 0.03 0.38 2 -10000 0 2
CNG Channel 0.028 0.077 -10000 0 -0.29 20 20
mol:Na + 0.058 0.058 -10000 0 -10000 0 0
mol:ADP -0.004 0.03 0.38 2 -10000 0 2
RGS9-1/Gbeta5/R9AP -0.003 0.12 -10000 0 -0.34 57 57
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel 0.074 0.069 0.25 22 -10000 0 22
CNGB1 0.04 0.061 0.23 44 -10000 0 44
RDH5 0.02 0.035 -10000 0 -0.53 2 2
SAG -0.013 0.013 -10000 0 -10000 0 0
mol:Ca2+ -0.004 0.09 0.35 14 -10000 0 14
Na + (4 Units) 0.044 0.043 -10000 0 -10000 0 0
RGS9 -0.036 0.17 -10000 0 -0.53 52 52
GNB1/GNGT1 0.077 0.078 0.27 19 -0.39 1 20
GNAT1/GDP 0.005 0.11 -10000 0 -0.3 57 57
GUCY2D 0.02 0.009 -10000 0 -10000 0 0
GNGT1 0.092 0.11 0.25 155 -10000 0 155
GUCY2F -0.006 0.019 -10000 0 -10000 0 0
GNB5 0.023 0.003 -10000 0 -10000 0 0
mol:GMP (4 units) 0.001 0.068 -10000 0 -0.3 22 22
mol:11-cis-retinal 0.02 0.035 -10000 0 -0.53 2 2
mol:cGMP 0.062 0.062 0.27 3 -10000 0 3
GNB1 0.021 0.025 -10000 0 -0.53 1 1
Rhodopsin 0.027 0.03 -10000 0 -0.4 2 2
SLC24A1 0.023 0.002 -10000 0 -10000 0 0
CNGA1 0.024 0.024 0.23 6 -10000 0 6
Metarhodopsin II 0.022 0.017 0.22 2 -10000 0 2
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.073 0.063 -10000 0 -10000 0 0
RGS9BP 0.011 0.074 -10000 0 -0.53 9 9
Metarhodopsin II/Transducin 0.023 0.045 0.17 15 -0.2 3 18
GCAP Family/Ca ++ 0.063 0.059 -10000 0 -10000 0 0
PDE6A/B 0.017 0.075 -10000 0 -0.39 15 15
mol:Pi -0.003 0.12 -10000 0 -0.34 57 57
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin 0.071 0.069 0.24 19 -0.31 1 20
PDE6B 0.014 0.062 0.23 1 -0.53 6 7
PDE6A 0.011 0.075 0.23 2 -0.53 9 11
PDE6G 0.012 0.074 -10000 0 -0.53 9 9
RHO 0 0.024 0.23 2 -10000 0 2
PDE6 0.002 0.14 -10000 0 -0.32 65 65
GUCA1A 0.076 0.097 0.23 134 -0.3 2 136
GC2/GCAP Family 0.072 0.062 -10000 0 -10000 0 0
GUCA1C -0.016 0.006 -10000 0 -10000 0 0
GUCA1B 0.022 0.005 -10000 0 -10000 0 0
Noncanonical Wnt signaling pathway

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 -0.051 0.19 -10000 0 -0.53 65 65
GNB1/GNG2 0.018 0.094 0.26 1 -0.35 10 11
mol:DAG -0.004 0.075 0.22 1 -0.34 7 8
PLCG1 -0.004 0.077 0.22 1 -0.35 7 8
YES1 -0.004 0.073 0.22 4 -0.29 19 23
FZD3 0.021 0.007 -10000 0 -10000 0 0
FZD6 0.022 0.005 -10000 0 -10000 0 0
G protein 0.013 0.09 0.24 1 -0.38 7 8
MAP3K7 -0.026 0.092 0.19 1 -0.38 14 15
mol:Ca2+ -0.004 0.073 0.22 1 -0.33 7 8
mol:IP3 -0.004 0.075 0.22 1 -0.34 7 8
NLK 0.005 0.072 -10000 0 -0.78 4 4
GNB1 0.021 0.025 -10000 0 -0.53 1 1
CAMK2A -0.019 0.099 0.2 1 -0.4 15 16
MAP3K7IP1 0 0 -10000 0 -10000 0 0
Noncanonical Wnts/FZD 0.008 0.077 0.23 2 -0.3 20 22
CSNK1A1 0.021 0.006 -10000 0 -10000 0 0
GNAS -0.004 0.074 0.24 4 -0.29 19 23
GO:0007205 -0.011 0.073 0.21 1 -0.34 7 8
WNT6 0.054 0.08 0.23 81 -0.3 1 82
WNT4 0.019 0.053 0.23 4 -0.53 4 8
NFAT1/CK1 alpha -0.012 0.14 0.27 2 -0.41 22 24
GNG2 0.016 0.055 -10000 0 -0.53 5 5
WNT5A 0.023 0.041 0.23 9 -0.42 2 11
WNT11 0.007 0.11 0.24 10 -0.53 18 28
CDC42 -0.005 0.069 0.23 3 -0.28 19 22
PDGFR-alpha signaling pathway

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA 0.008 0.067 0.36 1 -0.55 6 7
PDGF/PDGFRA/CRKL 0.019 0.045 0.25 1 -0.39 4 5
positive regulation of JUN kinase activity 0.042 0.044 -10000 0 -0.3 6 6
CRKL 0.021 0.006 -10000 0 -10000 0 0
PDGF/PDGFRA/Caveolin-3 -0.043 0.15 0.25 1 -0.39 74 75
AP1 -0.11 0.3 0.3 2 -0.92 60 62
mol:IP3 -0.015 0.04 0.3 1 -0.39 3 4
PLCG1 -0.015 0.04 0.3 1 -0.39 3 4
PDGF/PDGFRA/alphaV Integrin 0.019 0.052 0.25 1 -0.39 6 7
RAPGEF1 0.022 0.003 -10000 0 -10000 0 0
CRK 0.021 0.005 -10000 0 -10000 0 0
mol:Ca2+ -0.015 0.039 0.3 1 -0.39 3 4
CAV3 -0.081 0.18 -10000 0 -0.53 68 68
CAV1 -0.12 0.24 -10000 0 -0.53 127 127
SHC/Grb2/SOS1 0.044 0.045 -10000 0 -0.3 6 6
PDGF/PDGFRA/Shf 0.02 0.051 0.25 1 -0.39 6 7
FOS -0.12 0.29 -10000 0 -0.9 60 60
JUN -0.022 0.025 -10000 0 -10000 0 0
oligodendrocyte development 0.019 0.051 0.25 1 -0.39 6 7
GRB2 0.022 0.004 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:DAG -0.015 0.04 0.3 1 -0.39 3 4
PDGF/PDGFRA 0.008 0.067 0.36 1 -0.55 6 7
actin cytoskeleton reorganization 0.018 0.051 0.25 1 -0.38 6 7
SRF -0.005 0.014 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
PI3K 0.016 0.044 0.24 1 -0.33 5 6
PDGF/PDGFRA/Crk/C3G 0.029 0.047 0.24 1 -0.32 6 7
JAK1 -0.013 0.042 0.28 1 -0.39 5 6
ELK1/SRF -0.01 0.051 0.24 2 -0.31 2 4
SHB 0.021 0.007 -10000 0 -10000 0 0
SHF 0.022 0.003 -10000 0 -10000 0 0
CSNK2A1 0.024 0.02 -10000 0 -10000 0 0
GO:0007205 -0.013 0.045 0.3 1 -0.37 5 6
SOS1 0.022 0.004 -10000 0 -10000 0 0
Ras protein signal transduction 0.042 0.044 -10000 0 -0.3 6 6
PDGF/PDGFRA/SHB 0.019 0.051 0.25 1 -0.39 6 7
PDGF/PDGFRA/Caveolin-1 -0.087 0.19 0.25 1 -0.4 130 131
ITGAV 0.022 0.004 -10000 0 -10000 0 0
ELK1 -0.019 0.046 0.23 1 -0.34 5 6
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
PDGF/PDGFRA/Crk 0.019 0.05 0.25 1 -0.38 6 7
JAK-STAT cascade -0.013 0.042 0.28 1 -0.39 5 6
cell proliferation 0.02 0.051 0.25 1 -0.38 6 7
Syndecan-3-mediated signaling events

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.019 0.008 -10000 0 -10000 0 0
Syndecan-3/Src/Cortactin 0.028 0.077 -10000 0 -0.35 9 9
Syndecan-3/Neurocan 0.026 0.071 -10000 0 -0.37 9 9
POMC 0.037 0.081 0.24 43 -0.53 4 47
EGFR 0.023 0.081 0.36 12 -0.53 6 18
Syndecan-3/EGFR 0.019 0.07 0.29 3 -0.37 8 11
AGRP -0.24 0.26 -10000 0 -0.53 218 218
NCSTN 0.022 0.005 -10000 0 -10000 0 0
PSENEN 0.021 0.007 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
APH1B 0.023 0.002 -10000 0 -10000 0 0
APH1A 0.021 0.006 -10000 0 -10000 0 0
NCAN 0.029 0.059 0.23 35 -10000 0 35
long-term memory 0.026 0.064 -10000 0 -0.36 10 10
Syndecan-3/IL8 0.02 0.069 -10000 0 -0.37 10 10
PSEN1 0.022 0.005 -10000 0 -10000 0 0
Src/Cortactin 0.028 0.013 -10000 0 -10000 0 0
FYN 0.021 0.025 -10000 0 -0.53 1 1
limb bud formation 0.001 0.055 -10000 0 -0.38 10 10
MC4R 0.024 0.049 0.24 21 -10000 0 21
SRC 0.022 0.004 -10000 0 -10000 0 0
PTN 0.011 0.083 0.23 3 -0.53 11 14
FGFR/FGF/Syndecan-3 0.001 0.056 -10000 0 -0.39 10 10
neuron projection morphogenesis 0.029 0.092 0.27 10 -0.35 8 18
Syndecan-3/AgRP -0.11 0.15 -10000 0 -0.42 10 10
Syndecan-3/AgRP/MC4R -0.095 0.16 0.32 1 -0.37 15 16
Fyn/Cortactin 0.028 0.023 -10000 0 -0.39 1 1
SDC3 0.001 0.056 -10000 0 -0.39 10 10
GO:0007205 0 0 -10000 0 -10000 0 0
positive regulation of leukocyte migration 0.02 0.068 -10000 0 -0.36 10 10
IL8 0.025 0.058 0.25 14 -0.53 3 17
Syndecan-3/Fyn/Cortactin 0.026 0.065 -10000 0 -0.36 10 10
Syndecan-3/CASK -0.001 0.056 -10000 0 -0.37 10 10
alpha-MSH/MC4R 0.047 0.066 0.28 6 -0.4 4 10
Gamma Secretase 0.055 0.027 -10000 0 -10000 0 0
p75(NTR)-mediated signaling

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.027 0.044 -10000 0 -0.39 5 5
Necdin/E2F1 0.026 0.048 -10000 0 -0.39 6 6
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.058 0.073 -10000 0 -0.3 13 13
NGF (dimer)/p75(NTR)/BEX1 0.015 0.13 0.28 5 -0.34 51 56
NT-4/5 (dimer)/p75(NTR) 0.039 0.07 0.27 3 -0.39 8 11
IKBKB 0.021 0.017 0.38 1 -10000 0 1
AKT1 0.051 0.1 0.32 5 -0.3 6 11
IKBKG 0.022 0.004 -10000 0 -10000 0 0
BDNF -0.045 0.18 -10000 0 -0.53 60 60
MGDIs/NGR/p75(NTR)/LINGO1 0.062 0.06 0.3 8 -0.34 1 9
FURIN 0.022 0.003 -10000 0 -10000 0 0
proBDNF (dimer)/p75(NTR)/Sortilin 0.002 0.14 0.25 2 -0.34 64 66
LINGO1 0.041 0.06 0.23 43 -10000 0 43
Sortilin/TRAF6/NRIF 0.022 0.031 -10000 0 -0.28 4 4
proBDNF (dimer) -0.044 0.18 -10000 0 -0.53 60 60
NTRK1 0.016 0.056 -10000 0 -0.53 5 5
RTN4R 0.02 0.027 0.23 1 -0.53 1 2
neuron apoptosis -0.044 0.14 0.29 2 -0.54 17 19
IRAK1 0.022 0.004 -10000 0 -10000 0 0
SHC1 -0.019 0.048 0.23 3 -0.35 8 11
ARHGDIA 0.022 0.004 -10000 0 -10000 0 0
RhoA/GTP 0.015 0.005 -10000 0 -10000 0 0
Gamma Secretase 0.055 0.027 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.053 0.073 0.25 2 -0.31 13 15
MAGEH1 0.022 0.003 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/Necdin 0.048 0.086 0.25 3 -0.33 18 21
Mammalian IAPs/DIABLO 0.051 0.042 -10000 0 -0.31 6 6
proNGF (dimer) 0.013 0.077 0.28 3 -0.53 9 12
MAGED1 0.022 0.004 -10000 0 -10000 0 0
APP 0.022 0.005 -10000 0 -10000 0 0
NT-4/5 (dimer) 0.013 0.07 -10000 0 -0.53 8 8
ZNF274 0.022 0.005 -10000 0 -10000 0 0
RhoA/GDP/RHOGDI 0.016 0.049 -10000 0 -0.3 8 8
NGF 0.013 0.077 0.28 3 -0.53 9 12
cell cycle arrest -0.016 0.066 0.21 7 -0.28 13 20
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0.014 0.047 -10000 0 -0.25 8 8
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.049 0.063 0.25 2 -0.34 8 10
NCSTN 0.022 0.005 -10000 0 -10000 0 0
mol:GTP 0.046 0.065 0.25 3 -0.34 8 11
PSENEN 0.021 0.007 -10000 0 -10000 0 0
mol:ceramide -0.022 0.056 0.18 9 -0.31 13 22
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs 0.01 0.038 0.24 1 -0.32 1 2
p75(NTR)/beta APP 0.044 0.042 0.27 3 -10000 0 3
BEX1 -0.02 0.17 0.23 22 -0.53 44 66
mol:GDP -0.016 0.048 0.22 3 -0.34 8 11
NGF (dimer) 0.042 0.079 -10000 0 -0.33 17 17
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.071 0.059 0.33 5 -0.31 1 6
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
RAC1/GTP 0.04 0.057 0.22 3 -0.3 8 11
MYD88 0.021 0.006 -10000 0 -10000 0 0
CHUK 0.022 0.005 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/PKA 0.046 0.066 0.25 3 -0.35 8 11
RHOB 0.022 0.004 -10000 0 -10000 0 0
RHOA 0.021 0.007 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.032 0.009 -10000 0 -10000 0 0
NT3 (dimer) 0.014 0.067 0.23 2 -0.53 7 9
TP53 -0.046 0.11 0.38 4 -0.29 58 62
PRDM4 -0.022 0.056 0.18 9 -0.31 13 22
BDNF (dimer) 0.062 0.18 0.3 15 -0.34 66 81
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
SORT1 0.016 0.055 -10000 0 -0.53 5 5
activation of caspase activity 0.052 0.07 -10000 0 -0.3 13 13
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.053 0.073 0.25 3 -0.31 13 16
RHOC 0.022 0.005 -10000 0 -10000 0 0
XIAP 0.022 0.003 -10000 0 -10000 0 0
MAPK10 -0.031 0.1 0.32 6 -0.4 8 14
DIABLO 0.023 0.002 -10000 0 -10000 0 0
SMPD2 -0.022 0.056 0.18 9 -0.31 13 22
APH1B 0.023 0.002 -10000 0 -10000 0 0
APH1A 0.021 0.006 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin 0.043 0.076 0.25 3 -0.34 13 16
PSEN1 0.022 0.005 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.032 0.007 -10000 0 -10000 0 0
NT3 (dimer)/p75(NTR) 0.036 0.065 0.27 1 -0.39 7 8
MAPK8 -0.027 0.096 0.31 7 -0.4 4 11
MAPK9 -0.028 0.095 0.36 4 -0.37 6 10
APAF1 0.023 0.002 -10000 0 -10000 0 0
NTF3 0.014 0.067 0.23 2 -0.53 7 9
NTF4 0.013 0.07 -10000 0 -0.53 8 8
NDN 0.014 0.065 -10000 0 -0.53 7 7
RAC1/GDP 0.016 0.003 -10000 0 -10000 0 0
RhoA-B-C/GDP 0.052 0.057 -10000 0 -0.28 8 8
p75 CTF/Sortilin/TRAF6/NRIF 0.049 0.039 -10000 0 -0.31 4 4
RhoA-B-C/GTP 0.045 0.065 0.25 3 -0.34 8 11
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.021 0.13 -10000 0 -0.3 64 64
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.015 0.13 0.25 2 -0.32 64 66
PRKACB 0.022 0.004 -10000 0 -10000 0 0
proBDNF (dimer)/p75 ECD -0.019 0.14 -10000 0 -0.39 59 59
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 0.015 0.061 -10000 0 -0.53 6 6
BIRC2 0.022 0.004 -10000 0 -10000 0 0
neuron projection morphogenesis -0.004 0.071 0.23 3 -0.3 13 16
BAD -0.03 0.099 0.32 6 -0.38 5 11
RIPK2 0.022 0.005 -10000 0 -10000 0 0
NGFR 0.041 0.062 0.24 43 -10000 0 43
CYCS -0.021 0.054 -10000 0 -0.3 12 12
ADAM17 0.022 0.004 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.055 0.065 0.25 3 -0.32 8 11
BCL2L11 -0.029 0.098 0.33 5 -0.38 5 10
BDNF (dimer)/p75(NTR) -0.009 0.15 0.27 2 -0.4 60 62
PI3K 0.03 0.062 0.25 1 -0.32 6 7
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.053 0.074 0.25 3 -0.31 13 16
NDNL2 0.022 0.004 -10000 0 -10000 0 0
YWHAE 0.022 0.005 -10000 0 -10000 0 0
PRKCI 0.013 0.011 -10000 0 -10000 0 0
NGF (dimer)/p75(NTR) 0.036 0.072 0.27 3 -0.38 9 12
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.053 0.074 0.25 3 -0.31 13 16
TRAF6 0.022 0.004 -10000 0 -10000 0 0
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCZ 0.022 0.005 -10000 0 -10000 0 0
PLG -0.004 0.03 0.23 5 -10000 0 5
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 -0.029 0.11 0.21 2 -0.3 70 72
SQSTM1 0.021 0.006 -10000 0 -10000 0 0
NGFRAP1 0.022 0.003 -10000 0 -10000 0 0
CASP3 -0.03 0.097 0.29 7 -0.33 9 16
E2F1 0.022 0.005 -10000 0 -10000 0 0
CASP9 0.022 0.005 -10000 0 -10000 0 0
IKK complex 0.046 0.078 -10000 0 -0.33 8 8
NGF (dimer)/TRKA 0.019 0.073 0.27 1 -0.39 14 15
MMP7 0.021 0.087 0.23 22 -0.53 9 31
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.059 0.072 -10000 0 -0.3 13 13
MMP3 0.14 0.11 0.23 293 -0.3 4 297
APAF-1/Caspase 9 -0.035 0.046 -10000 0 -0.46 1 1
Ephrin B reverse signaling

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 0.02 0.025 -10000 0 -0.53 1 1
EPHB2 0.025 0.027 0.23 8 -10000 0 8
EFNB1 -0.005 0.013 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.062 0.054 0.28 1 -0.28 1 2
Ephrin B2/EPHB1-2 0.051 0.058 0.24 16 -0.31 2 18
neuron projection morphogenesis 0.043 0.042 0.21 1 -0.26 1 2
Ephrin B1/EPHB1-2/Tiam1 0.058 0.058 0.24 18 -0.29 1 19
DNM1 0.024 0.014 0.23 2 -10000 0 2
cell-cell signaling 0 0.004 -10000 0 -10000 0 0
MAP2K4 -0.02 0.1 0.24 1 -0.43 26 27
YES1 -0.023 0.15 -10000 0 -0.66 27 27
Ephrin B1/EPHB1-2/NCK2 0.059 0.058 0.24 18 -0.29 1 19
PI3K 0 0.091 -10000 0 -0.43 16 16
mol:GDP 0.056 0.057 0.24 16 -0.29 1 17
ITGA2B 0.006 0.092 -10000 0 -0.53 14 14
endothelial cell proliferation 0.026 0.019 -10000 0 -0.33 1 1
FYN -0.022 0.15 -10000 0 -0.66 27 27
MAP3K7 -0.021 0.11 0.23 1 -0.46 27 28
FGR -0.03 0.16 -10000 0 -0.68 26 26
TIAM1 0.021 0.025 -10000 0 -0.53 1 1
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
RGS3 0.022 0.004 -10000 0 -10000 0 0
cell adhesion -0.016 0.096 -10000 0 -0.42 16 16
LYN -0.023 0.15 -10000 0 -0.66 27 27
Ephrin B1/EPHB1-2/Src Family Kinases -0.023 0.14 -10000 0 -0.59 27 27
Ephrin B1/EPHB1-2 -0.02 0.11 -10000 0 -0.5 25 25
SRC -0.02 0.15 -10000 0 -0.64 27 27
ITGB3 0.01 0.082 -10000 0 -0.53 11 11
EPHB1 0.05 0.09 0.28 61 -0.53 1 62
EPHB4 0.021 0.005 -10000 0 -10000 0 0
RAC1 0.022 0.004 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.027 0.019 -10000 0 -0.33 1 1
alphaIIb/beta3 Integrin 0.012 0.093 -10000 0 -0.39 25 25
BLK -0.025 0.15 -10000 0 -0.66 26 26
HCK -0.022 0.15 -10000 0 -0.64 27 27
regulation of stress fiber formation -0.057 0.057 0.29 1 -0.24 16 17
MAPK8 -0.02 0.094 -10000 0 -0.41 25 25
Ephrin B1/EPHB1-2/RGS3 0.059 0.058 0.25 5 -0.29 1 6
endothelial cell migration -0.009 0.096 0.3 2 -0.37 25 27
NCK2 0.023 0.002 -10000 0 -10000 0 0
PTPN13 0.018 0.052 -10000 0 -0.64 3 3
regulation of focal adhesion formation -0.057 0.057 0.29 1 -0.24 16 17
chemotaxis -0.057 0.057 0.29 1 -0.26 2 3
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
Rac1/GTP 0.054 0.048 0.25 1 -0.27 1 2
angiogenesis -0.02 0.11 -10000 0 -0.49 26 26
LCK -0.019 0.15 -10000 0 -0.66 26 26
BCR signaling pathway

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.012 0.12 0.61 1 -0.41 23 24
IKBKB 0.026 0.082 0.34 6 -0.3 5 11
AKT1 0.049 0.11 0.25 60 -0.24 10 70
IKBKG 0.024 0.074 0.31 5 -0.3 4 9
CALM1 -0.006 0.096 0.28 2 -0.41 15 17
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
MAP3K1 -0.007 0.15 0.69 1 -0.53 22 23
MAP3K7 0.023 0.002 -10000 0 -10000 0 0
mol:Ca2+ -0.006 0.098 0.27 1 -0.4 18 19
DOK1 0.022 0.004 -10000 0 -10000 0 0
AP-1 -0.017 0.082 0.33 3 -0.26 13 16
LYN 0.02 0.035 -10000 0 -0.53 2 2
BLNK 0.021 0.025 -10000 0 -0.53 1 1
SHC1 0.022 0.005 -10000 0 -10000 0 0
BCR complex 0.019 0.09 0.33 1 -0.43 17 18
CD22 -0.039 0.16 0.26 1 -0.59 29 30
CAMK2G -0.007 0.092 0.3 3 -0.38 15 18
CSNK2A1 0.022 0.005 -10000 0 -10000 0 0
INPP5D 0.021 0.025 -10000 0 -0.53 1 1
SHC/GRB2/SOS1 0.014 0.063 -10000 0 -0.32 13 13
GO:0007205 -0.008 0.1 0.27 1 -0.42 19 20
SYK 0.022 0.004 -10000 0 -10000 0 0
ELK1 -0.01 0.1 0.25 2 -0.4 18 20
NFATC1 -0.016 0.11 0.44 2 -0.47 15 17
B-cell antigen/BCR complex 0.019 0.09 0.33 1 -0.43 17 18
PAG1/CSK 0.027 0.047 -10000 0 -0.39 6 6
NFKBIB 0.022 0.046 0.18 6 -0.13 16 22
HRAS -0.008 0.095 0.32 3 -0.39 15 18
NFKBIA 0.022 0.046 0.18 6 -0.12 17 23
NF-kappa-B/RelA/I kappa B beta 0.026 0.04 0.18 6 -10000 0 6
RasGAP/Csk 0.043 0.085 0.3 1 -0.34 19 20
mol:GDP -0.01 0.1 0.26 1 -0.41 19 20
PTEN 0.02 0.007 -10000 0 -10000 0 0
CD79B 0.018 0.051 0.23 1 -0.53 4 5
NF-kappa-B/RelA/I kappa B alpha 0.026 0.04 0.18 6 -10000 0 6
GRB2 0.022 0.004 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.011 0.14 0.58 1 -0.52 23 24
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:IP3 -0.008 0.097 0.28 1 -0.42 17 18
CSK 0.023 0.002 -10000 0 -10000 0 0
FOS -0.038 0.13 0.31 3 -0.41 23 26
CHUK 0.014 0.09 0.37 3 -0.29 16 19
IBTK 0.023 0.003 -10000 0 -10000 0 0
CARD11/BCL10/MALT1/TAK1 0.011 0.096 -10000 0 -0.38 14 14
PTPN6 -0.038 0.15 0.25 1 -0.59 25 26
RELA 0.023 0.002 -10000 0 -10000 0 0
BCL2A1 0.017 0.034 0.31 1 -0.13 1 2
VAV2 -0.015 0.13 -10000 0 -0.62 16 16
ubiquitin-dependent protein catabolic process 0.024 0.046 0.18 6 -0.12 16 22
BTK -0.093 0.33 -10000 0 -1.1 50 50
CD19 -0.021 0.12 0.26 2 -0.52 21 23
MAP4K1 0.016 0.05 -10000 0 -0.53 4 4
CD72 0.021 0.012 0.23 1 -10000 0 1
PAG1 0.015 0.061 -10000 0 -0.53 6 6
MAPK14 -0.005 0.12 0.46 2 -0.46 20 22
SH3BP5 0.014 0.061 -10000 0 -0.53 6 6
PIK3AP1 -0.007 0.11 0.29 1 -0.48 19 20
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.012 0.15 -10000 0 -0.62 20 20
RAF1 -0.009 0.087 0.34 2 -0.36 14 16
RasGAP/p62DOK/SHIP 0.042 0.084 -10000 0 -0.36 16 16
CD79A 0.008 0.1 0.23 9 -0.53 16 25
re-entry into mitotic cell cycle -0.017 0.082 0.33 3 -0.26 13 16
RASA1 0.021 0.006 -10000 0 -10000 0 0
MAPK3 -0.011 0.076 0.41 1 -0.35 8 9
MAPK1 -0.004 0.084 0.35 5 -0.37 6 11
CD72/SHP1 -0.007 0.15 0.29 6 -0.56 23 29
NFKB1 0.022 0.005 -10000 0 -10000 0 0
MAPK8 -0.005 0.12 0.66 1 -0.46 20 21
actin cytoskeleton organization -0.011 0.11 0.29 1 -0.56 13 14
NF-kappa-B/RelA 0.052 0.077 0.31 6 -10000 0 6
Calcineurin 0.014 0.092 0.27 1 -0.42 8 9
PI3K -0.019 0.093 -10000 0 -0.42 17 17
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 0.001 0.093 0.25 3 -0.42 16 19
SOS1 0.022 0.004 -10000 0 -10000 0 0
Bam32/HPK1 -0.014 0.19 -10000 0 -0.69 30 30
DAPP1 -0.031 0.21 -10000 0 -0.77 30 30
cytokine secretion -0.014 0.1 0.43 2 -0.43 15 17
mol:DAG -0.008 0.097 0.28 1 -0.42 17 18
PLCG2 0.022 0.005 -10000 0 -10000 0 0
MAP2K1 -0.011 0.082 0.43 1 -0.35 12 13
B-cell antigen/BCR complex/FcgammaRIIB 0.027 0.09 0.31 1 -0.39 19 20
mol:PI-3-4-5-P3 0.002 0.084 0.24 1 -0.33 11 12
ETS1 -0.013 0.094 0.28 3 -0.37 19 22
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.045 0.084 0.3 1 -0.34 18 19
B-cell antigen/BCR complex/LYN -0.013 0.13 0.27 2 -0.53 22 24
MALT1 0.022 0.005 -10000 0 -10000 0 0
TRAF6 0.022 0.004 -10000 0 -10000 0 0
RAC1 -0.013 0.12 -10000 0 -0.61 13 13
B-cell antigen/BCR complex/LYN/SYK 0.011 0.16 0.34 2 -0.53 27 29
CARD11 -0.008 0.1 0.3 3 -0.43 17 20
FCGR2B 0.015 0.061 -10000 0 -0.53 6 6
PPP3CA 0.022 0.005 -10000 0 -10000 0 0
BCL10 0.022 0.004 -10000 0 -10000 0 0
IKK complex 0.027 0.053 0.17 25 -0.12 3 28
PTPRC -0.012 0.13 -10000 0 -0.53 31 31
PDPK1 0.028 0.099 0.23 44 -0.24 8 52
PPP3CB 0.022 0.005 -10000 0 -10000 0 0
PPP3CC 0.02 0.007 -10000 0 -10000 0 0
POU2F2 0.02 0.031 0.27 2 -10000 0 2
Osteopontin-mediated events

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.009 0.063 -10000 0 -0.3 10 10
NF kappa B1 p50/RelA/I kappa B alpha 0.007 0.074 0.35 3 -10000 0 3
alphaV/beta3 Integrin/Osteopontin/Src 0.1 0.081 0.27 1 -0.2 5 6
AP1 0.002 0.12 0.3 1 -0.45 4 5
ILK -0.017 0.064 0.34 1 -0.32 10 11
bone resorption -0.017 0.06 -10000 0 -0.3 5 5
PTK2B 0.021 0.007 -10000 0 -10000 0 0
PYK2/p130Cas 0.095 0.095 0.28 2 -0.29 10 12
ITGAV 0.024 0.004 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.031 0.02 -10000 0 -0.39 1 1
alphaV/beta3 Integrin/Osteopontin 0.1 0.099 0.26 1 -0.35 10 11
MAP3K1 -0.017 0.064 0.34 1 -0.32 10 11
JUN 0.022 0.005 -10000 0 -10000 0 0
MAPK3 -0.02 0.059 0.38 1 -0.3 10 11
MAPK1 -0.02 0.058 0.38 1 -0.3 10 11
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
NFKB1 0.022 0.005 -10000 0 -10000 0 0
MAPK8 -0.026 0.057 0.24 3 -0.31 10 13
ITGB3 0.012 0.082 -10000 0 -0.53 11 11
NFKBIA -0.011 0.058 0.41 2 -0.31 6 8
FOS -0.043 0.18 -10000 0 -0.53 58 58
CD44 0.021 0.025 -10000 0 -0.53 1 1
CHUK 0.022 0.005 -10000 0 -10000 0 0
PLAU 0 0.072 0.44 2 -10000 0 2
NF kappa B1 p50/RelA 0.007 0.077 -10000 0 -10000 0 0
BCAR1 0.022 0.005 -10000 0 -10000 0 0
RELA 0.023 0.002 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.028 0.061 -10000 0 -0.39 10 10
mol:GDP 0 0 -10000 0 -10000 0 0
SYK -0.019 0.063 0.34 1 -0.32 10 11
VAV3 -0.028 0.061 0.24 6 -0.33 10 16
MAP3K14 -0.018 0.062 -10000 0 -0.32 10 10
ROCK2 0.022 0.004 -10000 0 -10000 0 0
SPP1 0.12 0.12 0.23 246 -0.3 6 252
RAC1 0.022 0.004 -10000 0 -10000 0 0
Rac1/GTP -0.018 0.06 0.33 1 -0.3 10 11
MMP2 -0.048 0.099 0.29 2 -0.61 4 6
Signaling events mediated by PTP1B

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.02 0.025 -10000 0 -0.53 1 1
Jak2/Leptin Receptor -0.017 0.15 -10000 0 -0.43 39 39
PTP1B/AKT1 0.002 0.084 0.26 1 -0.32 18 19
FYN 0.021 0.025 -10000 0 -0.53 1 1
p210 bcr-abl/PTP1B -0.009 0.088 0.24 2 -0.32 22 24
EGFR 0.021 0.082 0.36 12 -0.54 6 18
EGF/EGFR 0.005 0.098 0.24 8 -0.32 27 35
CSF1 0.017 0.05 -10000 0 -0.53 4 4
AKT1 0.021 0.007 -10000 0 -10000 0 0
INSR 0.022 0.006 -10000 0 -10000 0 0
PTP1B/N-cadherin 0.005 0.093 0.24 7 -0.32 19 26
Insulin Receptor/Insulin 0.014 0.083 -10000 0 -0.33 11 11
HCK 0.018 0.043 -10000 0 -0.53 3 3
CRK 0.021 0.005 -10000 0 -10000 0 0
TYK2 -0.01 0.085 0.28 3 -0.32 19 22
EGF 0.015 0.069 0.23 3 -0.54 7 10
YES1 0.021 0.006 -10000 0 -10000 0 0
CAV1 -0.044 0.13 0.26 5 -0.39 36 41
TXN 0.022 0.005 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 0.012 0.087 -10000 0 -0.34 14 14
cell migration 0.009 0.088 0.32 22 -0.24 2 24
STAT3 0.022 0.003 -10000 0 -10000 0 0
PRLR 0.019 0.098 0.29 21 -0.53 10 31
ITGA2B 0.007 0.092 -10000 0 -0.54 14 14
CSF1R 0.013 0.065 -10000 0 -0.53 7 7
Prolactin Receptor/Prolactin 0.026 0.075 0.28 9 -0.39 10 19
FGR -0.014 0.14 -10000 0 -0.53 32 32
PTP1B/p130 Cas 0.004 0.085 0.25 1 -0.31 19 20
Crk/p130 Cas 0.013 0.087 0.25 1 -0.32 14 15
DOK1 -0.009 0.1 0.37 1 -0.36 24 25
JAK2 -0.016 0.14 0.27 2 -0.44 42 44
Jak2/Leptin Receptor/Leptin 0.031 0.11 0.28 1 -0.4 13 14
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
PTPN1 -0.009 0.088 0.24 2 -0.32 22 24
LYN 0.02 0.035 -10000 0 -0.53 2 2
CDH2 0.032 0.059 0.25 26 -0.53 1 27
SRC 0.013 0.072 -10000 0 -0.63 5 5
ITGB3 0.01 0.082 -10000 0 -0.54 11 11
CAT1/PTP1B -0.018 0.14 0.24 3 -0.41 37 40
CAPN1 0.022 0.004 -10000 0 -10000 0 0
CSK 0.023 0.002 -10000 0 -10000 0 0
PI3K 0.011 0.064 -10000 0 -0.34 4 4
mol:H2O2 0 0.003 -10000 0 -10000 0 0
STAT3 (dimer) 0.03 0.1 0.25 1 -0.36 13 14
negative regulation of transcription -0.015 0.14 0.27 2 -0.43 42 44
FCGR2A 0.012 0.074 -10000 0 -0.53 9 9
FER 0.021 0.007 -10000 0 -10000 0 0
alphaIIb/beta3 Integrin 0.011 0.093 -10000 0 -0.39 25 25
BLK 0.013 0.088 0.23 12 -0.53 11 23
Insulin Receptor/Insulin/Shc 0.039 0.013 -10000 0 -10000 0 0
RHOA 0.021 0.007 -10000 0 -10000 0 0
LEPR -0.008 0.12 -10000 0 -0.53 27 27
BCAR1 0.022 0.005 -10000 0 -10000 0 0
p210 bcr-abl/Grb2 0.022 0.004 -10000 0 -10000 0 0
mol:NADPH 0 0.002 -10000 0 -10000 0 0
TRPV6 -0.015 0.13 -10000 0 -0.42 33 33
PRL 0.003 0.035 0.23 8 -10000 0 8
SOCS3 0.015 0.11 -10000 0 -1.2 4 4
SPRY2 0.019 0.036 -10000 0 -0.54 2 2
Insulin Receptor/Insulin/IRS1 0.04 0.012 -10000 0 -10000 0 0
CSF1/CSF1R 0.007 0.1 0.25 1 -0.37 17 18
Ras protein signal transduction 0.01 0.1 0.57 14 -10000 0 14
IRS1 0.022 0.004 -10000 0 -10000 0 0
INS 0.01 0.015 -10000 0 -10000 0 0
LEP 0.058 0.084 0.23 92 -0.3 1 93
STAT5B -0.007 0.11 0.31 1 -0.38 26 27
STAT5A -0.007 0.11 0.31 1 -0.4 24 25
GRB2 0.022 0.004 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.005 0.084 0.25 1 -0.31 19 20
CSN2 0.016 0.063 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
LAT 0.003 0.1 -10000 0 -0.49 17 17
YBX1 0.026 0.005 -10000 0 -10000 0 0
LCK 0.021 0.025 -10000 0 -0.53 1 1
SHC1 0.022 0.005 -10000 0 -10000 0 0
NOX4 0.024 0.019 0.3 2 -10000 0 2
Effects of Botulinum toxin

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A -0.006 0.005 -10000 0 -10000 0 0
UniProt:P19321 0 0 -10000 0 -10000 0 0
RIMS1/UNC13B -0.009 0.12 -10000 0 -0.38 46 46
STXBP1 0.018 0.05 -10000 0 -0.53 4 4
ACh/CHRNA1 0.014 0.05 0.18 9 -0.28 8 17
RAB3GAP2/RIMS1/UNC13B 0.005 0.11 -10000 0 -0.34 43 43
mol:Ca2+ 0 0 -10000 0 -10000 0 0
UniProt:P30996 0 0 -10000 0 -10000 0 0
UniProt:Q60393 0 0 -10000 0 -10000 0 0
CST086 0 0 -10000 0 -10000 0 0
RIMS1 -0.031 0.16 0.23 2 -0.53 45 47
mol:ACh 0 0.031 0.088 10 -0.14 10 20
RAB3GAP2 0.022 0.004 -10000 0 -10000 0 0
STX1A/SNAP25/VAMP2 0.001 0.094 -10000 0 -0.27 44 44
UniProt:P10844 0 0 -10000 0 -10000 0 0
muscle contraction 0.014 0.05 0.18 9 -0.28 8 17
UNC13B 0.018 0.036 -10000 0 -0.53 2 2
CHRNA1 0.02 0.063 0.23 9 -0.53 5 14
UniProt:P10845 0 0 -10000 0 -10000 0 0
ACh/Synaptotagmin 1 0.02 0.039 0.18 16 -0.15 3 19
SNAP25 -0.002 0.04 -10000 0 -0.29 9 9
VAMP2 0.003 0.001 -10000 0 -10000 0 0
SYT1 0.029 0.039 0.24 16 -10000 0 16
UniProt:Q00496 0 0 -10000 0 -10000 0 0
STXIA/STXBP1 0.016 0.032 -10000 0 -0.33 4 4
STX1A/SNAP25 fragment 1/VAMP2 0.001 0.094 -10000 0 -0.27 44 44
EGFR-dependent Endothelin signaling events

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.022 0.004 -10000 0 -10000 0 0
EGFR 0.023 0.081 0.36 12 -0.53 6 18
EGF/EGFR 0.005 0.11 -10000 0 -0.31 50 50
EGF/EGFR dimer/SHC/GRB2/SOS1 0.049 0.069 -10000 0 -0.32 12 12
mol:GTP 0 0 -10000 0 -10000 0 0
EDNRA 0.017 0.05 -10000 0 -0.53 4 4
response to oxidative stress 0 0 -10000 0 -10000 0 0
EGF 0.015 0.068 0.23 3 -0.53 7 10
EGF/EGFR dimer/SHC 0.033 0.071 0.25 7 -0.36 12 19
mol:GDP 0.044 0.066 -10000 0 -0.31 12 12
mol:Ca2+ 0 0 -10000 0 -10000 0 0
EDN1 -0.025 0.15 -10000 0 -0.53 42 42
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
HRAS/GTP 0.029 0.057 -10000 0 -0.29 12 12
SHC1 0.022 0.005 -10000 0 -10000 0 0
HRAS/GDP 0.042 0.063 -10000 0 -0.3 12 12
FRAP1 -0.017 0.05 0.15 7 -0.3 12 19
EGF/EGFR dimer 0.024 0.078 0.27 8 -0.42 12 20
SOS1 0.022 0.004 -10000 0 -10000 0 0
GRB2 0.022 0.004 -10000 0 -10000 0 0
ETA receptor/Endothelin-1 -0.009 0.12 -10000 0 -0.39 46 46
S1P4 pathway

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
GNAO1 0.021 0.029 0.23 2 -0.53 1 3
CDC42/GTP -0.007 0.093 -10000 0 -0.28 36 36
PLCG1 -0.012 0.081 -10000 0 -0.28 30 30
mol:GTP 0 0 -10000 0 -10000 0 0
GNAI2 0.021 0.007 -10000 0 -10000 0 0
GNAI3 0.022 0.005 -10000 0 -10000 0 0
G12/G13 0.032 0.008 -10000 0 -10000 0 0
cell migration -0.007 0.092 -10000 0 -0.27 36 36
S1PR5 0.024 0.035 0.23 7 -0.53 1 8
S1PR4 -0.02 0.15 -10000 0 -0.53 38 38
MAPK3 -0.012 0.08 -10000 0 -0.28 30 30
MAPK1 -0.011 0.077 -10000 0 -0.29 28 28
S1P/S1P5/Gi 0.017 0.035 -10000 0 -0.22 5 5
GNAI1 0.021 0.025 -10000 0 -0.53 1 1
CDC42/GDP 0.016 0.003 -10000 0 -10000 0 0
S1P/S1P5/G12 0.03 0.022 -10000 0 -0.33 1 1
RHOA -0.026 0.082 0.36 1 -0.28 37 38
S1P/S1P4/Gi -0.006 0.087 -10000 0 -0.28 37 37
mol:GDP 0 0 -10000 0 -10000 0 0
GNAZ 0.016 0.056 -10000 0 -0.53 5 5
S1P/S1P4/G12/G13 0.013 0.092 -10000 0 -0.3 37 37
GNA12 0.022 0.004 -10000 0 -10000 0 0
GNA13 0.022 0.003 -10000 0 -10000 0 0
CDC42 0.022 0.004 -10000 0 -10000 0 0
Aurora A signaling

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A -0.02 0.033 -10000 0 -10000 0 0
BIRC5 0.2 0.082 0.23 422 -0.3 1 423
NFKBIA -0.023 0.026 0.24 1 -10000 0 1
CPEB1 -0.015 0.14 -10000 0 -0.53 33 33
AKT1 -0.022 0.026 0.24 1 -10000 0 1
NDEL1 0.021 0.005 -10000 0 -10000 0 0
Aurora A/BRCA1 -0.018 0.03 -10000 0 -10000 0 0
NDEL1/TACC3 -0.008 0.041 -10000 0 -10000 0 0
GADD45A 0.022 0.004 -10000 0 -10000 0 0
GSK3B -0.019 0.02 -10000 0 -10000 0 0
PAK1/Aurora A -0.019 0.035 0.31 1 -10000 0 1
MDM2 0.023 0.016 0.38 1 -10000 0 1
JUB 0 0 -10000 0 -10000 0 0
TPX2 -0.024 0.095 0.3 36 -10000 0 36
TP53 -0.01 0.046 0.22 1 -0.23 18 19
DLG7 -0.021 0.022 0.15 2 -10000 0 2
AURKAIP1 0.022 0.005 -10000 0 -10000 0 0
ARHGEF7 0.021 0.006 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 -0.009 0.044 -10000 0 -10000 0 0
G2/M transition of mitotic cell cycle -0.018 0.029 -10000 0 -10000 0 0
AURKA -0.025 0.029 0.2 2 -10000 0 2
AURKB 0.076 0.057 0.15 15 -0.17 3 18
CDC25B -0.011 0.023 -10000 0 -0.31 1 1
G2/M transition checkpoint -0.021 0.022 -10000 0 -10000 0 0
mRNA polyadenylation -0.037 0.078 -10000 0 -0.31 32 32
Aurora A/CPEB -0.037 0.078 -10000 0 -0.31 32 32
Aurora A/TACC1/TRAP/chTOG -0.004 0.046 -10000 0 -10000 0 0
BRCA1 0.022 0.003 -10000 0 -10000 0 0
centrosome duplication -0.019 0.035 0.31 1 -10000 0 1
regulation of centrosome cycle -0.008 0.04 -10000 0 -10000 0 0
spindle assembly -0.004 0.045 -10000 0 -10000 0 0
TDRD7 0.022 0.004 -10000 0 -10000 0 0
Aurora A/RasGAP/Survivin 0.11 0.079 0.27 6 -10000 0 6
CENPA 0.096 0.05 0.16 72 -10000 0 72
Aurora A/PP2A -0.02 0.033 -10000 0 -10000 0 0
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process -0.011 0.032 0.24 1 -10000 0 1
negative regulation of DNA binding -0.01 0.046 0.21 1 -0.29 2 3
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.031 0.01 -10000 0 -10000 0 0
RASA1 0.021 0.006 -10000 0 -10000 0 0
Ajuba/Aurora A -0.021 0.022 -10000 0 -10000 0 0
mitotic prometaphase -0.02 0.029 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process -0.025 0.029 0.2 2 -10000 0 2
TACC1 0.018 0.026 -10000 0 -0.53 1 1
TACC3 0.021 0.022 0.38 1 -0.3 1 2
Aurora A/Antizyme1 -0.01 0.044 -10000 0 -10000 0 0
Aurora A/RasGAP -0.017 0.03 -10000 0 -10000 0 0
OAZ1 0.022 0.004 -10000 0 -10000 0 0
RAN 0.023 0.002 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA -0.021 0.019 -10000 0 -10000 0 0
GIT1 0.022 0.003 -10000 0 -10000 0 0
GIT1/beta-PIX/PAK1 0.042 0.017 0.25 1 -10000 0 1
Importin alpha/Importin beta/TPX2 -0.024 0.095 0.3 36 -10000 0 36
PPP2R5D 0.022 0.004 -10000 0 -10000 0 0
Aurora A/TPX2 -0.024 0.082 0.21 32 -10000 0 32
PAK1 0.023 0.016 0.38 1 -10000 0 1
CKAP5 0.022 0.004 -10000 0 -10000 0 0
HIF-2-alpha transcription factor network

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 0.015 0.12 -10000 0 -0.71 12 12
oxygen homeostasis 0.001 0.009 -10000 0 -10000 0 0
TCEB2 0.022 0.004 -10000 0 -10000 0 0
TCEB1 0.022 0.005 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C/HIF2A 0.008 0.13 0.27 5 -0.36 16 21
EPO 0.023 0.16 0.35 2 -0.49 9 11
FIH (dimer) 0.018 0.019 -10000 0 -10000 0 0
APEX1 0.022 0.024 -10000 0 -10000 0 0
SERPINE1 0.008 0.17 0.38 2 -0.53 10 12
FLT1 -0.034 0.22 -10000 0 -0.83 29 29
ADORA2A -0.003 0.16 0.37 3 -0.51 10 13
germ cell development 0.01 0.17 0.38 2 -0.55 10 12
SLC11A2 0.01 0.17 0.38 2 -0.54 9 11
BHLHE40 0.009 0.17 0.42 1 -0.54 9 10
HIF1AN 0.018 0.019 -10000 0 -10000 0 0
HIF2A/ARNT/SIRT1 0.02 0.14 0.3 5 -0.4 13 18
ETS1 0.012 0.083 -10000 0 -0.54 10 10
CITED2 -0.002 0.18 -10000 0 -1.1 13 13
KDR -0.07 0.33 -10000 0 -1 48 48
PGK1 0.01 0.17 0.38 2 -0.54 9 11
SIRT1 0.022 0.005 -10000 0 -10000 0 0
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF2A/ARNT 0.064 0.22 0.45 2 -0.6 11 13
EPAS1 -0.022 0.12 0.27 6 -0.36 28 34
SP1 0.026 0.003 -10000 0 -10000 0 0
ABCG2 -0.029 0.25 0.42 1 -0.63 58 59
EFNA1 0.007 0.17 -10000 0 -0.53 10 10
FXN -0.002 0.16 0.48 4 -0.53 8 12
POU5F1 0.01 0.18 0.42 1 -0.57 10 11
neuron apoptosis -0.062 0.22 0.58 11 -0.44 2 13
EP300 0.022 0.004 -10000 0 -10000 0 0
EGLN3 0.052 0.08 0.23 76 -10000 0 76
EGLN2 0.017 0.02 -10000 0 -10000 0 0
EGLN1 0.018 0.019 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C 0.041 0.015 -10000 0 -10000 0 0
VHL 0.021 0.006 -10000 0 -10000 0 0
ARNT 0.022 0.024 -10000 0 -10000 0 0
SLC2A1 0.008 0.18 0.41 8 -0.5 15 23
TWIST1 0.006 0.17 0.39 8 -0.51 12 20
ELK1 0.024 0.015 -10000 0 -10000 0 0
HIF2A/ARNT/Cbp/p300 0.022 0.15 0.32 1 -0.42 10 11
VEGFA 0.01 0.17 0.42 1 -0.54 9 10
CREBBP 0.022 0.005 -10000 0 -10000 0 0
Stabilization and expansion of the E-cadherin adherens junction

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization 0.017 0.006 -10000 0 -10000 0 0
epithelial cell differentiation 0.044 0.016 -10000 0 -10000 0 0
CYFIP2 0.007 0.089 -10000 0 -0.53 13 13
ENAH 0.006 0.067 0.26 11 -10000 0 11
EGFR 0.023 0.081 0.36 12 -0.53 6 18
EPHA2 0.018 0.043 -10000 0 -0.53 3 3
MYO6 -0.009 0.029 0.34 1 -10000 0 1
CTNNB1 0.021 0.006 -10000 0 -10000 0 0
ABI1/Sra1/Nap1 0.031 0.06 -10000 0 -0.34 11 11
AQP5 -0.14 0.22 -10000 0 -0.47 148 148
CTNND1 0.023 0.001 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.01 0.025 0.34 1 -10000 0 1
regulation of calcium-dependent cell-cell adhesion -0.082 0.12 0.34 1 -0.28 134 135
EGF 0.015 0.068 0.23 3 -0.53 7 10
NCKAP1 0.022 0.004 -10000 0 -10000 0 0
AQP3 -0.056 0.16 -10000 0 -0.46 64 64
cortical microtubule organization 0.044 0.016 -10000 0 -10000 0 0
GO:0000145 -0.01 0.024 0.19 5 -10000 0 5
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.048 0.017 -10000 0 -10000 0 0
MLLT4 0.022 0.004 -10000 0 -10000 0 0
ARF6/GDP -0.019 0.022 -10000 0 -10000 0 0
ARF6 0.022 0.005 -10000 0 -10000 0 0
Ephrin A1/EPHA2/NCK1/GIT1 0.043 0.037 -10000 0 -0.31 3 3
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.001 0.012 -10000 0 -10000 0 0
PVRL2 0.022 0.004 -10000 0 -10000 0 0
ZYX -0.01 0.023 -10000 0 -10000 0 0
ARF6/GTP 0.046 0.039 -10000 0 -0.29 3 3
CDH1 0.022 0.005 -10000 0 -10000 0 0
EGFR/EGFR/EGF/EGF 0.031 0.058 -10000 0 -0.3 12 12
RhoA/GDP 0.045 0.016 -10000 0 -10000 0 0
actin cytoskeleton organization -0.011 0.02 -10000 0 -10000 0 0
IGF-1R heterotetramer 0.022 0.004 -10000 0 -10000 0 0
GIT1 0.022 0.003 -10000 0 -10000 0 0
IGF1R 0.022 0.004 -10000 0 -10000 0 0
IGF1 0.003 0.1 0.23 1 -0.53 18 19
DIAPH1 -0.016 0.16 -10000 0 -0.58 19 19
Wnt receptor signaling pathway -0.044 0.016 -10000 0 -10000 0 0
RHOA 0.021 0.007 -10000 0 -10000 0 0
RhoA/GTP -0.019 0.022 -10000 0 -10000 0 0
CTNNA1 0.021 0.006 -10000 0 -10000 0 0
VCL -0.011 0.02 -10000 0 -10000 0 0
EFNA1 0.022 0.005 -10000 0 -10000 0 0
LPP -0.008 0.022 0.34 1 -10000 0 1
Ephrin A1/EPHA2 0.036 0.029 -10000 0 -0.28 3 3
SEC6/SEC8 -0.016 0.01 -10000 0 -10000 0 0
MGAT3 -0.083 0.12 0.34 1 -0.28 134 135
HGF/MET -0.023 0.12 -10000 0 -0.27 89 89
HGF -0.09 0.22 -10000 0 -0.53 100 100
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN 0.018 0.006 -10000 0 -10000 0 0
actin cable formation 0.046 0.1 0.33 25 -10000 0 25
KIAA1543 -0.01 0.024 0.2 5 -10000 0 5
KIFC3 -0.01 0.027 0.34 1 -10000 0 1
NCK1 0.019 0.008 -10000 0 -10000 0 0
EXOC3 0.018 0.009 -10000 0 -10000 0 0
ACTN1 -0.01 0.028 0.34 1 -10000 0 1
NCK1/GIT1 0.028 0.013 -10000 0 -10000 0 0
mol:GDP 0.044 0.016 -10000 0 -10000 0 0
EXOC4 0.022 0.004 -10000 0 -10000 0 0
STX4 -0.009 0.028 0.34 1 -10000 0 1
PIP5K1C -0.01 0.026 0.34 1 -10000 0 1
LIMA1 0.023 0.002 -10000 0 -10000 0 0
ABI1 0.022 0.004 -10000 0 -10000 0 0
ROCK1 0.015 0.084 0.31 17 -10000 0 17
adherens junction assembly -0.014 0.092 0.31 3 -0.65 7 10
IGF-1R heterotetramer/IGF1 0.029 0.058 -10000 0 -0.27 16 16
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.032 0.008 -10000 0 -10000 0 0
MET 0.02 0.039 0.38 1 -0.53 2 3
PLEKHA7 -0.01 0.026 0.34 1 -10000 0 1
mol:GTP 0.041 0.036 -10000 0 -0.31 3 3
establishment of epithelial cell apical/basal polarity 0.024 0.089 0.34 12 -10000 0 12
cortical actin cytoskeleton stabilization 0.017 0.006 -10000 0 -10000 0 0
regulation of cell-cell adhesion -0.011 0.02 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton 0.018 0.006 -10000 0 -10000 0 0
IGF1 pathway

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.023 0.002 -10000 0 -10000 0 0
PTK2 0.021 0.006 -10000 0 -10000 0 0
CRKL 0.001 0.05 -10000 0 -0.28 15 15
GRB2/SOS1/SHC 0.042 0.014 -10000 0 -10000 0 0
HRAS 0.022 0.004 -10000 0 -10000 0 0
IRS1/Crk 0.01 0.054 -10000 0 -0.28 16 16
IGF-1R heterotetramer/IGF1/PTP1B 0.032 0.063 -10000 0 -0.32 14 14
AKT1 0.055 0.095 0.22 19 -0.25 5 24
BAD 0.049 0.091 0.21 18 -10000 0 18
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.001 0.052 -10000 0 -0.28 16 16
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.015 0.056 -10000 0 -0.28 16 16
RAF1 0.054 0.11 0.28 12 -0.43 9 21
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos 0.04 0.059 -10000 0 -0.27 15 15
YWHAZ 0.022 0.005 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 0.018 0.06 -10000 0 -0.3 16 16
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
RPS6KB1 0.056 0.097 0.22 22 -0.25 5 27
GNB2L1 0.021 0.006 -10000 0 -10000 0 0
positive regulation of MAPKKK cascade 0.052 0.1 0.27 18 -0.34 4 22
PXN 0.023 0.002 -10000 0 -10000 0 0
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
HRAS/GTP 0.017 0.046 -10000 0 -0.25 12 12
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc 0.051 0.057 -10000 0 -0.26 12 12
IGF-1R heterotetramer 0.02 0.021 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS/Nck 0.03 0.058 -10000 0 -0.28 15 15
Crk/p130 Cas/Paxillin 0.036 0.057 -10000 0 -0.26 15 15
IGF1R 0.02 0.021 -10000 0 -10000 0 0
IGF1 0.005 0.11 0.26 1 -0.54 18 19
IRS2/Crk 0.007 0.054 -10000 0 -0.27 17 17
PI3K 0.022 0.045 -10000 0 -0.27 5 5
apoptosis -0.053 0.092 -10000 0 -0.26 13 13
HRAS/GDP 0.016 0.003 -10000 0 -10000 0 0
PRKCD -0.002 0.067 -10000 0 -0.35 16 16
RAF1/14-3-3 E 0.053 0.12 0.28 11 -0.37 11 22
BAD/14-3-3 0.056 0.096 0.28 14 -10000 0 14
PRKCZ 0.054 0.096 0.22 18 -0.25 5 23
Crk/p130 Cas/Paxillin/FAK1 0.052 0.062 -10000 0 -10000 0 0
PTPN1 0.022 0.004 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 -0.003 0.076 -10000 0 -0.38 17 17
BCAR1 0.022 0.005 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/SHC/GRB10 0.042 0.056 -10000 0 -0.28 12 12
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.022 0.004 -10000 0 -10000 0 0
IRS1/NCK2 0.018 0.057 -10000 0 -0.28 15 15
GRB10 0.022 0.005 -10000 0 -10000 0 0
PTPN11 0.001 0.052 -10000 0 -0.28 16 16
IRS1 0.004 0.059 -10000 0 -0.3 16 16
IRS2 0 0.054 -10000 0 -0.28 17 17
IGF-1R heterotetramer/IGF1 0.018 0.08 -10000 0 -0.41 16 16
GRB2 0.022 0.004 -10000 0 -10000 0 0
PDPK1 0.056 0.098 0.17 193 -0.26 5 198
YWHAE 0.022 0.005 -10000 0 -10000 0 0
PRKD1 -0.014 0.094 -10000 0 -0.42 18 18
SHC1 0.022 0.005 -10000 0 -10000 0 0
Ras signaling in the CD4+ TCR pathway

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.02 0.15 -10000 0 -0.53 17 17
MAP3K8 0.017 0.028 -10000 0 -0.53 1 1
FOS -0.014 0.12 -10000 0 -0.48 16 16
PRKCA 0.015 0.038 -10000 0 -0.54 2 2
PTPN7 0.016 0.035 0.38 1 -0.53 1 2
HRAS 0.022 0.004 -10000 0 -10000 0 0
PRKCB -0.011 0.12 -10000 0 -0.53 25 25
NRAS 0.021 0.005 -10000 0 -10000 0 0
RAS family/GTP 0.03 0.026 -10000 0 -10000 0 0
MAPK3 0.001 0.094 -10000 0 -0.6 8 8
MAP2K1 -0.016 0.12 -10000 0 -0.44 29 29
ELK1 0.015 0.02 -10000 0 -10000 0 0
BRAF -0.012 0.099 -10000 0 -0.42 25 25
mol:GTP -0.001 0.002 -10000 0 -0.005 60 60
MAPK1 0.001 0.091 -10000 0 -0.5 9 9
RAF1 -0.015 0.11 -10000 0 -0.47 25 25
KRAS 0.021 0.006 -10000 0 -10000 0 0
Sphingosine 1-phosphate (S1P) pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.022 0.004 -10000 0 -10000 0 0
SPHK1 0.022 0.004 -10000 0 -10000 0 0
GNAI2 0.021 0.007 -10000 0 -10000 0 0
mol:S1P 0.01 0.003 -10000 0 -10000 0 0
GNAO1 0.021 0.029 0.23 2 -0.53 1 3
mol:Sphinganine-1-P -0.01 0.002 -10000 0 -10000 0 0
growth factor activity 0 0 -10000 0 -10000 0 0
S1P/S1P2/G12/G13 0.043 0.033 -10000 0 -10000 0 0
GNAI3 0.022 0.005 -10000 0 -10000 0 0
G12/G13 0.032 0.008 -10000 0 -10000 0 0
S1PR3 0.022 0.004 -10000 0 -10000 0 0
S1PR2 0.022 0.004 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
S1P1/S1P 0.003 0.025 -10000 0 -0.2 4 4
S1PR5 0.024 0.035 0.23 7 -0.53 1 8
S1PR4 -0.02 0.15 -10000 0 -0.53 38 38
GNAI1 0.021 0.025 -10000 0 -0.53 1 1
S1P/S1P5/G12 0.033 0.037 -10000 0 -0.29 1 1
S1P/S1P3/Gq -0.051 0.13 -10000 0 -0.28 117 117
S1P/S1P4/Gi -0.004 0.09 0.26 1 -0.29 33 34
GNAQ 0.021 0.025 -10000 0 -0.53 1 1
GNAZ 0.016 0.056 -10000 0 -0.53 5 5
GNA14 -0.11 0.24 -10000 0 -0.53 117 117
GNA15 0.022 0.004 -10000 0 -10000 0 0
GNA12 0.022 0.004 -10000 0 -10000 0 0
GNA13 0.022 0.003 -10000 0 -10000 0 0
GNA11 0.022 0.004 -10000 0 -10000 0 0
ABCC1 0.023 0.01 0.23 1 -10000 0 1
Hedgehog signaling events mediated by Gli proteins

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.023 0.004 -10000 0 -10000 0 0
HDAC2 0.024 0.002 -10000 0 -10000 0 0
GNB1/GNG2 0.034 0.044 0.25 1 -0.34 6 7
forebrain development -0.1 0.16 -10000 0 -0.57 18 18
GNAO1 0.015 0.031 0.23 2 -0.54 1 3
SMO/beta Arrestin2 0.007 0.03 0.24 1 -10000 0 1
SMO 0.004 0.032 0.37 2 -10000 0 2
ARRB2 0.005 0.018 -10000 0 -10000 0 0
GLI3/SPOP 0.024 0.092 -10000 0 -0.42 9 9
mol:GTP -0.003 0.004 -10000 0 -10000 0 0
GSK3B 0.02 0.007 -10000 0 -10000 0 0
GNAI2 0.014 0.013 -10000 0 -10000 0 0
SIN3/HDAC complex 0.055 0.022 -10000 0 -10000 0 0
GNAI1 0.015 0.027 -10000 0 -0.54 1 1
XPO1 0 0.024 -10000 0 -10000 0 0
GLI1/Su(fu) -0.099 0.16 -10000 0 -0.59 18 18
SAP30 0.022 0.006 -10000 0 -10000 0 0
mol:GDP 0.004 0.032 0.37 2 -10000 0 2
MIM/GLI2A -0.041 0.069 -10000 0 -10000 0 0
IFT88 0.021 0.006 -10000 0 -10000 0 0
GNAI3 0.016 0.012 -10000 0 -10000 0 0
GLI2 0.015 0.075 0.31 2 -0.37 7 9
GLI3 0.013 0.096 0.41 1 -0.43 10 11
CSNK1D 0.022 0.004 -10000 0 -10000 0 0
CSNK1E 0.022 0.004 -10000 0 -10000 0 0
SAP18 0.022 0.006 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.021 0.006 -10000 0 -10000 0 0
GNG2 0.016 0.055 -10000 0 -0.53 5 5
Gi family/GTP -0.01 0.05 -10000 0 -0.26 7 7
SIN3B 0.023 0.005 -10000 0 -10000 0 0
SIN3A 0.024 0.003 -10000 0 -10000 0 0
GLI3/Su(fu) 0.011 0.11 -10000 0 -0.43 21 21
GLI2/Su(fu) 0.009 0.087 -10000 0 -0.4 12 12
FOXA2 -0.51 0.55 -10000 0 -1.1 248 248
neural tube patterning -0.1 0.16 -10000 0 -0.57 18 18
SPOP 0.022 0.003 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.008 0.046 -10000 0 -10000 0 0
GNB1 0.021 0.025 -10000 0 -0.53 1 1
CSNK1G2 0.022 0.004 -10000 0 -10000 0 0
CSNK1G3 0.021 0.006 -10000 0 -10000 0 0
MTSS1 -0.04 0.069 -10000 0 -10000 0 0
embryonic limb morphogenesis -0.1 0.16 -10000 0 -0.57 18 18
SUFU 0.004 0.016 -10000 0 -10000 0 0
LGALS3 0.022 0.004 -10000 0 -10000 0 0
catabolic process 0.025 0.12 -10000 0 -0.48 15 15
GLI3A/CBP 0.005 0.029 -10000 0 -0.36 1 1
KIF3A 0.021 0.006 -10000 0 -10000 0 0
GLI1 -0.1 0.16 -10000 0 -0.58 18 18
RAB23 0.022 0.004 -10000 0 -10000 0 0
CSNK1A1 0.021 0.006 -10000 0 -10000 0 0
IFT172 0.022 0.003 -10000 0 -10000 0 0
RBBP7 0.023 0.005 -10000 0 -10000 0 0
Su(fu)/Galectin3 0.01 0.041 -10000 0 -10000 0 0
GNAZ 0.01 0.056 -10000 0 -0.54 5 5
RBBP4 0.023 0.004 -10000 0 -10000 0 0
CSNK1G1 0.023 0.002 -10000 0 -10000 0 0
PIAS1 0.023 0.002 -10000 0 -10000 0 0
PRKACA 0.022 0.004 -10000 0 -10000 0 0
GLI2/SPOP 0.022 0.078 0.23 1 -0.38 7 8
STK36 0 0.025 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP -0.01 0.064 -10000 0 -0.33 13 13
PTCH1 -0.1 0.17 -10000 0 -0.74 14 14
MIM/GLI1 -0.22 0.27 -10000 0 -0.5 223 223
CREBBP 0.005 0.029 -10000 0 -0.36 1 1
Su(fu)/SIN3/HDAC complex 0.007 0.088 -10000 0 -0.4 16 16
Syndecan-2-mediated signaling events

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin 0.01 0.065 -10000 0 -0.35 15 15
EPHB2 0.025 0.027 0.23 8 -10000 0 8
Syndecan-2/TACI 0.016 0.053 -10000 0 -0.33 10 10
LAMA1 0.082 0.1 0.24 142 -0.42 2 144
Syndecan-2/alpha2 ITGB1 0.032 0.057 -10000 0 -0.29 13 13
HRAS 0.022 0.004 -10000 0 -10000 0 0
Syndecan-2/CASK 0.003 0.033 -10000 0 -0.32 5 5
ITGA5 0.023 0.002 -10000 0 -10000 0 0
BAX -0.007 0.026 -10000 0 -10000 0 0
EPB41 0.022 0.004 -10000 0 -10000 0 0
positive regulation of cell-cell adhesion 0.016 0.032 -10000 0 -0.3 5 5
LAMA3 0.009 0.082 -10000 0 -0.53 11 11
EZR 0.022 0.003 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 0.009 0.082 -10000 0 -0.53 11 11
Syndecan-2/MMP2 0.015 0.05 -10000 0 -0.36 8 8
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.031 0.01 -10000 0 -10000 0 0
dendrite morphogenesis 0.021 0.037 -10000 0 -0.33 4 4
Syndecan-2/GM-CSF -0.011 0.1 -10000 0 -0.33 44 44
determination of left/right symmetry 0.004 0.039 -10000 0 -0.38 5 5
Syndecan-2/PKC delta 0.017 0.035 -10000 0 -0.32 5 5
GNB2L1 0.021 0.006 -10000 0 -10000 0 0
MAPK3 -0.015 0.094 0.19 14 -0.3 44 58
MAPK1 -0.014 0.089 0.19 11 -0.3 39 50
Syndecan-2/RACK1 0.028 0.032 -10000 0 -0.27 5 5
NF1 0.022 0.004 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 0.004 0.039 -10000 0 -0.38 5 5
ITGA2 0.021 0.006 -10000 0 -10000 0 0
MAPK8 0.002 0.03 -10000 0 -0.33 4 4
Syndecan-2/alpha2/beta1 Integrin 0.071 0.076 0.26 12 -0.29 6 18
Syndecan-2/Kininogen 0.015 0.042 0.21 13 -0.33 2 15
ITGB1 0.022 0.004 -10000 0 -10000 0 0
SRC -0.003 0.041 0.18 17 -0.27 3 20
Syndecan-2/CASK/Protein 4.1 0.016 0.032 -10000 0 -0.3 5 5
extracellular matrix organization 0.018 0.035 -10000 0 -0.32 5 5
actin cytoskeleton reorganization 0.01 0.065 -10000 0 -0.35 15 15
Syndecan-2/Caveolin-2/Ras 0.023 0.058 -10000 0 -0.32 12 12
Syndecan-2/Laminin alpha3 0.01 0.062 -10000 0 -0.34 15 15
Syndecan-2/RasGAP 0.036 0.034 -10000 0 -0.26 5 5
alpha5/beta1 Integrin 0.033 0.007 -10000 0 -10000 0 0
PRKCD 0.021 0.007 -10000 0 -10000 0 0
Syndecan-2 dimer 0.021 0.037 -10000 0 -0.33 4 4
GO:0007205 0.001 0 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.023 0.027 -10000 0 -0.26 3 3
RHOA 0.021 0.007 -10000 0 -10000 0 0
SDCBP 0.022 0.005 -10000 0 -10000 0 0
TNFRSF13B 0.017 0.062 0.23 8 -0.53 5 13
RASA1 0.021 0.006 -10000 0 -10000 0 0
alpha2/beta1 Integrin 0.031 0.01 -10000 0 -10000 0 0
Syndecan-2/Synbindin 0.018 0.035 -10000 0 -0.33 5 5
TGFB1 0.022 0.005 -10000 0 -10000 0 0
CASP3 0.012 0.04 0.19 16 -0.3 3 19
FN1 0.009 0.085 -10000 0 -0.53 12 12
Syndecan-2/IL8 0.02 0.052 0.25 2 -0.33 8 10
SDC2 0.004 0.039 -10000 0 -0.38 5 5
KNG1 0.007 0.053 0.31 13 -10000 0 13
Syndecan-2/Neurofibromin 0.018 0.035 -10000 0 -0.33 5 5
TRAPPC4 0.022 0.004 -10000 0 -10000 0 0
CSF2 -0.028 0.15 -10000 0 -0.53 42 42
Syndecan-2/TGFB1 0.018 0.035 -10000 0 -0.32 5 5
Syndecan-2/Syntenin/PI-4-5-P2 0.017 0.032 -10000 0 -0.3 5 5
Syndecan-2/Ezrin 0.029 0.034 -10000 0 -0.29 5 5
PRKACA 0.013 0.046 0.19 19 -0.3 5 24
angiogenesis 0.02 0.052 0.25 2 -0.33 8 10
MMP2 0.017 0.05 -10000 0 -0.53 4 4
IL8 0.025 0.058 0.25 14 -0.53 3 17
calcineurin-NFAT signaling pathway 0.016 0.053 -10000 0 -0.33 10 10
Syndecan-4-mediated signaling events

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.014 0.14 -10000 0 -0.56 22 22
Syndecan-4/Syndesmos 0.019 0.093 -10000 0 -0.65 5 5
positive regulation of JNK cascade 0.006 0.12 -10000 0 -0.54 11 11
Syndecan-4/ADAM12 0.044 0.12 -10000 0 -0.67 5 5
CCL5 0.012 0.074 -10000 0 -0.53 9 9
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
DNM2 0.022 0.004 -10000 0 -10000 0 0
ITGA5 0.023 0.002 -10000 0 -10000 0 0
SDCBP 0.022 0.005 -10000 0 -10000 0 0
PLG 0.013 0.028 0.22 5 -10000 0 5
ADAM12 0.069 0.091 0.23 117 -0.3 2 119
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.022 0.004 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.032 0.019 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 0.051 0.12 0.35 1 -0.64 6 7
Syndecan-4/CXCL12/CXCR4 0.007 0.12 -10000 0 -0.57 11 11
Syndecan-4/Laminin alpha3 0.011 0.095 -10000 0 -0.6 5 5
MDK 0.027 0.033 0.26 9 -10000 0 9
Syndecan-4/FZD7 0.019 0.092 -10000 0 -0.62 5 5
Syndecan-4/Midkine 0.02 0.095 0.36 2 -0.62 5 7
FZD7 0.023 0.016 0.38 1 -10000 0 1
Syndecan-4/FGFR1/FGF 0.015 0.093 -10000 0 -0.59 5 5
THBS1 0.013 0.074 -10000 0 -0.53 9 9
integrin-mediated signaling pathway 0.019 0.093 -10000 0 -0.63 5 5
positive regulation of MAPKKK cascade 0.006 0.12 -10000 0 -0.54 11 11
Syndecan-4/TACI 0.019 0.098 -10000 0 -0.65 5 5
CXCR4 0.021 0.025 -10000 0 -0.53 1 1
cell adhesion 0.005 0.055 0.19 5 -0.3 13 18
Syndecan-4/Dynamin 0.018 0.093 -10000 0 -0.65 5 5
Syndecan-4/TSP1 0.014 0.11 -10000 0 -0.61 10 10
Syndecan-4/GIPC 0.018 0.092 -10000 0 -0.71 4 4
Syndecan-4/RANTES 0.013 0.1 -10000 0 -0.6 7 7
ITGB1 0.022 0.004 -10000 0 -10000 0 0
LAMA1 0.082 0.1 0.24 142 -0.42 2 144
LAMA3 0.009 0.082 -10000 0 -0.53 11 11
RAC1 0.022 0.004 -10000 0 -10000 0 0
PRKCA 0.004 0.1 0.76 9 -0.47 1 10
Syndecan-4/alpha-Actinin 0.019 0.093 -10000 0 -0.66 5 5
TFPI -0.017 0.14 -10000 0 -0.53 35 35
F2 0.026 0.039 0.23 16 -10000 0 16
alpha5/beta1 Integrin 0.033 0.007 -10000 0 -10000 0 0
positive regulation of cell adhesion 0.014 0.1 0.38 1 -0.57 6 7
ACTN1 0.022 0.004 -10000 0 -10000 0 0
TNC 0.025 0.039 0.23 10 -0.53 1 11
Syndecan-4/CXCL12 -0.003 0.12 -10000 0 -0.59 11 11
FGF6 -0.016 0.006 -10000 0 -10000 0 0
RHOA 0.021 0.007 -10000 0 -10000 0 0
CXCL12 -0.021 0.15 -10000 0 -0.53 39 39
TNFRSF13B 0.017 0.062 0.23 8 -0.53 5 13
FGF2 0.008 0.085 -10000 0 -0.53 12 12
FGFR1 0.017 0.026 -10000 0 -0.53 1 1
Syndecan-4/PI-4-5-P2 0.002 0.088 -10000 0 -0.65 5 5
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 0.006 0.084 -10000 0 -0.52 12 12
cell migration -0.018 0.01 -10000 0 -10000 0 0
PRKCD 0.018 0.013 -10000 0 -10000 0 0
vasculogenesis 0.014 0.1 -10000 0 -0.58 10 10
SDC4 0.011 0.08 -10000 0 -0.76 3 3
Syndecan-4/Tenascin C 0.02 0.097 -10000 0 -0.66 5 5
Syndecan-4/PI-4-5-P2/PKC alpha -0.026 0.015 -10000 0 -10000 0 0
Syndecan-4/Syntenin 0.018 0.091 -10000 0 -0.62 5 5
MMP9 0.034 0.049 0.23 27 -10000 0 27
Rac1/GTP 0.004 0.056 0.19 5 -0.31 13 18
cytoskeleton organization 0.019 0.09 -10000 0 -0.62 5 5
GIPC1 0.022 0.004 -10000 0 -10000 0 0
Syndecan-4/TFPI 0 0.12 -10000 0 -0.66 7 7
Regulation of nuclear SMAD2/3 signaling

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.022 0.006 -10000 0 -10000 0 0
HSPA8 0.022 0.004 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha 0.015 0.098 -10000 0 -0.38 22 22
AKT1 0.014 0.031 -10000 0 -10000 0 0
GSC 0.016 0.072 -10000 0 -0.47 2 2
NKX2-5 -0.001 0.015 -10000 0 -0.24 1 1
muscle cell differentiation -0.033 0.092 0.44 6 -10000 0 6
SMAD2-3/SMAD4/SP1 0.052 0.073 -10000 0 -10000 0 0
SMAD4 0.015 0.039 -10000 0 -10000 0 0
CBFB 0.022 0.005 -10000 0 -10000 0 0
SAP18 0.021 0.006 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.043 0.024 -10000 0 -0.34 1 1
SMAD3/SMAD4/VDR 0.053 0.051 -10000 0 -0.29 1 1
MYC 0.023 0.014 -10000 0 -10000 0 0
CDKN2B -0.22 0.48 -10000 0 -1.5 53 53
AP1 -0.001 0.1 -10000 0 -0.28 52 52
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 0.033 0.067 -10000 0 -0.39 4 4
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.014 0.11 -10000 0 -0.34 42 42
SP3 0.024 0.004 -10000 0 -10000 0 0
CREB1 0.022 0.003 -10000 0 -10000 0 0
FOXH1 0.042 0.07 0.27 40 -10000 0 40
SMAD3/SMAD4/GR 0.033 0.048 -10000 0 -10000 0 0
GATA3 0.009 0.091 0.23 2 -0.49 15 17
SKI/SIN3/HDAC complex/NCoR1 0 0.085 -10000 0 -0.41 14 14
MEF2C/TIF2 0.018 0.095 0.31 3 -0.52 10 13
endothelial cell migration -0.018 0.07 0.75 3 -10000 0 3
MAX 0.021 0.005 -10000 0 -10000 0 0
RBBP7 0.022 0.005 -10000 0 -10000 0 0
RBBP4 0.022 0.004 -10000 0 -10000 0 0
RUNX2 0.022 0.003 -10000 0 -10000 0 0
RUNX3 0.022 0.004 -10000 0 -10000 0 0
RUNX1 0.022 0.005 -10000 0 -10000 0 0
CTBP1 0.021 0.006 -10000 0 -10000 0 0
NR3C1 0.021 0.006 -10000 0 -10000 0 0
VDR 0.021 0.025 -10000 0 -0.53 1 1
CDKN1A 0.013 0.052 -10000 0 -10000 0 0
KAT2B 0.021 0.007 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.052 0.067 0.28 4 -0.25 3 7
DCP1A 0.021 0.007 -10000 0 -10000 0 0
SKI 0.022 0.005 -10000 0 -10000 0 0
SERPINE1 0.018 0.071 -10000 0 -0.76 3 3
SMAD3/SMAD4/ATF2 0.035 0.048 -10000 0 -10000 0 0
SMAD3/SMAD4/ATF3 0.034 0.055 -10000 0 -0.43 2 2
SAP30 0.021 0.006 -10000 0 -10000 0 0
Cbp/p300/PIAS3 0.04 0.019 -10000 0 -10000 0 0
JUN -0.01 0.098 -10000 0 -0.27 50 50
SMAD3/SMAD4/IRF7 0.036 0.05 -10000 0 -10000 0 0
TFE3 0.025 0.006 -10000 0 -10000 0 0
COL1A2 0.026 0.031 -10000 0 -10000 0 0
mesenchymal cell differentiation -0.035 0.048 -10000 0 -10000 0 0
DLX1 0.14 0.11 0.24 290 -0.3 1 291
TCF3 0.022 0.004 -10000 0 -10000 0 0
FOS -0.041 0.18 -10000 0 -0.54 58 58
SMAD3/SMAD4/Max 0.033 0.048 -10000 0 -10000 0 0
Cbp/p300/SNIP1 0.042 0.014 -10000 0 -10000 0 0
ZBTB17 0.022 0.007 -10000 0 -10000 0 0
LAMC1 0.013 0.034 -10000 0 -10000 0 0
TGIF2/HDAC complex/SMAD3/SMAD4 0.035 0.048 -10000 0 -10000 0 0
IRF7 0.023 0.005 -10000 0 -10000 0 0
ESR1 -0.005 0.12 -10000 0 -0.53 23 23
HNF4A 0.021 0.033 0.25 8 -10000 0 8
MEF2C 0.013 0.098 0.37 4 -0.52 10 14
SMAD2-3/SMAD4 0.034 0.064 -10000 0 -0.25 2 2
Cbp/p300/Src-1 0.043 0.015 -10000 0 -10000 0 0
IGHV3OR16-13 0.006 0.033 -10000 0 -0.35 4 4
TGIF2/HDAC complex 0.022 0.004 -10000 0 -10000 0 0
CREBBP 0.022 0.006 -10000 0 -10000 0 0
SKIL 0.013 0.011 -10000 0 -10000 0 0
HDAC1 0.022 0.004 -10000 0 -10000 0 0
HDAC2 0.023 0.002 -10000 0 -10000 0 0
SNIP1 0.023 0.016 0.38 1 -10000 0 1
GCN5L2 0 0.003 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.041 0.049 -10000 0 -10000 0 0
MSG1/HSC70 0.032 0.021 -10000 0 -0.39 1 1
SMAD2 0.016 0.032 -10000 0 -10000 0 0
SMAD3 0.015 0.036 -10000 0 -10000 0 0
SMAD3/E2F4-5/DP1/p107/SMAD4 0.015 0.037 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4 -0.003 0.065 0.23 2 -0.41 7 9
NCOR1 0.022 0.005 -10000 0 -10000 0 0
NCOA2 0.021 0.025 -10000 0 -0.53 1 1
NCOA1 0.022 0.003 -10000 0 -10000 0 0
MYOD/E2A 0.048 0.054 0.27 1 -0.2 3 4
SMAD2-3/SMAD4/SP1/MIZ-1 0.059 0.079 -10000 0 -10000 0 0
IFNB1 0.008 0.029 -10000 0 -10000 0 0
SMAD3/SMAD4/MEF2C 0.032 0.1 -10000 0 -0.55 9 9
CITED1 0.021 0.027 0.23 1 -0.53 1 2
SMAD2-3/SMAD4/ARC105 0.041 0.063 -10000 0 -10000 0 0
RBL1 0.022 0.004 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.03 0.16 -10000 0 -0.52 46 46
RUNX1-3/PEBPB2 0.042 0.014 -10000 0 -10000 0 0
SMAD7 0.003 0.099 -10000 0 -10000 0 0
MYC/MIZ-1 0.032 0.023 -10000 0 -10000 0 0
SMAD3/SMAD4 0.013 0.044 -10000 0 -0.43 1 1
IL10 0 0.075 -10000 0 -0.36 15 15
PIASy/HDAC complex 0.019 0.012 -10000 0 -10000 0 0
PIAS3 0.021 0.007 -10000 0 -10000 0 0
CDK2 0.023 0.004 -10000 0 -10000 0 0
IL5 -0.001 0.067 -10000 0 -0.35 7 7
CDK4 0.024 0.017 0.38 1 -10000 0 1
PIAS4 0.019 0.012 -10000 0 -10000 0 0
ATF3 0.02 0.035 -10000 0 -0.53 2 2
SMAD3/SMAD4/SP1 0.041 0.055 -10000 0 -10000 0 0
FOXG1 0.027 0.078 0.24 54 -0.3 1 55
FOXO3 0.001 0.033 -10000 0 -10000 0 0
FOXO1 0.002 0.03 -10000 0 -10000 0 0
FOXO4 0.001 0.032 -10000 0 -10000 0 0
heart looping 0.013 0.097 0.37 4 -0.51 10 14
CEBPB 0.016 0.022 -10000 0 -10000 0 0
SMAD3/SMAD4/DLX1 0.11 0.094 0.27 6 -10000 0 6
MYOD1 0.03 0.086 0.23 68 -0.3 3 71
SMAD3/SMAD4/HNF4 0.037 0.053 0.27 1 -10000 0 1
SMAD3/SMAD4/GATA3 0.027 0.085 -10000 0 -0.36 16 16
SnoN/SIN3/HDAC complex/NCoR1 0.013 0.011 -10000 0 -10000 0 0
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.049 0.054 -10000 0 -10000 0 0
SMAD3/SMAD4/SP1-3 0.054 0.056 -10000 0 -10000 0 0
MED15 0.021 0.006 -10000 0 -10000 0 0
SP1 0.023 0.016 -10000 0 -10000 0 0
SIN3B 0.022 0.004 -10000 0 -10000 0 0
SIN3A 0.023 0.002 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.05 0.072 0.26 4 -0.32 8 12
ITGB5 0.014 0.04 -10000 0 -10000 0 0
TGIF/SIN3/HDAC complex/CtBP 0.005 0.072 -10000 0 -0.34 16 16
SMAD3/SMAD4/AR -0.043 0.16 -10000 0 -0.36 99 99
AR -0.091 0.22 -10000 0 -0.53 100 100
negative regulation of cell growth 0.013 0.047 -10000 0 -10000 0 0
SMAD3/SMAD4/MYOD 0.049 0.071 0.27 1 -10000 0 1
E2F5 0.022 0.005 -10000 0 -10000 0 0
E2F4 0.022 0.005 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.063 0.063 -10000 0 -10000 0 0
SMAD2-3/SMAD4/FOXO1-3a-4 -0.014 0.11 -10000 0 -0.37 43 43
TFDP1 0.023 0.028 0.38 3 -10000 0 3
SMAD3/SMAD4/AP1 0.013 0.11 -10000 0 -0.28 52 52
SMAD3/SMAD4/RUNX2 0.035 0.049 -10000 0 -10000 0 0
TGIF2 0.022 0.004 -10000 0 -10000 0 0
TGIF1 0.022 0.005 -10000 0 -10000 0 0
ATF2 0.022 0.004 -10000 0 -10000 0 0
LPA receptor mediated events

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.035 0.061 -10000 0 -0.39 8 8
NF kappa B1 p50/RelA/I kappa B alpha -0.001 0.075 -10000 0 -0.36 2 2
AP1 -0.003 0.11 -10000 0 -0.28 61 61
mol:PIP3 -0.017 0.045 -10000 0 -0.3 9 9
AKT1 0.006 0.097 0.32 8 -0.46 2 10
PTK2B -0.017 0.079 0.18 1 -0.34 13 14
RHOA -0.014 0.082 -10000 0 -0.31 31 31
PIK3CB 0.019 0.009 -10000 0 -10000 0 0
mol:Ca2+ -0.029 0.064 -10000 0 -0.28 10 10
MAGI3 0.021 0.005 -10000 0 -10000 0 0
RELA 0.023 0.002 -10000 0 -10000 0 0
apoptosis 0.009 0.04 0.19 1 -0.28 8 9
HRAS/GDP 0.016 0.003 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization -0.002 0.094 0.29 5 -0.3 14 19
NF kappa B1 p50/RelA -0.006 0.076 -10000 0 -0.38 3 3
endothelial cell migration 0.007 0.063 -10000 0 -0.68 4 4
ADCY4 -0.004 0.075 -10000 0 -0.45 6 6
ADCY5 -0.008 0.071 -10000 0 -0.65 2 2
ADCY6 0.007 0.056 -10000 0 -0.38 5 5
ADCY7 0.008 0.052 -10000 0 -0.39 4 4
ADCY1 0.007 0.052 -10000 0 -0.83 1 1
ADCY2 0.002 0.064 0.21 2 -0.44 3 5
ADCY3 0.008 0.054 -10000 0 -0.39 4 4
ADCY8 -0.044 0.1 -10000 0 -0.47 7 7
ADCY9 0.007 0.057 -10000 0 -0.38 6 6
GSK3B -0.001 0.092 0.2 35 -0.34 10 45
arachidonic acid secretion 0.004 0.06 -10000 0 -0.41 6 6
GNG2 0.016 0.055 -10000 0 -0.53 5 5
TRIP6 0.015 0.007 -10000 0 -10000 0 0
GNAO1 0.01 0.039 -10000 0 -0.35 5 5
HRAS 0.022 0.004 -10000 0 -10000 0 0
NFKBIA -0.019 0.071 0.22 1 -0.33 7 8
GAB1 0.021 0.006 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly 0.008 0.16 -10000 0 -0.82 18 18
JUN 0.022 0.004 -10000 0 -10000 0 0
LPA/LPA2/NHERF2 0.028 0.027 -10000 0 -0.33 2 2
TIAM1 -0.009 0.18 -10000 0 -0.94 18 18
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
mol:IP3 -0.028 0.063 -10000 0 -0.29 9 9
PLCB3 0.011 0.032 0.18 9 -0.3 2 11
FOS -0.043 0.18 -10000 0 -0.53 58 58
positive regulation of mitosis 0.004 0.06 -10000 0 -0.41 6 6
LPA/LPA1-2-3 0.041 0.052 0.24 1 -0.31 8 9
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0 -10000 0 -10000 0 0
BCAR1 0.022 0.005 -10000 0 -10000 0 0
stress fiber formation -0.001 0.065 0.35 1 -0.38 6 7
GNAZ 0.007 0.048 -10000 0 -0.33 9 9
EGFR/PI3K-beta/Gab1 0.01 0.052 -10000 0 -0.32 9 9
positive regulation of dendritic cell cytokine production 0.039 0.051 0.24 1 -0.31 8 9
LPA/LPA2/MAGI-3 0.028 0.015 -10000 0 -10000 0 0
ARHGEF1 0.009 0.046 -10000 0 -0.51 1 1
GNAI2 0.009 0.035 -10000 0 -0.34 4 4
GNAI3 0.01 0.035 -10000 0 -0.34 4 4
GNAI1 0.01 0.045 -10000 0 -0.41 4 4
LPA/LPA3 0.017 0.044 0.17 10 -0.39 4 14
LPA/LPA2 0.017 0.011 -10000 0 -10000 0 0
LPA/LPA1 0.017 0.04 -10000 0 -0.39 4 4
HB-EGF/EGFR 0.006 0.082 0.26 9 -0.35 19 28
HBEGF -0.024 0.065 -10000 0 -0.39 14 14
mol:DAG -0.028 0.063 -10000 0 -0.29 9 9
cAMP biosynthetic process -0.004 0.067 0.33 2 -0.41 4 6
NFKB1 0.022 0.005 -10000 0 -10000 0 0
SRC 0.022 0.004 -10000 0 -10000 0 0
GNB1 0.02 0.026 -10000 0 -0.54 1 1
LYN -0.019 0.074 0.25 1 -0.34 10 11
GNAQ 0.009 0.033 0.19 1 -0.29 5 6
LPAR2 0.022 0.004 -10000 0 -10000 0 0
LPAR3 0.022 0.059 0.24 10 -0.53 4 14
LPAR1 0.022 0.036 -10000 0 -0.69 1 1
IL8 -0.016 0.12 0.3 3 -0.41 16 19
PTK2 0.004 0.048 -10000 0 -0.33 5 5
Rac1/GDP 0.016 0.003 -10000 0 -10000 0 0
CASP3 0.009 0.041 0.19 1 -0.29 8 9
EGFR 0.023 0.081 0.36 12 -0.53 6 18
PLCG1 -0.02 0.065 -10000 0 -0.24 15 15
PLD2 0.006 0.051 0.36 1 -0.33 5 6
G12/G13 0.041 0.036 -10000 0 -0.31 4 4
PI3K-beta -0.008 0.073 -10000 0 -0.37 7 7
cell migration 0.013 0.058 0.17 1 -0.25 17 18
SLC9A3R2 0.02 0.035 -10000 0 -0.53 2 2
PXN -0.001 0.066 0.35 1 -0.38 6 7
HRAS/GTP 0.004 0.061 -10000 0 -0.42 6 6
RAC1 0.022 0.004 -10000 0 -10000 0 0
MMP9 0.034 0.049 0.24 27 -10000 0 27
PRKCE 0.02 0.025 -10000 0 -0.53 1 1
PRKCD -0.027 0.061 -10000 0 -0.3 4 4
Gi(beta/gamma) 0.008 0.065 -10000 0 -0.54 4 4
mol:LPA 0.001 0.014 -10000 0 -0.17 3 3
TRIP6/p130 Cas/FAK1/Paxillin 0.021 0.056 0.26 1 -0.38 2 3
MAPKKK cascade 0.004 0.06 -10000 0 -0.41 6 6
contractile ring contraction involved in cytokinesis -0.021 0.095 -10000 0 -0.32 38 38
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.06 0.13 -10000 0 -0.3 116 116
GNA15 0.01 0.03 0.19 1 -0.29 4 5
GNA12 0.022 0.004 -10000 0 -10000 0 0
GNA13 0.022 0.003 -10000 0 -10000 0 0
MAPT -0.002 0.096 0.29 5 -0.3 15 20
GNA11 0.01 0.03 0.19 1 -0.29 4 5
Rac1/GTP 0.007 0.17 -10000 0 -0.86 18 18
MMP2 0.007 0.063 -10000 0 -0.69 4 4
ErbB2/ErbB3 signaling events

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 -0.007 0.006 -10000 0 -10000 0 0
RAS family/GTP 0.028 0.061 -10000 0 -0.3 2 2
NFATC4 -0.012 0.059 0.24 4 -0.24 3 7
ERBB2IP 0.021 0.007 -10000 0 -10000 0 0
HSP90 (dimer) 0.022 0.005 -10000 0 -10000 0 0
mammary gland morphogenesis 0.008 0.059 -10000 0 -0.29 13 13
JUN 0.013 0.061 0.2 4 -0.44 1 5
HRAS 0.022 0.004 -10000 0 -10000 0 0
DOCK7 -0.016 0.063 0.28 1 -0.28 13 14
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.025 0.057 -10000 0 -0.3 12 12
AKT1 -0.004 0.006 -10000 0 -10000 0 0
BAD -0.008 0.004 -10000 0 -10000 0 0
MAPK10 -0.01 0.054 0.18 6 -0.24 7 13
mol:GTP 0 0.001 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta 0.009 0.064 -10000 0 -0.31 13 13
RAF1 0.019 0.075 0.26 12 -0.35 1 13
ErbB2/ErbB3/neuregulin 2 -0.007 0.099 0.2 2 -0.32 44 46
STAT3 0.012 0.1 -10000 0 -0.79 8 8
cell migration -0.005 0.054 0.22 8 -0.26 2 10
mol:PI-3-4-5-P3 0 0.001 -10000 0 -10000 0 0
cell proliferation -0.016 0.17 0.43 1 -0.54 18 19
FOS -0.033 0.19 0.31 3 -0.47 68 71
NRAS 0.021 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0.008 0.059 -10000 0 -0.29 13 13
MAPK3 -0.006 0.14 0.37 2 -0.53 15 17
MAPK1 -0.008 0.15 0.36 2 -0.55 18 20
JAK2 -0.017 0.059 -10000 0 -0.28 13 13
NF2 -0.002 0.071 -10000 0 -0.56 8 8
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0.01 0.053 0.19 1 -0.28 11 12
NRG1 0.005 0.092 -10000 0 -0.54 14 14
GRB2/SOS1 0.032 0.008 -10000 0 -10000 0 0
MAPK8 0.002 0.067 0.24 1 -0.29 13 14
MAPK9 -0.009 0.044 0.18 4 -10000 0 4
ERBB2 -0.016 0.021 0.29 2 -10000 0 2
ERBB3 0.023 0.003 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
RAC1 0.022 0.004 -10000 0 -10000 0 0
apoptosis 0.005 0.017 -10000 0 -0.17 3 3
STAT3 (dimer) 0.014 0.1 -10000 0 -0.77 8 8
RNF41 -0.01 0.007 -10000 0 -10000 0 0
FRAP1 -0.003 0.003 -10000 0 -10000 0 0
RAC1-CDC42/GTP -0.024 0.034 -10000 0 -0.21 13 13
ErbB2/ErbB2/HSP90 (dimer) -0.014 0.018 0.21 2 -10000 0 2
CHRNA1 0.003 0.13 0.34 2 -0.52 10 12
myelination -0.001 0.077 0.29 13 -10000 0 13
PPP3CB -0.015 0.059 0.27 1 -0.26 13 14
KRAS 0.021 0.006 -10000 0 -10000 0 0
RAC1-CDC42/GDP 0.032 0.059 -10000 0 -0.25 11 11
NRG2 -0.036 0.16 -10000 0 -0.53 48 48
mol:GDP 0.01 0.053 0.18 2 -0.28 11 13
SOS1 0.022 0.004 -10000 0 -10000 0 0
MAP2K2 0.012 0.077 0.26 11 -0.39 1 12
SRC 0.022 0.004 -10000 0 -10000 0 0
mol:cAMP -0.001 0.001 -10000 0 -10000 0 0
PTPN11 -0.014 0.064 0.28 1 -0.28 13 14
MAP2K1 -0.011 0.15 0.4 1 -0.5 15 16
heart morphogenesis 0.008 0.059 -10000 0 -0.29 13 13
RAS family/GDP 0.033 0.062 -10000 0 -0.29 2 2
GRB2 0.022 0.004 -10000 0 -10000 0 0
PRKACA 0 0.079 -10000 0 -0.58 9 9
CHRNE 0.007 0.017 0.099 1 -0.2 1 2
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
activation of caspase activity 0.004 0.006 -10000 0 -10000 0 0
nervous system development 0.008 0.059 -10000 0 -0.29 13 13
CDC42 0.022 0.004 -10000 0 -10000 0 0
Cellular roles of Anthrax toxin

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 0.02 0.035 -10000 0 -0.53 2 2
ANTXR2 0.015 0.061 -10000 0 -0.53 6 6
negative regulation of myeloid dendritic cell antigen processing and presentation -0.002 0.009 -10000 0 -0.084 6 6
monocyte activation -0.009 0.1 -10000 0 -0.37 34 34
MAP2K2 -0.009 0.11 -10000 0 -0.57 18 18
MAP2K1 -0.005 0.008 -10000 0 -0.1 1 1
MAP2K7 -0.005 0.008 -10000 0 -0.1 1 1
MAP2K6 -0.005 0.01 0.12 1 -10000 0 1
CYAA -0.011 0.042 -10000 0 -0.37 6 6
MAP2K4 -0.005 0.007 -10000 0 -0.1 1 1
IL1B -0.009 0.051 0.24 2 -0.28 14 16
Channel 0.022 0.049 -10000 0 -0.39 6 6
NLRP1 -0.006 0.025 -10000 0 -0.32 3 3
CALM1 0.022 0.005 -10000 0 -10000 0 0
negative regulation of phagocytosis -0.003 0.068 -10000 0 -0.4 14 14
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.002 0.009 0.084 6 -10000 0 6
MAPK3 -0.005 0.009 -10000 0 -10000 0 0
MAPK1 -0.005 0.008 -10000 0 -10000 0 0
PGR -0.06 0.11 -10000 0 -0.29 98 98
PA/Cellular Receptors 0.023 0.053 -10000 0 -0.43 6 6
apoptosis -0.002 0.009 -10000 0 -0.084 6 6
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.021 0.046 -10000 0 -0.37 6 6
macrophage activation -0.008 0.008 -10000 0 -10000 0 0
TNF 0.012 0.079 0.23 1 -0.53 10 11
VCAM1 -0.008 0.1 -10000 0 -0.37 32 32
platelet activation -0.003 0.068 -10000 0 -0.4 14 14
MAPKKK cascade 0.001 0.021 0.12 2 -0.14 3 5
IL18 -0.005 0.032 -10000 0 -0.25 6 6
negative regulation of macrophage activation -0.002 0.009 -10000 0 -0.084 6 6
LEF -0.002 0.009 -10000 0 -0.085 6 6
CASP1 -0.003 0.023 -10000 0 -0.18 5 5
mol:cAMP -0.004 0.069 -10000 0 -0.4 14 14
necrosis -0.002 0.009 -10000 0 -0.084 6 6
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.021 0.047 -10000 0 -0.37 6 6
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
mTOR signaling pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0 0 -10000 0 -10000 0 0
MKNK1 0.022 0.004 -10000 0 -10000 0 0
mol:PIP3 -0.005 0.017 -10000 0 -10000 0 0
FRAP1 0.049 0.058 0.26 2 -0.37 2 4
AKT1 0.052 0.079 0.19 17 -10000 0 17
INSR 0.022 0.004 -10000 0 -10000 0 0
Insulin Receptor/Insulin 0.025 0.007 -10000 0 -10000 0 0
mol:GTP 0.081 0.077 0.26 22 -10000 0 22
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit 0.006 0.015 -10000 0 -10000 0 0
TSC2 0.022 0.004 -10000 0 -10000 0 0
RHEB/GDP 0.008 0.017 -10000 0 -10000 0 0
TSC1 0.023 0.004 -10000 0 -10000 0 0
Insulin Receptor/IRS1 0.019 0.032 -10000 0 -0.18 10 10
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.015 0.026 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.022 0.004 -10000 0 -10000 0 0
RPS6KB1 0.075 0.08 0.23 42 -0.29 2 44
MAP3K5 0 0.025 0.19 2 -0.18 7 9
PIK3R1 0.021 0.007 -10000 0 -10000 0 0
apoptosis 0 0.025 0.19 2 -0.18 7 9
mol:LY294002 0 0 -10000 0 -0.001 12 12
EIF4B 0.07 0.077 0.23 42 -0.26 2 44
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.073 0.067 0.23 21 -0.25 1 22
eIF4E/eIF4G1/eIF4A1 0.008 0.017 -10000 0 -0.27 1 1
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K 0.016 0.027 -10000 0 -10000 0 0
mTOR/RHEB/GTP/Raptor/GBL 0.058 0.069 0.2 48 -0.15 1 49
FKBP1A 0.023 0.005 -10000 0 -10000 0 0
RHEB/GTP 0.062 0.058 -10000 0 -10000 0 0
mol:Amino Acids 0 0 -10000 0 -0.001 12 12
FKBP12/Rapamycin 0.019 0.006 -10000 0 -10000 0 0
PDPK1 -0.002 0.034 0.17 15 -10000 0 15
EIF4E 0.022 0.005 -10000 0 -10000 0 0
ASK1/PP5C 0.052 0.083 -10000 0 -0.52 8 8
mTOR/RHEB/GTP/Raptor/GBL/eIF4E -0.007 0.063 -10000 0 -0.34 6 6
TSC1/TSC2 0.092 0.085 0.29 26 -10000 0 26
tumor necrosis factor receptor activity 0 0 0.001 12 -10000 0 12
RPS6 0.021 0.007 -10000 0 -10000 0 0
PPP5C 0.022 0.004 -10000 0 -10000 0 0
EIF4G1 0.013 0.011 -10000 0 -10000 0 0
IRS1 0.005 0.031 -10000 0 -0.19 12 12
INS -0.017 0.003 -10000 0 -10000 0 0
PTEN 0.019 0.007 -10000 0 -10000 0 0
PDK2 -0.002 0.031 0.16 13 -10000 0 13
EIF4EBP1 0.01 0.17 -10000 0 -1 11 11
PIK3CA 0.013 0.011 -10000 0 -10000 0 0
PPP2R5D 0.049 0.06 0.24 10 -0.34 2 12
peptide biosynthetic process -0.013 0.015 0.17 3 -10000 0 3
RHEB 0.022 0.004 -10000 0 -10000 0 0
EIF4A1 0.021 0.005 -10000 0 -10000 0 0
mol:Rapamycin 0.001 0.002 0.004 69 -10000 0 69
EEF2 -0.013 0.015 0.18 3 -10000 0 3
eIF4E/4E-BP1 0.015 0.15 -10000 0 -0.93 11 11
Retinoic acid receptors-mediated signaling

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.022 0.004 -10000 0 -10000 0 0
HDAC3 0.021 0.006 -10000 0 -10000 0 0
VDR 0.021 0.025 -10000 0 -0.53 1 1
Cbp/p300/PCAF 0.041 0.017 -10000 0 -10000 0 0
EP300 0.022 0.004 -10000 0 -10000 0 0
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.018 0.049 0.23 1 -0.37 6 7
KAT2B 0.021 0.006 -10000 0 -10000 0 0
MAPK14 0.022 0.004 -10000 0 -10000 0 0
AKT1 -0.009 0.055 -10000 0 -0.28 3 3
RAR alpha/9cRA/Cyclin H 0.037 0.044 -10000 0 -0.35 1 1
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA -0.001 0.086 -10000 0 -0.38 18 18
CDC2 0 0 -10000 0 -10000 0 0
response to UV 0 0 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.021 0.029 -10000 0 -0.22 3 3
NCOR2 0.021 0.025 -10000 0 -0.53 1 1
VDR/VDR/Vit D3 0.016 0.018 -10000 0 -0.39 1 1
RXRs/RARs/NRIP1/9cRA -0.033 0.11 -10000 0 -0.59 9 9
NCOA2 0.021 0.025 -10000 0 -0.53 1 1
NCOA3 0.022 0.004 -10000 0 -10000 0 0
NCOA1 0.022 0.003 -10000 0 -10000 0 0
VDR/VDR/DNA 0.021 0.025 -10000 0 -0.53 1 1
RARG 0.023 0.002 -10000 0 -10000 0 0
RAR gamma1/9cRA 0.03 0.007 -10000 0 -10000 0 0
MAPK3 0.023 0.003 -10000 0 -10000 0 0
MAPK1 0.021 0.006 -10000 0 -10000 0 0
MAPK8 0.022 0.005 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 -0.026 0.09 -10000 0 -0.51 6 6
RARA 0.015 0.023 0.2 1 -0.22 3 4
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA -0.001 0.087 -10000 0 -0.35 23 23
PRKCA 0.022 0.035 -10000 0 -0.53 2 2
RXRs/RARs/NRIP1/9cRA/HDAC1 -0.044 0.12 0.34 1 -0.58 12 13
RXRG -0.15 0.18 -10000 0 -0.33 240 240
RXRA 0.012 0.029 -10000 0 -0.32 2 2
RXRB 0.018 0.032 0.25 1 -0.28 4 5
VDR/Vit D3/DNA 0.016 0.018 -10000 0 -0.39 1 1
RBP1 0.028 0.049 0.27 18 -10000 0 18
CRBP1/9-cic-RA 0.02 0.033 0.18 18 -10000 0 18
RARB 0.02 0.036 -10000 0 -0.53 2 2
PRKCG 0.036 0.058 0.24 34 -0.3 2 36
MNAT1 0.022 0.005 -10000 0 -10000 0 0
RAR alpha/RXRs -0.039 0.096 -10000 0 -0.54 9 9
RXRs/RARs/SMRT(N-CoR2)/9cRA -0.023 0.091 0.24 1 -0.48 10 11
proteasomal ubiquitin-dependent protein catabolic process -0.001 0.1 0.29 1 -0.38 25 26
RXRs/RARs/NRIP1/9cRA/HDAC3 -0.045 0.12 0.34 1 -0.6 12 13
positive regulation of DNA binding 0.029 0.04 -10000 0 -0.33 1 1
NRIP1 -0.043 0.12 -10000 0 -0.67 6 6
RXRs/RARs -0.048 0.13 -10000 0 -0.58 16 16
RXRs/RXRs/DNA/9cRA -0.035 0.083 -10000 0 -0.49 7 7
PRKACA 0.022 0.004 -10000 0 -10000 0 0
CDK7 0.021 0.006 -10000 0 -10000 0 0
TFIIH 0.042 0.014 -10000 0 -10000 0 0
RAR alpha/9cRA 0.045 0.035 -10000 0 -10000 0 0
CCNH 0.021 0.006 -10000 0 -10000 0 0
CREBBP 0.022 0.005 -10000 0 -10000 0 0
RAR gamma2/9cRA 0.039 0.016 -10000 0 -10000 0 0
IL2 signaling events mediated by PI3K

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.041 0.071 -10000 0 -0.67 1 1
UGCG 0.016 0.082 -10000 0 -0.69 6 6
AKT1/mTOR/p70S6K/Hsp90/TERT 0.073 0.11 0.29 13 -0.43 11 24
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucosylceramide 0.017 0.081 -10000 0 -0.68 6 6
mol:DAG -0.019 0.16 -10000 0 -0.8 19 19
CaM/Ca2+/Calcineurin A alpha-beta B1 0.048 0.093 -10000 0 -0.4 8 8
FRAP1 0.047 0.1 0.49 1 -0.44 9 10
FOXO3 0.043 0.1 0.34 3 -0.43 10 13
AKT1 0.045 0.11 -10000 0 -0.45 11 11
GAB2 0.007 0.092 -10000 0 -0.53 14 14
SMPD1 0.005 0.12 -10000 0 -0.69 14 14
SGMS1 0.001 0.13 -10000 0 -0.64 18 18
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP -0.003 0.003 -10000 0 -10000 0 0
CALM1 0.022 0.005 -10000 0 -10000 0 0
cell proliferation 0.032 0.1 0.48 1 -0.44 16 17
EIF3A 0.022 0.004 -10000 0 -10000 0 0
PI3K 0.019 0.018 -10000 0 -10000 0 0
RPS6KB1 0.023 0.056 -10000 0 -0.79 2 2
mol:sphingomyelin -0.019 0.16 -10000 0 -0.8 19 19
natural killer cell activation 0 0 -10000 0 -10000 0 0
JAK3 0.023 0.005 -10000 0 -10000 0 0
PIK3R1 0.022 0.007 -10000 0 -10000 0 0
JAK1 0.023 0.005 -10000 0 -10000 0 0
NFKB1 0.022 0.005 -10000 0 -10000 0 0
MYC 0.059 0.11 0.37 8 -0.45 5 13
MYB 0.017 0.083 -10000 0 -1.2 2 2
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0.04 0.089 -10000 0 -0.47 7 7
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.044 0.055 -10000 0 -0.72 2 2
mol:PI-3-4-5-P3 0.042 0.089 -10000 0 -0.46 7 7
Rac1/GDP 0.01 0.01 -10000 0 -10000 0 0
T cell proliferation 0.041 0.085 0.26 2 -0.44 6 8
SHC1 0.022 0.005 -10000 0 -10000 0 0
RAC1 0.022 0.004 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity 0.003 0.005 -10000 0 -0.064 2 2
PRKCZ 0.041 0.086 -10000 0 -0.46 6 6
NF kappa B1 p50/RelA 0.061 0.099 0.46 1 -0.44 5 6
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K 0.008 0.053 -10000 0 -0.45 5 5
HSP90AA1 0.022 0.005 -10000 0 -10000 0 0
RELA 0.023 0.002 -10000 0 -10000 0 0
IL2RA 0.021 0.039 0.23 3 -0.53 2 5
IL2RB 0.02 0.043 -10000 0 -0.53 3 3
TERT 0.12 0.13 0.27 194 -0.3 1 195
E2F1 0.023 0.038 -10000 0 -0.41 3 3
SOS1 0.023 0.004 -10000 0 -10000 0 0
RPS6 0.021 0.007 -10000 0 -10000 0 0
mol:cAMP -0.001 0.003 0.03 2 -0.01 14 16
PTPN11 0.023 0.002 -10000 0 -10000 0 0
IL2RG 0.016 0.066 -10000 0 -0.53 7 7
actin cytoskeleton organization 0.041 0.085 0.26 2 -0.44 6 8
GRB2 0.023 0.004 -10000 0 -10000 0 0
IL2 0.02 0.006 -10000 0 -10000 0 0
PIK3CA 0.013 0.012 -10000 0 -10000 0 0
Rac1/GTP 0.023 0.023 -10000 0 -10000 0 0
LCK 0.023 0.025 -10000 0 -0.53 1 1
BCL2 0.045 0.093 0.48 2 -0.48 2 4
EPHB forward signaling

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.028 0.03 -10000 0 -0.33 2 2
cell-cell adhesion 0.019 0.021 0.26 2 -10000 0 2
Ephrin B/EPHB2/RasGAP 0.059 0.034 -10000 0 -0.29 1 1
ITSN1 0.022 0.004 -10000 0 -10000 0 0
PIK3CA 0.012 0.011 -10000 0 -10000 0 0
SHC1 0.022 0.005 -10000 0 -10000 0 0
Ephrin B1/EPHB3 0.025 0.041 0.24 14 -10000 0 14
Ephrin B1/EPHB1 0.044 0.055 0.24 18 -0.33 1 19
HRAS/GDP -0.024 0.09 -10000 0 -0.29 3 3
Ephrin B/EPHB1/GRB7 0.065 0.057 -10000 0 -0.29 1 1
Endophilin/SYNJ1 -0.011 0.026 0.2 1 -0.28 1 2
KRAS 0.021 0.006 -10000 0 -10000 0 0
Ephrin B/EPHB1/Src 0.064 0.056 -10000 0 -0.29 1 1
endothelial cell migration 0.023 0.028 -10000 0 -0.29 1 1
GRB2 0.022 0.004 -10000 0 -10000 0 0
GRB7 0.025 0.032 0.38 4 -10000 0 4
PAK1 0.004 0.072 0.31 3 -0.28 5 8
HRAS 0.022 0.004 -10000 0 -10000 0 0
RRAS -0.012 0.025 -10000 0 -0.28 1 1
DNM1 0.023 0.014 0.23 2 -10000 0 2
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK 0.007 0.068 0.34 1 -0.28 2 3
lamellipodium assembly -0.019 0.021 -10000 0 -0.26 2 2
Ephrin B/EPHB1/Src/p52 SHC/GRB2 0.021 0.042 0.26 1 -0.26 2 3
PIK3R1 0.021 0.006 -10000 0 -10000 0 0
EPHB2 0.025 0.027 0.23 8 -10000 0 8
EPHB3 0.025 0.064 0.34 18 -10000 0 18
EPHB1 0.05 0.09 0.27 61 -0.53 1 62
EPHB4 0.021 0.005 -10000 0 -10000 0 0
mol:GDP -0.04 0.07 -10000 0 -0.32 2 2
Ephrin B/EPHB2 0.049 0.029 -10000 0 -0.29 1 1
Ephrin B/EPHB3 0.034 0.046 0.24 12 -0.29 1 13
JNK cascade 0.032 0.13 0.35 62 -0.29 1 63
Ephrin B/EPHB1 0.054 0.054 0.24 12 -0.29 2 14
RAP1/GDP -0.03 0.086 -10000 0 -0.3 3 3
EFNB2 0.02 0.025 -10000 0 -0.53 1 1
EFNB3 0.022 0.014 0.23 2 -10000 0 2
EFNB1 0.023 0.003 -10000 0 -10000 0 0
Ephrin B2/EPHB1-2 0.051 0.058 0.24 16 -0.31 2 18
RAP1B 0.022 0.005 -10000 0 -10000 0 0
RAP1A 0.022 0.005 -10000 0 -10000 0 0
CDC42/GTP 0.039 0.046 -10000 0 -0.3 1 1
Rap1/GTP 0.011 0.029 -10000 0 -0.26 1 1
axon guidance 0.028 0.03 -10000 0 -0.33 2 2
MAPK3 0.01 0.039 0.23 4 -10000 0 4
MAPK1 0.01 0.043 0.25 6 -10000 0 6
Rac1/GDP -0.038 0.084 -10000 0 -0.29 6 6
actin cytoskeleton reorganization -0.039 0.044 -10000 0 -0.24 1 1
CDC42/GDP -0.038 0.084 -10000 0 -0.29 6 6
PI3K 0.025 0.03 -10000 0 -0.29 1 1
EFNA5 0.019 0.036 -10000 0 -0.53 2 2
Ephrin B2/EPHB4 0.027 0.019 -10000 0 -0.33 1 1
Ephrin B/EPHB2/Intersectin/N-WASP 0.015 0.034 -10000 0 -0.25 1 1
CDC42 0.022 0.004 -10000 0 -10000 0 0
RAS family/GTP -0.021 0.021 -10000 0 -0.26 1 1
PTK2 0.026 0.13 0.55 31 -10000 0 31
MAP4K4 0.033 0.13 0.35 62 -0.29 1 63
SRC 0.022 0.004 -10000 0 -10000 0 0
KALRN 0.015 0.056 -10000 0 -0.53 5 5
Intersectin/N-WASP 0.032 0.008 -10000 0 -10000 0 0
neuron projection morphogenesis 0.015 0.1 0.29 46 -0.38 1 47
MAP2K1 0.013 0.038 0.24 1 -10000 0 1
WASL 0.022 0.004 -10000 0 -10000 0 0
Ephrin B1/EPHB1-2/NCK1 0.057 0.05 0.28 2 -0.31 1 3
cell migration 0.012 0.072 0.29 7 -10000 0 7
NRAS 0.022 0.005 -10000 0 -10000 0 0
SYNJ1 -0.011 0.026 0.2 1 -0.28 1 2
PXN 0.023 0.002 -10000 0 -10000 0 0
TF -0.015 0.039 0.18 6 -0.28 5 11
HRAS/GTP 0.04 0.037 -10000 0 -0.26 2 2
Ephrin B1/EPHB1-2 0.054 0.056 0.24 18 -0.31 1 19
cell adhesion mediated by integrin -0.02 0.051 0.29 1 -0.21 4 5
RAC1 0.022 0.004 -10000 0 -10000 0 0
mol:GTP 0.044 0.042 -10000 0 -0.28 2 2
RAC1-CDC42/GTP -0.015 0.023 -10000 0 -0.26 2 2
RASA1 0.021 0.006 -10000 0 -10000 0 0
RAC1-CDC42/GDP -0.031 0.087 -10000 0 -0.29 4 4
ruffle organization 0.009 0.082 0.35 9 -10000 0 9
NCK1 0.019 0.008 -10000 0 -10000 0 0
receptor internalization -0.014 0.026 0.2 1 -0.27 1 2
Ephrin B/EPHB2/KALRN 0.051 0.051 -10000 0 -0.29 6 6
ROCK1 0.07 0.094 0.18 209 -10000 0 209
RAS family/GDP -0.043 0.047 -10000 0 -0.26 1 1
Rac1/GTP -0.02 0.023 -10000 0 -0.27 2 2
Ephrin B/EPHB1/Src/Paxillin 0.019 0.042 -10000 0 -0.25 1 1
IL27-mediated signaling events

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.024 0.007 -10000 0 -10000 0 0
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.012 0.093 0.42 8 -10000 0 8
IL27/IL27R/JAK1 0.028 0.085 -10000 0 -10000 0 0
TBX21 -0.046 0.15 -10000 0 -0.48 38 38
IL12B 0.019 0.012 -10000 0 -10000 0 0
IL12A -0.002 0.043 -10000